<!DOCTYPE html> <html lang = "en">
 <body>

<h2>Pubmed_ID: 33046114</h2>

<h3>Early-life gut dysbiosis linked to juvenile mortality in ostriches</h3>

<h3>早期生活中的肠道营养不良与鸵鸟的青少年死亡率有关</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1186/s40168-020-00925-7</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/33046114/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Microbiome  {'ISSN': '2049-2618', 'Name': 'microbiome', '2015': '9', '2016': '9.133', '2017': '9.133', '2018': '10.465', '2019': '11.607'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 10/12/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Background: Imbalances in the gut microbial community (dysbiosis) of vertebrates have been associated with several gastrointestinal and autoimmune diseases. However, it is unclear which taxa are associated with gut dysbiosis, and if particular gut regions or specific time periods during ontogeny are more susceptible. We also know very little of this process in non-model organisms, despite an increasing realization of the general importance of gut microbiota for health. Methods: Here, we examine the changes that occur in the microbiome during dysbiosis in different parts of the gastrointestinal tract in a long-lived bird with high juvenile mortality, the ostrich (Struthio camelus). We evaluated the 16S rRNA gene composition of the ileum, cecum, and colon of 68 individuals that died of suspected enterocolitis during the first 3 months of life (diseased individuals), and of 50 healthy individuals that were euthanized as age-matched controls. We combined these data with longitudinal environmental and fecal sampling to identify potential sources of pathogenic bacteria and to unravel at which stage of development dysbiosis-associated bacteria emerge. Results: Diseased individuals had drastically lower microbial alpha diversity and differed substantially in their microbial beta diversity from control individuals in all three regions of the gastrointestinal tract. The clear relationship between low diversity and disease was consistent across all ages in the ileum, but decreased with age in the cecum and colon. Several taxa were associated with mortality (Enterobacteriaceae, Peptostreptococcaceae, Porphyromonadaceae, Clostridium), while others were associated with health (Lachnospiraceae, Ruminococcaceae, Erysipelotrichaceae, Turicibacter, Roseburia). Environmental samples showed no evidence of dysbiosis-associated bacteria being present in either the food, water, or soil substrate. Instead, the repeated fecal sampling showed that pathobionts were already present shortly after hatching and proliferated in individuals with low microbial diversity, resulting in high mortality several weeks later. Conclusions: Identifying the origins of pathobionts in neonates and the factors that subsequently influence the establishment of diverse gut microbiota may be key to understanding dysbiosis and host development. Video Abstract.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 背景：脊椎动物肠道微生物群落的失衡（营养不良）与多种胃肠道和自身免疫性疾病有关。但是，尚不清楚哪些分类单元与肠道营养不良有关，以及个体发育过程中特定的肠道区域或特定时间段是否更易感。尽管人们越来越意识到肠道菌群对健康的重要性，但我们在非模式生物中对这一过程的了解却很少。方法：在这里，我们检查了一只长寿的，具有高幼体死亡率的鸵鸟（鸵鸟（Struthiocamelus））在胃肠道不同部位营养不良期间微生物组中的变化。我们评估了生命的前三个月死于可疑小肠结肠炎的68名个体（患病的个体）和被安乐死作为年龄匹配的对照的50名健康个体的回肠，盲肠和结肠的16SrRNA基因组成。我们将这些数据与纵向环境和粪便采样相结合，以确定潜在的病原细菌来源，并揭示与发育不良相关的细菌出现的哪个阶段。结果：患病个体在胃肠道所有三个区域的微生物α多样性都大大降低，并且其微生物β多样性与对照个体大不相同。回肠的所有年龄段中，多样性低下与疾病之间的明确关系是一致的，但盲肠和结肠中的年龄则随着年龄的增长而降低。几种分类单位与死亡率有关（肠杆菌科，Peptostreptococcaceae，卟啉单胞菌科，梭状芽孢杆菌），而其他分类单位与健康有关（Lachnospiraceae，Ruminococcaceae，Erysipelotrichaceaceae，Turicibacter，Roseburia）。环境样品没有证据表明食物，水或土壤基质中存在与营养不良相关的细菌。取而代之的是，重复的粪便采样显示病原体在孵化后不久就已经存在，并且在微生物多样性低的个体中扩散，导致数周后死亡率很高。结论：确定新生儿病态交感神经的起源以及随后影响多种肠道菌群建立的因素，可能是了解营养不良和宿主发育的关键。录像摘要。</p>

<h2>Pubmed_ID: 33043833</h2>

<h3>The early life education of the immune system: Moms, microbes and (missed) opportunities</h3>

<h3>免疫系统的早期生命教育：妈妈，微生物和（错过的）机会</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1824564</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/33043833/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 10/12/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: The early life immune system is characterized by unique developmental milestones. Functionally diverse immune cells arise from distinct waves of hematopoietic stem cells, a phenomenon referred to as 'layered' immunity. This stratified development of immune cells extends to lineages of both innate and adaptive cells. The defined time window for the development of these immune cells lends itself to the influence of specific exposures typical of the early life period. The perinatal immune system develops in a relatively sterile fetal environment but emerges into one filled with a multitude of antigenic encounters. A major burden of this comes in the form of the microbiota that is being newly established at mucosal surfaces of the newborn. Accumulating evidence suggests that early life microbial exposures, including those arising in utero, can imprint long-lasting changes in the offspring's immune system and determine disease risk throughout life. In this review, I highlight unique features of early life immunity and explore the role of intestinal bacteria in educating the developing immune system.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 生命早期免疫系统具有独特的发展里程碑。功能多样的免疫细胞源于造血干细胞的独特波动，这种现象称为“分层”免疫。免疫细胞的这种分层发展扩展到先天和适应性细胞的谱系。这些免疫细胞发育的限定时间窗使其容易受到生命早期典型的特定暴露的影响。围产期免疫系统在相对无菌的胎儿环境中发育，但出现在充满大量抗原的环境中。这方面的主要负担来自在新生儿的粘膜表面新建立的微生物群的形式。越来越多的证据表明，生命早期的微生物暴露，包括在子宫内产生的微生物暴露，可以影响子代免疫系统的长期变化，并确定整个生命的疾病风险。在这篇综述中，我强调了早期生命免疫的独特特征，并探讨了肠道细菌在发展免疫系统中的作用。</p>

<h2>Pubmed_ID: 33040738</h2>

<h3>Ontogeny, species identity, and environment dominate microbiome dynamics in wild populations of kissing bugs (Triatominae)</h3>

<h3>在接吻臭虫的野生种群中，个体发育，物种特性和环境主导着微生物组的动力学（Triatominae）</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1186/s40168-020-00921-x</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/33040738/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Microbiome  {'ISSN': '2049-2618', 'Name': 'microbiome', '2015': '9', '2016': '9.133', '2017': '9.133', '2018': '10.465', '2019': '11.607'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 10/11/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Background: Kissing bugs (Triatominae) are blood-feeding insects best known as the vectors of Trypanosoma cruzi, the causative agent of Chagas' disease. Considering the high epidemiological relevance of these vectors, their biology and bacterial symbiosis remains surprisingly understudied. While previous investigations revealed generally low individual complexity but high among-individual variability of the triatomine microbiomes, any consistent microbiome determinants have not yet been identified across multiple Triatominae species. Methods: To obtain a more comprehensive view of triatomine microbiomes, we investigated the host-microbiome relationship of five Triatoma species sampled from white-throated woodrat (Neotoma albigula) nests in multiple locations across the USA. We applied optimised 16S rRNA gene metabarcoding with a novel 18S rRNA gene blocking primer to a set of 170 T. cruzi-negative individuals across all six instars. Results: Triatomine gut microbiome composition is strongly influenced by three principal factors: ontogeny, species identity, and the environment. The microbiomes are characterised by significant loss in bacterial diversity throughout ontogenetic development. First instars possess the highest bacterial diversity while adult microbiomes are routinely dominated by a single taxon. Primarily, the bacterial genus Dietzia dominates late-stage nymphs and adults of T. rubida, T. protracta, and T. lecticularia but is not present in the phylogenetically more distant T. gerstaeckeri and T. sanguisuga. Species-specific microbiome composition, particularly pronounced in early instars, is further modulated by locality-specific effects. In addition, pathogenic bacteria of the genus Bartonella, acquired from the vertebrate hosts, are an abundant component of Triatoma microbiomes. Conclusion: Our study is the first to demonstrate deterministic patterns in microbiome composition among all life stages and multiple Triatoma species. We hypothesise that triatomine microbiome assemblages are produced by species- and life stage-dependent uptake of environmental bacteria and multiple indirect transmission strategies that promote bacterial transfer between individuals. Altogether, our study highlights the complexity of Triatominae symbiosis with bacteria and warrant further investigation to understand microbiome function in these important vectors. Video abstract.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 背景：接吻臭虫（Triatominae）是食血昆虫，最常被称为恰加斯氏锥虫（查氏锥虫病的病原体）的媒介。考虑到这些载体在流行病学上的高度相关性，其生物学和细菌共生关系仍然令人惊讶地未被研究。尽管先前的研究表明三聚体微生物群的个体复杂度普遍较低，但个体间变异性较高，但尚未在多个三角藻物种中鉴定出任何一致的微生物组决定因素。方法：为了更全面地了解三藻类微生物群，我们调查了在美国多个地方的白喉伍德拉特（Neotomaalbigula）巢中采样的五个Triatoma物种的宿主-微生物组关系。我们将新颖的18SrRNA基因封闭引物应用于优化的16SrRNA基因metabarcoding，将其应用于所有6龄幼虫中的170例克鲁氏阴性个体。结果：Triatomine肠道微生物组的组成受到三个主要因素的强烈影响：个体发育，物种身份和环境。微生物组的特征在于整个个体发育过程中细菌多样性的显着丧失。初生幼虫具有最高的细菌多样性，而成年微生物群通常由单一分类群控制。最初，细菌属Dietzia占了后期若虫和红斑锥虫，延绵线虫和圆角虫的成虫的主宰，但在系统发育上较远的T.gerstaeckeri和T.sanguisuga中却不存在。物种特异性的微生物组组成，尤其是在早期的幼龄期中特别明显，其通过位置特异性的作用进一步调节。另外，从脊椎动物宿主中获得的巴尔通体属的致病细菌是Triatoma微生物群落的丰富组成部分。结论：我们的研究首次证明了所有生命阶段和多种Triatoma物种之间微生物组组成的确定性模式。我们假设三atomine微生物组集合是由与物种和生命阶段有关的环境细菌摄取以及促进个体之间细菌转移的多种间接传播策略产生的。总的来说，我们的研究突出了与细菌共生的三角藻共生的复杂性，并有待于进一步研究以了解这些重要载体中的微生物组功能。录像摘要。</p>

<h2>Pubmed_ID: 33023370</h2>

<h3>A compromised developmental trajectory of the infant gut microbiome and metabolome in atopic eczema</h3>

<h3>特应性湿疹婴儿肠道微生物组和代谢组的发育轨迹受损</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1801964</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/33023370/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Evidence is accumulating that the establishment of the gut microbiome in early life influences the development of atopic eczema. In this longitudinal study, we used integrated multi-omics analyses to infer functional mechanisms by which the microbiome modulates atopic eczema risk. We measured the functionality of the gut microbiome and metabolome of 63 infants between ages 3 weeks and 12 months with well-defined eczema cases and controls in a sub-cohort from the Growing Up in Singapore Toward healthy Outcomes (GUSTO) mother-offspring cohort. At 3 weeks, the microbiome and metabolome of allergen-sensitized atopic eczema infants were characterized by an enrichment of Escherichia coli and Klebsiella pneumoniae, associated with increased stool D-glucose concentration and increased gene expression of associated virulence factors. A delayed colonization by beneficial Bacteroides fragilis and subsequent delayed accumulation of butyrate and propionate producers after 3 months was also observed. Here, we describe an aberrant developmental trajectory of the gut microbiome and stool metabolome in allergen sensitized atopic eczema infants. The infographic describes an impaired developmental trajectory of the gut microbiome and metabolome in allergen-sensitized atopic eczema (AE) infants and infer its contribution in modulating allergy risk in the Singaporean mother-offspring GUSTO cohort. The key microbial signature of AE is characterized by (1) an enrichment of Escherichia coli and Klebsiella pneumoniae which are associated with accumulation of pre-glycolysis intermediates (D-glucose) via the trehalose metabolic pathway, increased gene expression of associated virulence factors (invasin, adhesin, flagellin and lipopolysaccharides) by utilizing ATP from oxidative phosphorylation and delayed production of butyrate and propionate, (2) depletion of Bacteroides fragilis which resulted in lower expression of immunostimulatory bacterial cell envelope structure and folate (vitamin B9) biosynthesis pathway, and (3) accompanied depletion of bacterial groups with the ability to derive butyrate and propionate through direct or indirect pathways which collectively resulted in reduced glycolysis, butyrate and propionate biosynthesis.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 越来越多的证据表明，肠道菌群在早期的建立会影响特应性湿疹的发展。在这项纵向研究中，我们使用综合的多组学分析来推断微生物组调节特应性湿疹风险的功能机制。我们测量了63名年龄在3周至12个月之间的婴儿的肠道微生物组和代谢组的功能，这些婴儿有明确的湿疹病例和对照组，来自新加坡从成年迈向健康结果（GUSTO）母子队列。在3周时，变应原致敏性特应性湿疹婴儿的微生物组和代谢组的特征是大肠杆菌和肺炎克雷伯菌的富集，与粪便D-葡萄糖浓度增加和相关毒力因子的基因表达增加有关。还观察到了有益的脆弱拟杆菌拟定的定居延迟，以及随后三个月后丁酸和丙酸酯生产者的蓄积延迟。在这里，我们描述了过敏原致敏性特应性湿疹婴儿肠道微生物组和粪便代谢组的异常发育轨迹。信息图描述了过敏原致敏性特应性湿疹（AE）婴儿肠道微生物组和代谢组的发育轨迹受损，并推断了其在调节新加坡母亲后代GUSTO队列中的过敏风险中的作用。AE的关键微生物特征是（1）大肠杆菌和肺炎克雷伯菌的富集，它们通过海藻糖代谢途径与糖原分解中间体（D-葡萄糖）的积累有关，相关毒力因子（入侵素）的基因表达增加，粘附素，鞭毛蛋白和脂多糖），利用氧化磷酸化作用的ATP以及丁酸和丙酸的延迟生产；（2）脆弱拟杆菌的耗尽，导致免疫刺激性细菌细胞膜结构和叶酸（维生素B9）生物合成途径的表达降低；3）伴随着细菌群体的耗竭，其具有通过直接或间接途径获得丁酸酯和丙酸酯的能力，这些途径共同导致糖酵解，丁酸酯和丙酸酯的生物合成减少。</p>

<h2>Pubmed_ID: 33016221</h2>

<h3>Targeting the gut microbial metabolic pathway with small molecules decreases uremic toxin production</h3>

<h3>用小分子靶向肠道微生物代谢途径可减少尿毒症毒素的产生</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1823800</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/33016221/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Uremic toxins are a class of toxins that accumulate in patients with chronic kidney disease (CKD). Indoxyl sulfate (IS), a typical uremic toxin, is not efficiently removed by hemodialysis. Modulation of IS production in the gut microbiota may be a promising strategy for decreasing IS concentration, thus, delaying CKD progression. In the present study, we identified isoquercitrin (ISO) as a natural product that can perturb microbiota-mediated indole production without directly inhibiting the growth of microbes or the indole-synthesizing enzyme TnaA. ISO inhibits the establishment of H proton potential by regulating the gut bacteria electron transport chain, thereby inhibiting the transport of tryptophan and further reducing indole biosynthesis. This non-microbiocidal mechanism may enable ISO to be used as a therapeutic tool, specifically against pathologies triggered by the accumulation of the microbial-produced toxin IS, as in CKD. Herein, we have shown that it is possible to inhibit gut microbial indole production using natural components. Therefore, targeting the uremic toxin metabolic pathway in gut bacteria may be a promising strategy to control host uremic toxin production.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 尿毒症毒素是在慢性肾脏病（CKD）患者中累积的一类毒素。硫酸吲哚酚（IS）是一种典型的尿毒症毒素，不能通过血液透析有效地去除。肠道菌群中IS产生的调节可能是降低IS浓度从而延迟CKD进展的一种有前途的策略。在本研究中，我们将异槲皮苷（ISO）鉴定为天然产物，它可以干扰微生物群介导的吲哚生产，而又不直接抑制微生物或吲哚合成酶TnaA的生长。ISO通过调节肠道细菌电子传输链来抑制H质子势的建立，从而抑制色氨酸的传输并进一步减少吲哚的生物合成。这种非微生物杀灭机制可以使ISO用作治疗工具，特别是针对由微生物产生的毒素IS积累引起的病理，如CKD。在本文中，我们已经表明可以使用天然成分抑制肠道微生物吲哚的产生。因此，靶向肠道细菌中的尿毒症毒素代谢途径可能是控制宿主尿毒症毒素产生的有前途的策略。</p>

<h2>Pubmed_ID: 33016202</h2>

<h3>Lactobacillus paracasei KBL382 administration attenuates atopic dermatitis by modulating immune response and gut microbiota</h3>

<h3>副干酪乳杆菌KBL382的给药通过调节免疫应答和肠道菌群来减轻特应性皮炎</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1819156</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/33016202/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Administration of probiotics has been linked to immune regulation and changes in gut microbiota composition, with effects on atopic dermatitis (AD). In this study, we investigated amelioration of the symptoms of AD using Lactobacillus paracasei KBL382 isolated from the feces of healthy Koreans. Mice with Dermatophagoides farinae extract (DFE)-induced AD were fed 1 × 109 CFU d-1 of L. paracasei KBL382 for 4 weeks. Oral administration of L. paracasei KBL382 significantly reduced AD-associated skin lesions, epidermal thickening, serum levels of immunoglobulin E, and immune cell infiltration. L. paracasei KBL382-treated mice showed decreased production of T helper (Th)1-, Th2-, and Th17-type cytokines, including thymic stromal lymphopoietin, thymus, and activation-regulated chemokine, and macrophage-derived chemokine, and increased production of the anti-inflammatory cytokine IL-10 and transforming growth factor-β in skin tissue. Intake of L. paracasei KBL382 also increased the proportion of CD4+ CD25+ Foxp3+ regulatory T cells in mesenteric lymph nodes. In addition, administration of L. paracasei KBL382 dramatically changed the composition of gut microbiota in AD mice. Administration of KBL382 significantly ameliorates AD-like symptoms by regulating the immune response and altering the composition of gut microbiota.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 益生菌的给药与免疫调节和肠道菌群组成的变化有关，对特应性皮炎（AD）有影响。在这项研究中，我们调查了从健康韩国人粪便中分离到的副干酪乳杆菌KBL382对AD症状的缓解作用。将具有法氏皮肤癣菌提取物（DFE）诱导的AD的小鼠喂食1×109CFUd-1副干酪乳杆菌KBL382，持续4周。口服副干酪乳杆菌KBL382可显着减少AD相关的皮肤病变，表皮增厚，血清免疫球蛋白E水平和免疫细胞浸润。用副干酪乳杆菌KBL382处理的小鼠显示T辅助（Th）1-，Th2-和Th17型细胞因子的产量降低，包括胸腺基质淋巴细胞生成素，胸腺和活化调节趋化因子以及巨噬细胞衍生的趋化因子，并增加了产量皮肤组织中抗炎细胞因子IL-10和转化生长因子-β的表达副干酪乳杆菌KBL382的摄入也增加了肠系膜淋巴结中CD4+CD25+Foxp3+调节性T细胞的比例。另外，副干酪乳杆菌KBL382的施用显着改变了AD小鼠中肠道菌群的组成。通过调节免疫应答和改变肠道菌群的组成，KBL382的使用可显着改善AD样症状。</p>

<h2>Pubmed_ID: 33006494</h2>

<h3>Gut microbial bile acid metabolite skews macrophage polarization and contributes to high-fat diet-induced colonic inflammation</h3>

<h3>肠道微生物的胆汁酸代谢物使巨噬细胞偏斜，并导致高脂饮食引起的结肠炎症</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1819155</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/33006494/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: High-fat diet (HFD) leads to systemic low-grade inflammation, which has been involved in the pathogenesis of diverse metabolic and inflammatory diseases. Colon is thought to be the first organ suffering from inflammation under HFD conditions due to the pro-inflammatory macrophages infiltration, however, the mechanisms concerning the induction of pro-inflammatory phenotype of colonic macrophages remains unclear. In this study, we show that HFD increased the percentage of gram-positive bacteria, especially genus Clostridium, and resulted in the significant increment of fecal deoxycholic acid (DCA), a gut microbial metabolite produced by bacteria mainly restricted to genus Clostridium. Notably, reducing gram-positive bacteria with vancomycin diminished fecal DCA and profoundly alleviated pro-inflammatory macrophage infiltration in colon, whereas DCA-supplemented feedings to vancomycin-treated mice provoked obvious pro-inflammatory macrophage infiltration and colonic inflammation. Meanwhile, intra-peritoneal administration of DCA also elicited considerable recruitment of macrophages with pro-inflammatory phenotype. Mechanistically, DCA dose-dependently promoted M1 macrophage polarization and pro-inflammatory cytokines production at least partially through toll-like receptor 2 (TLR2) transactivated by M2 muscarinic acetylcholine receptor (M2-mAchR)/Src pathway. In addition, M2-mAchR mediated increase of TLR2 transcription was mainly achieved via targeting AP-1 transcription factor. Moreover, NF-κB/ERK/JNK signalings downstream of TLR2 are involved in the DCA-induced macrophage polarization. In conclusion, our findings revealed that high level DCA induced by HFD may serve as an initiator to activate macrophages and drive colonic inflammation, thus offer a mechanistic basis that modulation of gut microbiota or intervening specific bile acid receptor signaling could be potential therapeutic approaches for HFD-related inflammatory diseases.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 高脂饮食（HFD）会导致全身性低度炎症，该炎症已参与各种代谢性疾病和炎症性疾病的发病机理。由于促炎性巨噬细胞浸润，结肠被认为是在HFD条件下遭受炎症的第一器官，但是，关于诱导结肠巨噬细胞促炎表型的机制仍不清楚。在这项研究中，我们表明，HFD增加了革兰氏阳性细菌（尤其是梭状芽胞杆菌属）的百分比，并导致粪便脱氧胆酸（DCA）显着增加，粪便脱氧胆酸（一种主要由梭状芽胞杆菌属产生的细菌产生的肠道微生物代谢产物）。值得注意的是，用万古霉素减少革兰氏阳性菌可减少粪便DCA并显着减轻结肠中促炎性巨噬细胞浸润，而DCA补充给万古霉素治疗的小鼠喂食会引起明显的促炎性巨噬细胞浸润和结肠炎症。同时，腹膜内给予DCA也引起具有促炎表型的巨噬细胞大量募集。从机制上讲，DCA剂量依赖性地至少部分地通过由M2毒蕈碱乙酰胆碱受体（M2-mAchR）/Src途径反式激活的收费样受体2（TLR2）来促进M1巨噬细胞极化和促炎细胞因子的产生。此外，M2-mAchR介导的TLR2转录增加主要是通过靶向AP-1转录因子来实现的。此外，TLR2下游的NF-κB/ERK/JNK信号与DCA诱导的巨噬细胞极化有关。总之，我们的研究结果表明，HFD诱导的高水平DCA可能作为激活巨噬细胞和驱动结肠炎症的引发剂，因此为调节肠道微生物群或干预特定胆汁酸受体信号传导可能是HFD的潜在治疗方法提供了机制基础。相关的炎性疾病。</p>

<h2>Pubmed_ID: 32991827</h2>

<h3>Relationship between gut environment, feces-to-food ratio, and androgen deficiency-induced metabolic disorders</h3>

<h3>肠道环境，粪便与食物的比例以及雄激素缺乏引起的代谢紊乱之间的关系</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1817719</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32991827/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Androgen action generates sex-related differences that include changes in the gut microbiota composition. Hypoandrogenism and hyperandrogenism in males and females, respectively, are associated with the prevalence of metabolic disorders. Our recent work showed that male androgen receptor knockout (ARKO) mice developed high-fat diet (HFD)-dependent sarcopenic abdominal obesity, hyperglycemia, and hepatic steatosis, leading to early death. The ARKO mice also exhibited alterations in intestinal microbiota but did not experience metabolic abnormalities when administered with antibiotics. Here, we show that time-dependent changes in feed efficiency (ratio of body weight gain to food intake) and weight of dried feces-to-food ratio could be good markers for changes in gut microbiota. Turicibacter spp., Lactobacillus spp., and L. reuteri increased in the gut in both HFD-fed ARKO and castrated mice having metabolic abnormalities. HFD-fed ARKO mice showed increased plasma levels of aspartate, but not alanine, aminotransferase. Changes in the gut microbiome appear to provoke androgen deficiency-induced metabolic diseases, leading to early mortality.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 雄激素作用产生与性别有关的差异，其中包括肠道菌群组成的变化。男性和女性的低雄激素血症和高雄激素血症分别与代谢紊乱的患病率有关。我们最近的工作表明，雄性雄激素受体敲除（ARKO）小鼠发展了高脂饮食（HFD）依赖性肌肉减少性腹部肥胖，高血糖症和肝脂肪变性，导致早期死亡。给予抗生素后，ARKO小鼠的肠道菌群也表现出变化，但未出现代谢异常。在这里，我们表明饲料效率（体重增加与食物摄入的比率）和干粪与食物的重量比随时间的变化可能是肠道菌群变化的良好标志。在由HFD喂养的ARKO和具有代谢异常的cast割小鼠中，肠道中的杆菌杆菌属，乳杆菌属和罗伊氏乳杆菌均增加。用HFD喂养的ARKO小鼠血浆中的天冬氨酸水平升高，但丙氨酸转氨酶未升高。肠道微生物组的变化似乎引发了雄激素缺乏引起的代谢性疾病，导致了早期死亡。</p>

<h2>Pubmed_ID: 32991820</h2>

<h3>Long-term effects of antimicrobial drugs on the composition of the human gut microbiota</h3>

<h3>抗菌药物对人体肠道菌群组成的长期影响</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1791677</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32991820/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Introduction: Antimicrobial drugs are known to have effects on the human gut microbiota. We studied the long-term temporal relationship between several antimicrobial drug groups and the composition of the human gut microbiota determined in feces samples. Methods: Feces samples were obtained from a community-dwelling cohort of middle-aged and elderly individuals (Rotterdam Study). Bacterial DNA was isolated and sequenced using V3/V4 16 S ribosomal RNA sequencing (Illumina MiSeq). The time between the last prescription of several antimicrobial drug groups and the day of sampling was categorized into 0-12, 12-24, 24-48 and >48 months. The effects of the antimicrobial drug groups on the Shannon alpha-diversity (diversity), the Bray-Curtis beta-diversity (community structure), the Firmicutes/Bacteroidetes (F/B) ratio and individual genera were determined. Results: We studied the gut microbiota of 1413 individuals (57.5% female, median age 62.6 years). The alpha-diversity was significantly lower up to 4 years after prescriptions of macrolides and lincosamides. It was also lower in the first year after the use of beta-lactams. The community structure (beta-diversity) of the microbiota was significantly different up to 4 years for macrolides and lincosamides, the first year for beta-lactams and at least the first year for quinolones. For the F/B ratio, drugs with a high anaerobic activity shifted the ratio toward Firmicutes in the first year whereas other antimicrobial drugs shifted the ratio toward Bacteroidetes. Conclusion: Use of antimicrobial drugs is associated with a shift in the composition of the gut microbiota.These effects differ in strength and duration, depending on the antimicrobial drug group used. These findings should be considered when prescribing antimicrobial drugs.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 简介：抗菌药物对人体肠道菌群有影响。我们研究了几种抗菌药物组与粪便样品中确定的人类肠道菌群组成之间的长期时间关系。方法：粪便样本取自中老年人的一个社区居民队列（鹿特丹研究）。分离细菌DNA，并使用V3/V416S核糖体RNA测序（IlluminaMiSeq）进行测序。从几种抗菌药物的最后一次处方到取样之日的时间分为0-12个月，12-24、24-48和>48个月。确定了抗菌药物组对香农α-多样性（多样性），Bray-Curtisβ-多样性（社区结构），硬毛虫/拟杆菌（F/B）比和个体属的影响。结果：我们研究了1413个人（女性57.5％，中位年龄62.6岁）的肠道菌群。开处方大环内酯类和林可酰胺类药物后的4年内，α多样性显着降低。使用β-内酰胺类药物后的第一年这一比例也较低。大环内酯类和林可酰胺类的微生物群的群落结构（β-多样性）在4年内显着不同，β-内酰胺类在第一年，而喹诺酮类在至少一年。对于F/B比率，具有高厌氧活性的药物在第一年就将比率朝着Firmicutes转移，而其他抗菌药物将比率朝着拟杆菌转变。结论：抗菌药物的使用与肠道菌群组成的改变有关，这些作用的强度和持续时间各不相同，具体取决于所使用的抗菌药物组。处方抗菌药物时应考虑这些发现。</p>

<h2>Pubmed_ID: 32991818</h2>

<h3>Effects of fecal microbiota transplantation in subjects with irritable bowel syndrome are mirrored by changes in gut microbiome</h3>

<h3>肠道微生物组的变化反映出肠道微生物群粪便微生物群移植的效果</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1794263</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32991818/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Irritable bowel syndrome (IBS) is a common disorder of the lower gastrointestinal tract. The pathophysiology is far from settled, but a gut microbial dysbiosis is hypothesized to be a contributing factor. We earlier published a randomized double-blind placebo-controlled clinical trial on fecal microbiota transplantation (FMT) for IBS - the REFIT trial. The present data set describes the engraftment and includes participants from the study who received active FMT; 14 participants with effect of FMT (Effect) and 8 without (No effect). Samples were collected at baseline, after 6 and 12 months. Samples from the transplants (Donor) served as a comparator. In total 66 recipient samples and 17 donor samples were subjected to deep metagenomic sequencing, and taxonomic and functional analyses were performed. Alpha diversity measures showed a significantly increased diversity and evenness in the IBS groups compared to the donors. Taxonomic profiles showed higher relative abundance of phylum Firmicutes, and lower relative abundance of phylum Bacteroidetes, compared to donors at baseline. This profile was shifted toward the donor profile following FMT. Imputed growth rates showed that the resulting growth pattern was a conglomerate of donor and recipient activity. Thirty-four functional subclasses showed distinct differences between baseline samples and donors, most of which were shifted toward a donor-like profile after FMT. All of these changes were less pronounced in the No effect group. We conclude that FMT induces long-term changes in gut microbiota, and these changes mirror the clinical effect of the treatment. The study was registered in ClinicalTrials.gov (NCT02154867).</p>

<p style="line-height:1.8;margin:20px"> 摘要: 肠易激综合症（IBS）是下消化道的常见疾病。病理生理学还远未解决，但是假设肠道微生物营养不良是其中的一个促成因素。我们之前针对IBS的粪便微生物群移植（FMT）发表了一项随机双盲安慰剂对照临床试验-REFIT试验。本数据集描述了移植物，并包括接受主动FMT的研究参与者。FMT有效的参与者14位（有效），而FMT有效的参与者8位（无效果）。6和12个月后在基线时收集样品。来自移植物（供体）的样品用作比较物。总共对66个受体样品和17个供体样品进行了深度宏基因组测序，并进行了分类和功能分析。与捐献者相比，IBS组的Alpha多样性测算表明其多样性和均匀性显着提高。与基线时的供体相比，分类学特征显示硬毛门的相对丰度较高，而拟杆菌门的相对丰度较低。在FMT之后，此配置文件已朝供体配置文件转移。推定的增长率表明，最终的增长模式是捐助者和接受者活动的综合体。34个功能亚类显示出基线样品和供体之间的明显差异，其中大多数在FMT后转向了类似供体的特征。在无效组中，所有这些变化都不太明显。我们得出的结论是，FMT会引起肠道菌群的长期变化，而这些变化反映了该疗法的临床效果。该研究已在ClinicalTrials.gov（NCT02154867）中进行了注册。</p>

<h2>Pubmed_ID: 32991816</h2>

<h3>Changes in dietary fiber intake in mice reveal associations between colonic mucin O-glycosylation and specific gut bacteria</h3>

<h3>小鼠膳食纤维摄入量的变化揭示了结肠粘蛋白O-糖基化与特定肠道细菌之间的关联</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1802209</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32991816/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: The colonic mucus layer, comprised of highly O-glycosylated mucins, is vital to mediating host-gut microbiota interactions, yet the impact of dietary changes on colonic mucin O-glycosylation and its associations with the gut microbiota remains unexplored. Here, we used an array of omics techniques including glycomics to examine the effect of dietary fiber consumption on the gut microbiota, colonic mucin O-glycosylation and host physiology of high-fat diet-fed C57BL/6J mice. The high-fat diet group had significantly impaired glucose tolerance and altered liver proteome, gut microbiota composition, and short-chain fatty acid production compared to normal chow diet group. While dietary fiber inclusion did not reverse all high fat-induced modifications, it resulted in specific changes, including an increase in the relative abundance of bacterial families with known fiber digesters and a higher propionate concentration. Conversely, colonic mucin O-glycosylation remained similar between the normal chow and high-fat diet groups, while dietary fiber intervention resulted in major alterations in O-glycosylation. Correlation network analysis revealed previously undescribed associations between specific bacteria and mucin glycan structures. For example, the relative abundance of the bacterium Parabacteroides distasonis positively correlated with glycan structures containing one terminal fucose and correlated negatively with glycans containing two terminal fucose residues or with both an N-acetylneuraminic acid and a sulfate residue. This is the first comprehensive report of the impact of dietary fiber on the colonic mucin O-glycosylation and associations of these mucosal glycans with specific gut bacteria.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 结肠粘液层由高度O-糖基化的粘蛋白组成，对于介导宿主-肠道微生物区系的相互作用至关重要，但饮食变化对结肠粘蛋白O-糖基化及其与肠道菌群的关系的影响尚待探索。在这里，我们使用了包括糖组学在内的多种组学技术，研究了膳食纤维消耗对高脂饮食喂养的C57BL/6J小鼠肠道微生物群，结肠粘蛋白O-糖基化和宿主生理的影响。与正常食物相比，高脂饮食组的葡萄糖耐量明显受损，肝脏蛋白质组，肠道菌群组成和短链脂肪酸产生发生了改变。尽管膳食纤维的加入并不能逆转所有由高脂肪引起的修饰，但它导致了特定的变化，包括已知纤维消化物的细菌家族的相对丰度增加和丙酸盐浓度更高。相反，正常饮食和高脂饮食组之间的结肠粘蛋白O-糖基化仍然相似，而膳食纤维干预导致O-糖基化发生重大变化。相关网络分析显示以前未描述的特定细菌和粘蛋白聚糖结构之间的关联。例如，副细菌副杆菌的相对丰度与含有一个末端岩藻糖的聚糖结构正相关，而与含有两个末端岩藻糖残基的聚糖或N-乙酰神经氨酸和硫酸盐残基呈负相关。这是关于膳食纤维对结肠粘蛋白O-糖基化以及这些粘膜聚糖与特定肠道细菌的关联的影响的第一份综合报告。</p>

<h2>Pubmed_ID: 32985923</h2>

<h3>Metagenomic analysis reveals distinct patterns of gut lactobacillus prevalence, abundance, and geographical variation in health and disease</h3>

<h3>元基因组分析揭示了肠道乳酸菌在健康和疾病中的普遍性，丰富度和地理差异的独特模式</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1822729</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32985923/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Lactobacilli are exploited extensively for food fermentation and biotechnology. Some food and gut isolates have been developed as probiotics, for which species that may be commensal to the human host are considered desirable. However, the robustness of defining original niches for lactobacilli - food, environment, the gut - is questionable, and culture-independent analyses of prevalence in different human populations is lacking. Here we analyzed the abundance of lactobacilli in 6,154 subjects from a database of highly curated fecal shotgun metagenomics data spanning 25 nationalities, with ages ranging from infancy to 102 years. Twenty-five species were detected, which we assigned into low, medium, and high prevalence groups. The microbiome of apparently healthy individuals could be categorized into 6 clusters or Lactobacillotypes (LbTypes), with three of the Lbtypes being dominated by L. delbrueckii, L. ruminis, L. casei, and the other three comprising a combination of different species. These Lactobacillus clusters exhibit distinct global abundance patterns. The cluster prevalences also display distinct age-specific trends influenced by geography, with overall lactobacillus prevalence increasing significantly with age in North America and Europe but declining with age in non-Westernized societies. Regression analysis stratified by regional location identified distinct associations of the Lactobacillotypes with age, BMI, and gender. Cirrhosis, fatty-liver, , IBD and T2D were characterized by net gain of lactobacilli, whereas hypertension patients harbored depleted lactobacillus levels. Collectively these data indicate that the species abundance of gut lactobacilli is moderated by geography, diet, and interaction with the whole microbiome, and has strong interactions with diseases associated with a western lifestyle.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 乳酸杆菌被广泛用于食品发酵和生物技术。已经开发了一些食物和肠道分离物作为益生菌，对于这些食物和肠道分离物，人们认为它们可能与人类宿主相称。然而，为乳杆菌定义原始壁ni（食物，环境，肠道）的鲁棒性值得怀疑，并且缺乏对不同人群中流行率的文化独立分析。在这里，我们分析了来自25个民族，年龄从婴儿期到102岁的高度粪便shot弹枪宏基因组学数据的数据库中的6154名受试者的乳酸杆菌含量。检测到二十五个物种，我们将其分为低，中和高患病率组。看起来健康的个体的微生物组可以分为6个簇或乳杆菌型（LbType），其中三个Lb型由德氏乳杆菌，鲁米尼乳杆菌，干酪乳杆菌主导，另外三个由不同物种的组合组成。这些乳酸杆菌簇表现出独特的总体丰度模式。集群患病率还显示出受地理影响的特定年龄趋势，北美和欧洲的总体乳酸菌患病率随着年龄的增长而显着增加，而在非西方社会则随着年龄的增长而下降。通过区域位置分层的回归分析确定了乳杆菌型与年龄，BMI和性别之间的明显不同。肝硬化，脂肪肝，IBD和T2D的特征是乳酸菌的净增加，而高血压患者的乳酸菌水平却降低了。这些数据共同表明，肠道乳酸菌的物种丰富度受地理，饮食和与整个微生物组的相互作用的调节，并且与与西方生活方式有关的疾病具有强烈的相互作用。</p>

<h2>Pubmed_ID: 32985336</h2>

<h3>Bacteriophage endolysins as a potential weapon to combat Clostridioides difficile infection</h3>

<h3>噬菌体溶菌素可作为抵抗艰难梭菌感染的潜在武器</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1813533</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32985336/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Clostridioides difficile is the leading cause of health-care-associated infection throughout the developed world and contributes significantly to patient morbidity and mortality. Typically, antibiotics are used for the primary treatment of C. difficile infections (CDIs), but they are not universally effective for all ribotypes and can result in antibiotic resistance and recurrent infection, while also disrupting the microbiota. Novel targeted therapeutics are urgently needed to combat CDI. Bacteriophage-derived endolysins are required to disrupt the bacterial cell wall of their target bacteria and are possible alternatives to antibiotics. These lytic proteins could potentially replace or augment antibiotics in CDI treatment. We discuss candidate therapeutic lysins derived from phages/prophages of C. difficile and their potential as antimicrobials against CDI. Additionally, we review the antibacterial potential of some recently identified homologues of C. difficile endolysins. Finally, the challenges of endolysins are considered with respect to the development of novel lysin-based therapies.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 艰难梭状芽胞杆菌是整个发达国家与卫生保健相关的感染的主要原因，对患者的发病率和死亡率有重要贡献。通常，抗生素用于艰难梭菌感染的初步治疗，但它们并非对所有核糖型均有效，并可能导致抗生素耐药性和反复感染，同时也破坏了微生物群。迫切需要新型靶向疗法来对抗CDI。噬菌体来源的溶菌素需要破坏其靶细菌的细菌细胞壁，并且可能是抗生素的替代品。这些裂解蛋白可能会在CDI治疗中替代或增强抗生素。我们讨论了源自艰难梭菌噬菌体/噬菌体的候选治疗性溶素及其作为抗CDI抗菌剂的潜力。此外，我们审查了艰难梭菌内溶素的一些最近鉴定的同源物的抗菌潜力。最后，关于基于溶素的新型疗法的发展，考虑了溶素的挑战。</p>

<h2>Pubmed_ID: 32985332</h2>

<h3>Prophylactic Faecalibacterium prausnitzii treatment prevents the acute breakdown of colonic epithelial barrier in a preclinical model of pelvic radiation disease</h3>

<h3>预防性Faecalibacterium prausnitzii治疗可防止盆腔放射疾病的临床前模型中结肠上皮屏障的急性破坏</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1812867</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32985332/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Every year, millions of people around the world benefit from radiation therapy to treat cancers localized in the pelvic area. Damage to healthy tissue in the radiation field can cause undesirable toxic effects leading to gastrointestinal complications called pelvic radiation disease. A change in the composition and/or function of the microbiota could contribute to radiation-induced gastrointestinal toxicity. In this study, we tested the prophylactic effect of a new generation of probiotic like Faecalibacterium prausnitzii (F. prausnitzii) on acute radiation-induced colonic lesions. Experiments were carried out in a preclinical model of pelvic radiation disease. Rats were locally irradiated at 29 Gray in the colon resulting in colonic epithelial barrier rupture. Three days before the irradiation and up to 3 d after the irradiation, the F. prausnitzii A2-165 strain was administered daily (intragastrically) to test its putative protective effects. Results showed that prophylactic F. prausnitzii treatment limits radiation-induced para-cellular hyperpermeability, as well as the infiltration of neutrophils (MPO+ cells) in the colonic mucosa. Moreover, F. prausnitzii treatment reduced the severity of the morphological change of crypts, but also preserved the pool of Sox-9+ stem/progenitor cells, the proliferating epithelial PCNA+ crypt cells and the Dclk1+/IL-25+ differentiated epithelial tuft cells. The benefit of F. prausnitzii was associated with increased production of IL-18 by colonic crypt epithelial cells. Thus, F. prausnitzii treatment protected the epithelial colonic barrier from colorectal irradiation. New-generation probiotics may be promising prophylactic treatments to reduce acute side effects in patients treated with radiation therapy and may improve their quality of life.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 每年，全世界有数百万人受益于放射疗法来治疗骨盆区域的局部癌症。辐射场中对健康组织的损害会导致不良的毒性作用，导致胃肠道并发症，称为骨盆辐射症。微生物群的组成和/或功能的变化可能会导致辐射诱发的胃肠道毒性。在这项研究中，我们测试了新一代益生菌（如普氏嗜藻杆菌（F.prausnitzii））对急性辐射诱发的结肠病变的预防作用。实验是在盆腔放射疾病的临床前模型中进行的。在结肠以29Gray局部照射大鼠，导致结肠上皮屏障破裂。辐照前三天和辐照后最多3d，每天（胃内）施用F.prausnitziiA2-165菌株以测试其假定的保护作用。结果表明，预防性prausnitzii处理限制了辐射引起的细胞旁通透性过高，以及结肠黏膜中嗜中性粒细胞（MPO+细胞）的浸润。此外，F。prausnitzii处理降低了隐窝形态学改变的严重性，但还保留了Sox-9+干/祖细胞，增殖的上皮PCNA+隐窝细胞和Dclk1+/IL-25+分化的上皮簇状细胞池。F.prausnitzii的好处与结肠隐窝上皮细胞增加IL-18的产生有关。因此，F。prausnitzii处理可保护上皮结肠屏障免受大肠照射。新一代益生菌可能是有希望的预防性治疗方法，以减少接受放射治疗的患者的急性副作用，并可能改善其生活质量。</p>

<h2>Pubmed_ID: 32931352</h2>

<h3>Bacteria-related changes in host DNA methylation and the risk for CRC</h3>

<h3>细菌相关的宿主DNA甲基化变化和CRC风险</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1800898</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32931352/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Colorectal cancer (CRC) is the second most common cause of cancer deaths in men and women combined. Colon-tumor growth is multistage and the result of the accumulation of spontaneous mutations and epigenetic events that silence tumor-suppressor genes and activate oncogenes. Environmental factors are primary contributors to these somatic gene alterations, which account for the increase in incidence of CRC in western countries. In recent decades, gut microbiota and their metabolites have been recognized as essential contributing factors to CRC, and now serve as biomarkers for the diagnosis and prognosis of CRC. In the present review, we highlight holistic approaches to understanding how gut microbiota contributes to CRC. We particularly focus herein on bacteria-related changes in host DNA methylation and the risk for CRC.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 大肠癌（CRC）是男女死亡的第二大最常见癌症死亡原因。结肠肿瘤的生长是多阶段的，是自发突变和表观遗传事件积累的结果，这些突变使表皮抑制基因沉默并激活癌基因。环境因素是造成这些体细胞基因改变的主要因素，这导致西方国家CRC的发病率增加。近几十年来，肠道菌群及其代谢产物已被认为是CRC的重要促成因素，现在已成为CRC诊断和预后的生物标志物。在本综述中，我们重点介绍了整体方法，以了解肠道菌群如何促进CRC。我们在这里特别关注与细菌相关的宿主DNA甲基化变化和CRC风险。</p>

<h2>Pubmed_ID: 32915102</h2>

<h3>Growth rate alterations of human colorectal cancer cells by 157 gut bacteria</h3>

<h3>157种肠道细菌对人大肠癌细胞生长的影响</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1799733</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32915102/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Several bacteria in the human gut microbiome have been associated with colorectal cancer (CRC) by high-throughput screens. In some cases, molecular mechanisms have been elucidated that drive tumorigenesis, including bacterial membrane proteins or secreted molecules that interact with the human cancer cells. For most gut bacteria, however, it remains unknown if they enhance or inhibit cancer cell growth. Here, we screened bacteria-free supernatants (secretomes) and inactivated cells of over 150 cultured bacterial strains for their effects on cell growth. We observed family-level and strain-level effects that often differed between bacterial cells and secretomes, suggesting that different molecular mechanisms are at play. Secretomes of Bacteroidaceae, Enterobacteriaceae, and Erysipelotrichaceae bacteria enhanced cell growth, while most Fusobacteriaceae cells and secretomes inhibited growth, contrasting prior findings. In some bacteria, the presence of specific functional genes was associated with cell growth rates, including the virulence genes TcdA, TcdB in Clostridiales and FadA in Fusobacteriaceae, which both inhibited growth. Bacteroidaceae cells that enhanced growth were enriched for genes of the cobalamin synthesis pathway, while Fusobacteriaceae cells that inhibit growth were enriched for genes of the ethanolamine utilization pathway. Together, our results reveal how different gut bacteria have wide-ranging effects on cell growth, contribute a better understanding of the effects of the gut microbiome on host cells, and provide a valuable resource for identifying candidate target genes for potential microbiome-based diagnostics and treatment strategies.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 人类肠道微生物组中的几种细菌已通过高通量筛选与大肠癌（CRC）相关联。在某些情况下，已经阐明了驱动肿瘤发生的分子机制，包括细菌膜蛋白或与人癌细胞相互作用的分泌分子。但是，对于大多数肠道细菌而言，它们是否能增强或抑制癌细胞的生长仍是未知的。在这里，我们筛选了超过150种培养细菌菌株的无细菌上清液（分泌组）和失活的细胞对细胞生长的影响。我们观察到细菌细胞和分泌组之间常常有不同的家族水平和菌株水平影响，表明不同的分子机制在起作用。与以前的发现相反，细菌类杆菌科，肠杆菌科和刺梨科的细菌的分泌菌素增强了细胞的生长，而大多数融合杆菌科的细菌和分泌菌素抑制了细菌的生长。在某些细菌中，特定功能基因的存在与细胞生长速率相关，包括梭菌中的毒力基因TcdA，TcdB和梭菌科的FadA均抑制生长。钴胺素合成途径的基因富含能促进生长的拟杆菌科细胞，而乙醇胺利用途径的基因则富含抑制生长的细菌杆菌科细胞。总之，我们的结果揭示了不同的肠道细菌如何对细胞生长产生广泛影响，如何更好地理解肠道微生物组对宿主细胞的作用，并为鉴定潜在的基于微生物组的诊断方法和潜在目标基因提供了宝贵的资源。治疗策略。</p>

<h2>Pubmed_ID: 32900255</h2>

<h3>How oral probiotics affect the severity of an experimental model of progressive multiple sclerosis? Bringing commensal bacteria into the neurodegenerative process</h3>

<h3>口服益生菌如何影响进行性多发性硬化症实验模型的严重性？将共生细菌带入神经变性过程</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1813532</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32900255/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: A growing number of studies support that the bidirectional interactions between the gut microbiota, the immune system and the CNS are relevant for the pathophysiology of MS. Several studies have reported alterations in the gut microbiome of MS patients. In addition, a variety of studies in animal models of MS have suggested that specific members of the gut commensal microbiota can exacerbate or ameliorate neuroinflammation. Probiotics represent oral nontoxic immunomodulatory agents that would exert benefits when using in combination with current MS therapy. Here we investigate the effect of Vivomixx on the gut microbiome and central and peripheral immune responses in a murine model of primary progressive MS. Vivomixx administration was associated with increased abundance of many taxa such as Bacteroidetes, Actinobacteria, Tenericutes and TM7. This was accompanied by a clear improvement of the motor disability of Theiler's virus infected mice; in the CNS Vivomixx reduced microgliosis, astrogliosis and leukocyte infiltration. Notably, the presence of Breg cells (CD19+CD5+CD1dhigh) in the CNS was enhanced by Vivomixx, and while spinal cord gene expression of IL-1β and IL-6 was diminished, the probiotic promoted IL-10 gene expression. One of the most significant findings was the increased plasma levels of butyrate and acetate levels in TMEV-mice that received Vivomixx. Peripheral immunological changes were subtle but interestingly, the probiotic restricted IL-17 production by Th17-polarized CD4+ T-cells purified from the mesenteric lymph nodes of Theiler's virus infected mice. Our data reinforce the beneficial effects of oral probiotics that would be coadjuvant treatments to current MS therapies.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 越来越多的研究支持肠道微生物群，免疫系统和CNS之间的双向相互作用与MS的病理生理有关。几项研究报道了MS患者肠道微生物组的改变。此外，在多发性硬化症动物模型中的各种研究表明，肠道共生微生物群的特定成员可以加剧或减轻神经炎症。益生菌代表口服无毒免疫调节剂，当与当前的MS治疗结合使用时，将发挥作用。在这里，我们研究了原发进行性MS小鼠模型中Vivomixx对肠道微生物组以及中枢和外周免疫应答的影响。Vivomixx的施用与许多类群如拟杆菌，放线菌，Tenericutes和TM7的丰度增加有关。伴随着泰勒病毒感染小鼠运动障碍的明显改善。在中枢神经系统体内，Vivomixx减少了小胶质细胞减少，星形胶质细胞减少和白细胞浸润。值得注意的是，Vivomixx增强了CNS中Breg细胞（CD19+CD5+CD1dhigh）的存在，并且虽然减少了IL-1β和IL-6的脊髓基因表达，但益生菌促进了IL-10基因表达。最重要的发现之一是接受Vivomixx的TMEV小鼠血浆丁酸和乙酸盐水平升高。外周免疫学变化微妙，但有趣的是，益生菌限制了从泰勒病毒感染小鼠的肠系膜淋巴结中纯化的Th17极化CD4+T细胞产生的IL-17。我们的数据加强了口服益生菌的有益效果，这将是目前MS治疗的辅助治疗方法。</p>

<h2>Pubmed_ID: 32893721</h2>

<h3>Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent Clostridioides difficile infection and beyond: the contribution of gut microbial-derived metabolites</h3>

<h3>了解粪便微生物群移植物治疗复发性艰难梭菌及其他困难的功效机制：肠道微生物衍生的代谢产物的贡献</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1810531</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32893721/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Fecal microbiota transplant (FMT) is a highly-effective therapy for recurrent Clostridioides difficile infection (rCDI), and shows promise for certain non-CDI indications. However, at present, its mechanisms of efficacy have remained poorly understood. Recent studies by our laboratory have noted the particular key importance of restoration of gut microbe-metabolite interactions in the ability of FMT to treat rCDI, including the impact of FMT upon short chain fatty acid (SCFAs) and bile acid metabolism. This includes a significant impact of these metabolites upon the life cycle of C. difficile directly, along with potential postulated additional benefits, including effects upon host immune response. In this Addendum, we first present an overview of these recent advancements in this field, and then describe additional novel data from our laboratory on the impact of FMT for rCDI upon several gut microbial-derived metabolites which had not previously been implicated as being of relevance.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 粪便微生物菌群移植（FMT）是复发性艰难梭菌感染（rCDI）的高效疗法，对某些非CDI适应症显示出希望。然而，目前，其功效机制仍知之甚少。我们实验室最近的研究表明，肠道微生物与代谢物之间的相互作用恢复对FMT治疗rCDI的能力具有特别重要的意义，包括FMT对短链脂肪酸（SCFA）和胆汁酸代谢的影响。这包括这些代谢物直接对艰难梭菌的生命周期产生重大影响，以及潜在的假定附加利益，包括对宿主免疫反应的影响。在本附录中，我们首先概述了该领域的最新进展，然后描述了来自实验室的有关FMTforrCDI对几种肠道微生物衍生代谢产物的影响的其他新颖数据，这些数据以前没有被暗示具有相关性。。</p>

<h2>Pubmed_ID: 32893715</h2>

<h3>Impact and consequences of intensive chemotherapy on intestinal barrier and microbiota in acute myeloid leukemia: the role of mucosal strengthening</h3>

<h3>强化化疗对急性髓细胞性白血病肠道屏障和微生物群的影响和后果：粘膜强化作用</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1800897</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32893715/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Induction chemotherapy (7 + 3 regimen) remains the gold standard for patients with acute myeloid leukemia (AML) but is responsible for gut damage leading to several complications such as bloodstream infection (BSI). We aimed to investigate the impact of induction chemotherapy on the intestinal barrier of patients with AML and in wild-type mice. Next, we assessed the potential benefit of strengthening the mucosal barrier in transgenic mice releasing a recombinant protein able to reinforce the mucus layer (Tg222). In patients, we observed a decrease of plasma citrulline, which is a marker of the functional enterocyte mass, of short-chain fatty acids and of fecal bacterial load, except for Escherichia coli and Enterococcus spp., which became dominant. Both the α and β-diversities of fecal microbiota decreased. In wild-type mice, citrulline levels decreased under chemotherapy along with an increase of E. coli and Enterococcus spp load associated with concomitant histologic impairment. By comparison with wild-type mice, Tg222 mice, 3 days after completing chemotherapy, had higher citrulline levels, a faster healing epithelium, and preserved α-diversity of their intestinal microbiota. This was associated with reduced bacterial translocations. Our results highlight the intestinal damage and the dysbiosis induced by the 7 + 3 regimen. As a proof of concept, our transgenic model suggests that strengthening the intestinal barrier is a promising approach to limit BSI and improve AML patients' outcome.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 诱导化疗（7+3方案）仍然是急性髓细胞性白血病（AML）患者的金标准，但会导致肠道受损，导致多种并发症，例如血流感染（BSI）。我们旨在研究诱导化疗对AML患者和野生型小鼠肠屏障的影响。接下来，我们评估了在释放能够增强粘液层（Tg222）的重组蛋白的转基因小鼠中增强粘膜屏障的潜在益处。在患者中，我们观察到血浆瓜氨酸的减少，而瓜氨酸是功能性肠上皮细胞质量，短链脂肪酸和粪便细菌负荷的标志物，但大肠杆菌和肠球菌属除外，这些占主导地位。粪便微生物群的α和β多样性均降低。在野生型小鼠中，瓜氨酸水平在化学疗法下下降，同时伴随组织学损害的大肠杆菌和肠球菌载量增加。与野生型小鼠相比，Tg222小鼠在完成化疗后3天具有较高的瓜氨酸水平，较快的上皮愈合，并保留了肠道菌群的α多样性。这与减少细菌易位有关。我们的结果强调了7+3方案引起的肠道损害和营养不良。作为概念的证明，我们的转基因模型表明加强肠屏障是限制BSI和改善AML患者预后的有前途的方法。</p>

<h2>Pubmed_ID: 32893709</h2>

<h3>Metabolite profiling reveals the interaction of chitin-glucan with the gut microbiota</h3>

<h3>代谢物分析揭示了几丁质-葡聚糖与肠道菌群的相互作用</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1810530</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32893709/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Dietary fibers are considered beneficial nutrients for health. Current data suggest that their interaction with the gut microbiota largely contributes to their physiological effects. In this context, chitin-glucan (CG) improves metabolic disorders associated with obesity in mice, but its effect on gut microbiota has never been evaluated in humans. This study explores the effect of a 3-week intervention with CG supplementation in healthy individuals on gut microbiota composition and bacterial metabolites. CG was given to healthy volunteers (n = 15) for three weeks as a supplement (4.5 g/day). Food diary, visual analog and Bristol stool form scales and a "quality of life" survey were analyzed. Among gut microbiota-derived metabolites, bile acids (BA), long- and short-chain fatty acids (LCFA, SCFA) profiling were assessed in stool samples. The gut microbiota (primary outcome) was analyzed by Illumina sequencing. A 3-week supplementation with CG is well tolerated in healthy humans. CG induces specific changes in the gut microbiota composition, with Eubacterium, Dorea and Roseburia genera showing the strongest regulation. In addition, CG increased bacterial metabolites in feces including butyric, iso-valeric, caproic and vaccenic acids. No major changes were observed for the fecal BA profile following CG intervention. In summary, our work reveals new potential bacterial genera and gut microbiota-derived metabolites characterizing the interaction between an insoluble dietary fiber -CG- and the gut microbiota.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 膳食纤维被认为对健康有益。当前数据表明它们与肠道菌群的相互作用在很大程度上促进了它们的生理作用。在这种情况下，几丁质-葡聚糖（CG）改善了与肥胖相关的小鼠代谢紊乱，但其对肠道菌群的作用尚未在人类中进行评估。这项研究探讨了在健康个体中进行为期3周的CG干预干预对肠道菌群组成和细菌代谢产物的影响。CG给予健康志愿者（n=15）三周作为补充（4.5g/天）。分析了食物日记，视觉类似物和布里斯托尔粪便形式量表以及“生活质量”调查。在肠道微生物群衍生的代谢产物中，对粪便样品中的胆汁酸（BA），长链和短链脂肪酸（LCFA，SCFA）进行了分析。通过Illumina测序分析肠道菌群（主要结局）。在健康的人中，对CG的3周补充剂耐受良好。CG诱导肠道菌群组成发生特定变化，其中Eubacterium，Dorea和Roseburia属显示出最强的调节作用。此外，CG增加了粪便中的细菌代谢产物，包括丁酸，等戊酸，己酸和痘苗酸。在CG干预后，未观察到粪便BA曲线的重大变化。总之，我们的工作揭示了新的潜在细菌属和肠道菌群衍生的代谢产物，这些代谢产物表征了不溶性膳食纤维-CG-和肠道菌群之间的相互作用。</p>

<h2>Pubmed_ID: 32887944</h2>

<h3>Activity-based cell sorting reveals responses of uncultured archaea and bacteria to substrate amendment</h3>

<h3>基于活动的细胞分选揭示了未培养的古细菌和细菌对底物修饰的反应</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1038/s41396-020-00749-1</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32887944/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: The ISME journal   ||| Not finding IF</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 2020 Nov</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Metagenomic studies have revolutionized our understanding of the metabolic potential of uncultured microorganisms in various ecosystems. However, many of these genomic predictions have yet to be experimentally tested, and the functional expression of genomic potential often remains unaddressed. In order to obtain a more thorough understanding of cell physiology, novel techniques capable of testing microbial metabolism under close to in situ conditions must be developed. Here, we provide a benchmark study to demonstrate that bioorthogonal non-canonical amino acid tagging (BONCAT) in combination with fluorescence-activated cell sorting (FACS) and 16S rRNA gene sequencing can be used to identify anabolically active members of a microbial community incubated in the presence of various growth substrates or under changing physicochemical conditions. We applied this approach to a hot spring sediment microbiome from Yellowstone National Park (Wyoming, USA) and identified several microbes that changed their activity levels in response to substrate addition, including uncultured members of the phyla Thaumarchaeota, Acidobacteria, and Fervidibacteria. Because shifts in activity in response to substrate amendment or headspace changes are indicative of microbial preferences for particular growth conditions, results from this and future BONCAT-FACS studies could inform the development of cultivation media to specifically enrich uncultured microbes. Most importantly, BONCAT-FACS is capable of providing information on the physiology of uncultured organisms at as close to in situ conditions as experimentally possible.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 元基因组学研究彻底改变了我们对各种生态系统中未培养微生物代谢潜力的理解。但是，许多这些基因组预测尚未经过实验测试，而基因组潜力的功能表达通常仍未解决。为了获得对细胞生理学的更彻底的了解，必须开发能够在接近原位条件下测试微生物代谢的新技术。在这里，我们提供了一项基准研究，以证明生物正交非规范性氨基酸标签（BONCAT）结合荧光激活细胞分选（FACS）和16SrRNA基因测序可用于鉴定在以下条件下培养的微生物群落的合成代谢活性成员各种生长底物的存在或物理化学条件的变化。我们将这种方法应用于黄石国家公园（美国怀俄明州）的温泉沉积物微生物组，并发现了几种微生物，这些微生物会根据底物的添加而改变其活性水平，包括未培养的Thaumarchaeota门，Acidobacteria和Fervidibacteria。由于响应底物修饰或顶空变化而发生的活性变化表明微生物对特定生长条件的偏爱，因此本次和未来的BONCAT-FACS研究的结果可能会为培养培养基的发展提供信息，以特别丰富未培养的微生物。最重要的是，BONCAT-FACS能够在尽可能接近原位条件的条件下提供未培养生物的生理信息。</p>

<h2>Pubmed_ID: 32887539</h2>

<h3>Lactose-reduced infant formula with added corn syrup solids is associated with a distinct gut microbiota in Hispanic infants</h3>

<h3>乳糖减少的婴儿配方奶粉加上玉米糖浆固体成分与西班牙裔婴儿独特的肠道菌群相关</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1813534</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32887539/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Infant formula feeding, compared with human milk, has been associated with development of a distinct infant gut microbiome, but no previous study has examined effects of formula with added sugars. This work examined differences in gut microbiota among 91 Hispanic infants who consumed human milk [at breast (BB) vs. pumped in bottle (BP)] and 2 kinds of infant formula [(traditional lactose-based (TF) vs. lactose-reduced with added sugar (ASF)]. At 1 and 6 months, infant stool was collected to characterize gut microbiota. At 6 months, mothers completed 24-hour dietary recalls and questionnaires to determine infant consumption of human milk (BB vs. BP) or formula (TF vs. ASF). Linear regression models were used to determine associations of milk consumption type and microbial features at 6 months. Infants in the formula groups exhibited a significantly more 'mature' microbiome than infants in the human milk groups with the most pronounced differences observed between the ASF vs. BB groups. In the ASF group, we observed reduced log-normalized abundance of Bifidobacteriaceae (TF-BB Mean Difference = -0.71, ASF-BB Mean Difference = -1.10), and increased abundance of Lachnospiraceae (TF-BB Mean Difference = +0.89, ASF-BB Mean Difference = +1.20). We also observed a higher Community Phenotype Index of propionate, most likely produced by Lachnospiraceae, in the ASF group (TF-BB Mean Difference = +0.27, ASF-BB Mean Difference = +0.36). This study provides the first evidence that consumption of infant formula with added sugar may have a stronger association than birth delivery mode, infant caloric intake, and maternal BMI on the infant's microbiome at 6 months of age.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 与母乳相比，婴儿配方食品的喂养与独特的婴儿肠道微生物组的发展有关，但是以前没有研究检查添加糖的配方食品的效果。这项工作研究了91名西班牙裔婴儿中肠道菌群的差异，这些婴儿在母乳中食用[母乳（BB）与在瓶中抽奶（BP）]和2种婴儿配方奶粉[（传统乳糖基（TF）与乳糖减少）在第1和6个月时，收集婴儿粪便以表征肠道菌群。在6个月时，母亲完成24小时的饮食召回和问卷调查，以确定婴儿的母乳消耗量（BBvs.BP）或配方奶粉（TFvs.ASF）。线性回归模型用于确定6个月时的牛奶摄入类型与微生物特征的关系。配方奶粉组中婴儿的“成熟”微生物组明显多于婴儿奶粉组中婴儿的“成熟”微生物组。在ASF组和BB组之间观察到明显的差异。在ASF组中，我们观察到双歧杆菌科的对数归一化的丰度降低（TF-BB平均差异=-0.71，ASF-BB平均差异=-1.10），斜纹藻科的丰度增加（TF-BB平均差=+0.89，ASF-BB平均差=+1.20）。我们还观察到在ASF组中丙酸的群落表型指数更高，最有可能是由斜纹菌科产生的（TF-BB平均差异=+0.27，ASF-BB平均差异=+0.36）。这项研究提供了第一个证据，即与分娩方式，婴儿热量摄入和6个月大时婴儿的微生物组中的母亲BMI相比，食用含糖的婴儿配方食品可能具有更强的关联性。</p>

<h2>Pubmed_ID: 32865119</h2>

<h3>Gut commensal microbiota and decreased risk for Enterobacteriaceae bacteriuria and urinary tract infection</h3>

<h3>肠道共生菌群和肠杆菌科细菌尿症和尿路感染的风险降低</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1805281</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32865119/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Urinary tract infection (UTI) is a common complication in kidney transplant recipients and can lead to significant morbidity and mortality. Recent evidence supports a role for the gut as a source for UTIs but little is known about the relationship between gut commensal bacteria and UTI development. We hypothesized that the abundance of gut commensal bacteria is associated with a lower risk of developing bacteriuria and UTIs. We performed gut microbiome profiling using 16S rRNA gene sequencing of the V4-V5 hypervariable region on 510 fecal specimens in 168 kidney transplant recipients. Fifty-one kidney transplant recipients (30%) developed Enterobacteriaceae bacteriuria within the first 6 months after transplantation (Enterobacteriaceae Bacteriuria Group) and 117 did not (No Enterobacteriaceae Bacteriuria Group). The relative abundances of Faecalibacterium and Romboutsia were significantly higher in the fecal specimens from the No Enterobacteriaceae Bacteriuria Group than those from the Enterobacteriaceae Bacteriuria Group (Adjusted P value<.01). The combined relative abundance of Faecalibacterium and Romboutsia was inversely correlated with the relative abundance of Enterobacteriaceae (r = -0.13, P = .003). In a multivariable Cox Regression, a top tercile cutoff of the combined relative abundance of Faecalibacterium and Romboutsia of ≥13.7% was independently associated with a decreased risk for Enterobacteriaceae bacteriuria (hazard ratio 0.3, P = .02) and Enterobacteriaceae UTI (hazard ratio 0.4, P = .09). In conclusion, we identify bacterial taxa associated with decreased risk for Enterobacteriaceae bacteriuria and Enterobacteriaceae UTI in kidney transplant recipients, which supports future studies on modulating the gut microbiota as a novel treatment for preventing UTIs.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 尿路感染（UTI）是肾移植患者的常见并发症，可导致明显的发病率和死亡率。最近的证据支持肠道作为UTI的来源，但对肠道共生细菌与UTI发育之间的关系知之甚少。我们假设肠道共生细菌的丰富与细菌尿症和泌尿道感染的风险降低有关。我们在168个肾脏移植受者的510个粪便标本上使用V4-V5高变区的16SrRNA基因测序对肠道微生物组进行了分析。51名肾移植受者（30％）在移植后的前6个月内发展了肠杆菌科细菌（肠杆菌科细菌性尿杆菌群），而117例则没有（肠杆菌科细菌性尿杆菌群）。无肠杆菌科细菌粪便组中粪便标本中费氏杆菌和罗氏菌的相对丰度明显高于肠杆菌科细菌粪便组（校正后的P值<.01）。Faecalibacterium和Rom​​boutsia的总相对丰度与肠杆菌科的相对丰度呈负相关（r=-0.13，P=.003）。在多变量Cox回归中，费氏细菌和罗氏菌的相对相对丰度最高的临界截止值≥13.7％与降低肠杆菌科细菌尿的风险（危险比0.3，P=.02）和肠杆菌科尿路感染（危险比0.4）有关。，P=.09）。总之，我们确定了与肾脏移植受者肠杆菌科细菌尿杆菌和肠杆菌科尿路感染的风险降低相关的细菌类群，这为将来调节肠道菌群作为预防尿路感染的新方法提供了支持。</p>

<h2>Pubmed_ID: 32845788</h2>

<h3>Modulation of gut microbiota in healthy rats after exposure to nutritional supplements</h3>

<h3>暴露于营养补充剂后健康大鼠肠道菌群的调节</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1779002</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32845788/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Introduction: Rats are experimental animals, frequently used as model organisms in the biomedical studies, and increasingly used to study the gut microbiota. Specifically, the aim of latter studies is either the elucidation of relationship between intestinal dysbiosis and diseases or the determination of nutrients or pharmaceutical agents which can cause the modulation in the presence or abundance of gut microbiota. Aim: Herein, the research studies conducted on the gut microbiota of healthy rats are presented in a summarized and concise overview. The focus is on studies aimed to reveal the shifts in microbial composition and functional changes after exposure to various types of nutritional supplements. Methods: We performed the search of PubMed database using the term "rat gut microbiome microbiota" and examined studies aimed to assess the composition of gut microbiota in physiological homeostasis as well as the effect of various nutritional supplements on the gut microbiota of healthy rats.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 简介：大鼠是实验动物，在生物医学研究中经常用作模型生物，并越来越多地用于研究肠道菌群。具体而言，后一研究的目的是阐明肠道营养不良与疾病之间的关系，或者确定可能导致肠道菌群存在或丰富的调节的营养素或药物。目的：在本文中，对健康大鼠的肠道菌群进行的研究总结在简明扼要的概述中。重点是旨在揭示暴露于各种类型营养补品后微生物成分变化和功能变化的研究。方法：我们使用术语“大鼠肠道微生物组微生物群”进行PubMed数据库搜索，并检查了旨在评估生理稳态中肠道微生物群组成以及各种营养补充剂对健康大鼠肠道微生物群的影响的研究。</p>

<h2>Pubmed_ID: 32844722</h2>

<h3>Pre-therapy fasting slows epithelial turnover and modulates the microbiota but fails to mitigate methotrexate-induced gastrointestinal mucositis</h3>

<h3>治疗前的禁食可减慢上皮周转并调节微生物群，但不能缓解甲氨蝶呤引起的胃肠道粘膜炎</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1809332</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32844722/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Background: Recent findings by Tang et al. (2020) show dietary restriction (30%, 2 weeks) prevents methotrexate-induced mortality by modulation of the microbiota, specifically the expansion of Lactobacillus. While fundamentally insightful, upscaling this schedule is a major obstacle to clinical uptake. Here, we evaluate a safe and clinically achievable schedule of pre-therapy fasting for 48 h on microbiota composition, body composition and intestinal proliferation, and assess its impact on the severity of methotrexate-induced gastrointestinal mucositis using a validated preclinical rat model. Methods: Age- and weight-matched male Wistar rats were treated with a sublethal dose of 45 mg/kg methotrexate with or without pre-therapy fasting. The impact of acute fasting on epithelial proliferation, body composition and the microbiota was assessed using plasma citrulline, Ki67 immunohistochemistry, miniSpec and 16S rRNA sequencing. The severity of gastrointestinal mucositis was evaluated using plasma citrulline and body weight. Results: Whilst pre-therapy fasting slowed epithelial proliferation and increased microbial diversity and richness, it also induced significant weight loss and was unable to attenuate the severity of mucositis in both age- and weight-matched groups. In contrast to Tang et al., we saw no expansion of Lactobacillus following acute fasting. Conclusions: Our findings suggest that the beneficial effects of acute fasting are masked by the detrimental effects on body weight and composition and lacking influence on Lactobacillus. Future studies should consider alternative fasting schedules or aim to induce comparable microbial and mucosal manipulation without compromising body composition using clinically feasible methods of dietary or microbial intervention.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 背景：Tang等人的最新发现。（2020年）显示饮食限制（30％，2周）可通过调节微生物群（特别是乳杆菌的膨胀）来防止甲氨蝶呤致死。虽然从根本上具有洞察力，但扩大此时间表是临床吸收的主要障碍。在这里，我们评估禁食前48小时对微生物群组成，身体组成和肠道增殖的安全且临床上可实现的时间表，并使用经过验证的临床前大鼠模型评估其对甲氨蝶呤诱发的胃肠道粘膜炎严重程度的影响。方法：年龄和体重相匹配的雄性Wistar大鼠接受亚致死剂量45mg/kg甲氨蝶呤治疗，禁食或不禁食。使用血浆瓜氨酸，Ki67免疫组织化学，miniSpec和16SrRNA测序评估了急性禁食对上皮增殖，身体成分和微生物群的影响。使用血浆瓜氨酸和体重评估胃肠道粘膜炎的严重程度。结果：尽管禁食可以减缓上皮细胞的增殖，增加微生物的多样性和丰富性，但它也引起体重的明显减轻，并且不能减轻年龄和体重匹配组的粘膜炎的严重性。与Tang等人相反，我们发现急性禁食后乳酸杆菌没有扩增。结论：我们的发现表明，急性禁食的有益作用被体重和组成的不利影响所掩盖，而对乳杆菌缺乏影响。未来的研究应考虑替代性的禁食时间表，或旨在通过临床上可行的饮食或微生物干预方法，在不损害人体成分的前提下诱导可比的微生物和粘膜操作。</p>

<h2>Pubmed_ID: 32835617</h2>

<h3>The effects of dairy and dairy derivatives on the gut microbiota: a systematic literature review</h3>

<h3>乳制品和乳制品衍生物对肠道菌群的影响：系统文献综述</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1799533</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32835617/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: The effects of dairy and dairy-derived products on the human gut microbiota remains understudied. A systematic literature search was conducted using Medline, CINAHL, Embase, Scopus, and PubMed databases with the aim of collating evidence on the intakes of all types of dairy and their effects on the gut microbiota in adults. Risk of bias was assessed using the Cochrane risk-of-bias tool.The search resulted in 6,592 studies, of which eight randomized controlled trials (RCTs) met pre-determined eligibility criteria for inclusion, consisting of a total of 468 participants. Seven studies assessed the effect of type of dairy (milk, yogurt, and kefir) and dairy derivatives (whey and casein) on the gut microbiota, and one study assessed the effect of the quantity of dairy (high dairy vs low dairy). Three studies showed that dairy types consumed (milk, yogurt, and kefir) increased the abundance of beneficial genera Lactobacillus and Bifidobacterium. One study showed that yogurt reduced the abundance of Bacteroides fragilis, a pathogenic strain. Whey and casein isolates and the quantity of dairy consumed did not prompt changes to the gut microbiota composition. All but one study reported no changes to bacterial diversity in response to dairy interventions and one study reported reduction in bacterial diversity in response to milk intake.In conclusion, the results of this review suggest that dairy products such as milk, yogurt, and kefir may modulate the gut microbiota composition in favor to the host. However, the broader health implications of these findings remain unclear and warrant further studies.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 乳制品和乳制品衍生产品对人类肠道菌群的影响尚待研究。使用Medline，CINAHL，Embase，Scopus和PubMed数据库进行了系统的文献检索，目​​的是收集各种类型乳制品的摄入量及其对成年人肠道菌群的影响的证据。使用Cochrane偏见风险工具评估了偏见风险。该搜索结果进行了6,592项研究，其中八项随机对照试验（RCT）符合预定的纳入资格标准，共有468名参与者。七项研究评估了乳制品类型（牛奶，酸奶和开菲尔）和乳制品衍生物（乳清蛋白和酪蛋白）对肠道菌群的影响，一项研究评估了乳制品数量的影响（高乳制品与低乳制品）。三项研究表明，食用的乳制品类型（牛奶，酸奶和开菲尔）增加了有益的乳酸杆菌和双歧杆菌属的数量。一项研究表明，酸奶可以减少致病菌株脆弱拟杆菌（Bacteroidesfragilis）的含量。乳清和酪蛋白分离物以及食用的乳制品数量并未促使肠道菌群组成发生变化。除一项研究外，所有研究均未报告对乳制品干预措施引起的细菌多样性变化，而另一项研究报告对摄入乳汁引起的细菌多样性降低。总而言之，本评价的结果表明，乳制品如牛奶，酸奶和开菲尔可能调节肠道菌群组成，使其对宿主有利。但是，这些发现对健康的广泛影响尚不清楚，需要进一步研究。</p>

<h2>Pubmed_ID: 32835590</h2>

<h3>Gut microbes from the phylogenetically diverse genus Eubacterium and their various contributions to gut health</h3>

<h3>系统发育多样的真细菌属的肠道微生物及其对肠道健康的各种贡献</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1802866</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32835590/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Over the last two decades our understanding of the gut microbiota and its contribution to health and disease has been transformed. Among a new 'generation' of potentially beneficial microbes to have been recognized are members of the genus Eubacterium, who form a part of the core human gut microbiome. The genus consists of phylogenetically, and quite frequently phenotypically, diverse species, making Eubacterium a taxonomically unique and challenging genus. Several members of the genus produce butyrate, which plays a critical role in energy homeostasis, colonic motility, immunomodulation and suppression of inflammation in the gut. Eubacterium spp. also carry out bile acid and cholesterol transformations in the gut, thereby contributing to their homeostasis. Gut dysbiosis and a consequently modified representation of Eubacterium spp. in the gut, have been linked with various human disease states. This review provides an overview of Eubacterium species from a phylogenetic perspective, describes how they alter with diet and age and summarizes its association with the human gut and various health conditions.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 在过去的二十年中，我们对肠道菌群及其对健康和疾病的贡献的认识已经转变。公认的新一代潜在有益微生物是真细菌属的成员，它们构成人类核心肠道微生物组的一部分。该属包括系统发育的，并且在表型上经常是多种多样的物种，使真细菌成为分类学上独特且具有挑战性的属。该属的几个成员产生丁酸酯，丁酸酯在能量稳态，结肠运动，免疫调节和肠道炎症抑制中起关键作用。真细菌还会在肠道中进行胆汁酸和胆固醇的转化，从而促进其体内稳态。肠道营养不良，并因此修饰了真细菌属。在肠道中，已经与各种人类疾病状态相关联。这篇综述从系统发育的角度概述了真细菌，描述了它们如何随着饮食和年龄而变化，并总结了其与人类肠道和各种健康状况的关系。</p>

<h2>Pubmed_ID: 32816619</h2>

<h3>Modifying macronutrients is superior to microbiome transplantation in treating nonalcoholic fatty liver disease</h3>

<h3>在治疗非酒精性脂肪性肝病中，修饰大量营养素优于微生物组移植</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1792256</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32816619/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver injury and liver transplantation in Western countries. The pathogenesis of NAFLD includes overnutrition-associated metabolic syndrome or the improper consumption of dietary macro- and micro-nutrients that either support or prevent disease development. This altered nutrient landscape has been linked to shifts within the gut microbiota which can exacerbate liver pathology and the progression of NAFLD. Treatment goals for NAFLD target lifestyle and dietary modifications that restrict calories and adjust macronutrient content. It is not well understood how different macronutrients alter the microbiota and whether the diet-educated microbiota contribute to the resolution of disease. We fed mice a diet high in fat, cholesterol and fructose for 6 weeks and then in two different arms of the study, intervened with either a diet high in saturated and polyunsaturated fats and fiber or low in fats and fiber. In a second set of experiments, we performed microbiota transplants using cecal contents from mice fed one of the intervention diets to assess whether the diet-educated microbiota could impact clinical outcomes in mice fed a NAFLD-inducing diet. Pathology, steatosis, ALT/AST levels, and liver cytokine levels were measured as primary outcomes. We found that despite different microbiota compositions, both of the intervention diets reversed the progression of NAFLD and dampened inflammation. In contrast, transplantation of cecal contents from the intervention diet-fed mice to mice receiving a NAFLD-inducing diet was unable to prevent disease progression, and, in some cases, worsened disease. These data underscore the importance of dietary modifications to treat NAFLD and caution against the use of microbiota transplantation in the absence of dietary and lifestyle modifications.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 非酒精性脂肪肝疾病（NAFLD）是西方国家慢性肝损伤和肝移植的主要原因。NAFLD的发病机制包括与营养过度相关的代谢综合症，或不适当摄入支持或预防疾病发展的饮食中大量和微量营养素。营养素格局的这种变化与肠道菌群内的变化有关，这种变化会加剧肝脏病理和NAFLD的进展。NAFLD的治疗目标针对限制卡路里和调节常量营养素的生活方式和饮食习惯。人们尚不了解不同的常量营养素如何改变微生物群，以及饮食中培养的微生物群是否有助于疾病的解决。我们给小鼠喂了高脂肪，高胆固醇和果糖的饮食，持续了6周，然后在研究的两个不同方面进行了干预，干预措施是高饱和和多不饱和脂肪和纤维的饮食，或者低脂肪和纤维的饮食。在第二组实验中，我们使用饲喂一种干预饮食的小鼠的盲肠内容物进行了微生物菌群移植，以评估饮食诱导的微生物菌群是否会影响喂养NAFLD诱导饮食的小鼠的临床结局。病理，脂肪变性，ALT/AST水平和肝细胞因子水平被作为主要结局进行了测量。我们发现，尽管微生物群组成不同，但两种干预饮食均能逆转NAFLD的进展并减轻炎症。相反，将盲肠内容物从干预饮食喂养的小鼠移植到接受NAFLD诱导饮食的小鼠不能预防疾病进展，在某些情况下还可以使疾病恶化。这些数据强调了饮食调整对治疗NAFLD的重要性，并警告在没有饮食和生活方式调整的情况下不要使用微生物菌群移植。</p>

<h2>Pubmed_ID: 32804018</h2>

<h3>The development of metabolic endotoxemia is dependent on the type of sweetener and the presence of saturated fat in the diet</h3>

<h3>代谢性内毒素血症的发展取决于甜味剂的类型和饮食中饱和脂肪的存在</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1801301</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32804018/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Fat and sweeteners contribute to obesity. However, it is unknown whether specific bacteria are selectively modified by different caloric and noncaloric sweeteners with or without a high-fat diet (HFD). Here, we combined extensive host phenotyping and shotgun metagenomics of the gut microbiota to investigate this question. We found that the type of sweetener and its combination with an HFD selectively modified the gut microbiota. Sucralose and steviol glycosides led to the lowest α-diversity of the gut microbiota. Sucralose increased the abundance of B. fragilis in particular, resulting in a decrease in the abundance of occludin and an increase in proinflammatory cytokines, glucose intolerance, fatty acid oxidation and ketone bodies. Sucrose+HFD showed the highest metabolic endotoxemia, weight gain, body fat, total short chain fatty acids (SCFAs), serum TNFα concentration and glucose intolerance. Consumption of sucralose or sucrose resulted in enrichment of the bacterial genes involved in the synthesis of LPS and SCFAs. Notably, brown sugar and honey were associated with the absence of metabolic endotoxemia, increases in bacterial gene diversity and anti-inflammatory markers such as IL-10 and sIgA, the maintenance of glucose tolerance and energy expenditure, similar to the control group, despite the consumption of an HFD. These findings indicate that the type of sweetener and an HFD selectively modify the gut microbiota, bacterial gene enrichment of metabolic pathways involved in LPS and SCFA synthesis, and metabolic endotoxemia associated with different metabolic profiles.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 脂肪和甜味剂有助于肥胖。然而，未知特定的细菌是否会被高热量饮食（HFD）或不含高脂肪饮食（HFD）的不同热量和非热量甜味剂选择性地修饰。在这里，我们结合了肠道菌群的广泛宿主表型和shot弹枪宏基因组学来研究这个问题。我们发现甜味剂的类型及其与HFD的组合选择性修饰了肠道菌群。三氯蔗糖和甜菊醇苷导致肠道菌群的最低α-多样性。三氯蔗糖特别增加了脆弱芽孢杆菌的丰度，导致闭合蛋白的丰度降低，促炎细胞因子，葡萄糖耐量，脂肪酸氧化和酮体增加。蔗糖+HFD表现出最高的代谢内毒素血症，体重增加，体脂，总短链脂肪酸（SCFA），血清TNFα浓度和葡萄糖耐受不良。三氯蔗糖或蔗糖的消耗导致参与LPS和SCFAs合成的细菌基因的富集。值得注意的是，与对照组类似，红糖和蜂蜜与缺乏代谢性内毒素血症，细菌基因多样性增加和抗炎标记物（如IL-10和sIgA），维持葡萄糖耐量和能量消耗有关，与对照组相关。HFD的消耗。这些发现表明，甜味剂和HFD的类型可以选择性地改变肠道菌群，参与LPS和SCFA合成的代谢途径的细菌基因富集以及与不同代谢谱相关的代谢内毒素血症。</p>

<h2>Pubmed_ID: 32795243</h2>

<h3>Research in a time of enteroids and organoids: how the human gut model has transformed the study of enteric bacterial pathogens</h3>

<h3>肠道和类器官的时代研究：人类肠道模型如何改变了肠道细菌病原体的研究</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1795389</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32795243/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Enteric bacterial pathogens cause significant morbidity and mortality globally. Studies in tissue culture and animal models shaped our initial understanding of these host-pathogen interactions. However, intrinsic shortcomings in these models limit their application, especially in translational applications like drug screening and vaccine development. Human intestinal enteroid and organoid models overcome some limitations of existing models and advance the study of enteric pathogens. In this review, we detail the use of human enteroids and organoids to investigate the pathogenesis of invasive bacteria Shigella, Listeria, and Salmonella, and noninvasive bacteria pathogenic Escherichia coli, Clostridium difficile, and Vibrio cholerae. We highlight how these studies confirm previously identified mechanisms and, importantly, reveal novel ones. We also discuss the challenges for model advancement, including platform engineering to integrate environmental conditions, innate immune cells and the resident microbiome, and the potential for pre-clinical testing of recently developed antimicrobial drugs and vaccines.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 肠道细菌性病原体在全球范围内引起大量发病和死亡。在组织培养和动物模型中的研究塑造了我们对这些宿主-病原体相互作用的初步了解。但是，这些模型的固有缺陷限制了它们的应用，尤其是在诸如药物筛选和疫苗开发等转化应用中。人肠小肠和类器官模型克服了现有模型的某些局限性，并促进了肠道病原体的研究。在这篇综述中，我们详细介绍了人类小肠类和类器官的使用，以研究侵袭性细菌志贺氏菌，李斯特菌和沙门氏菌以及非侵害性细菌致病性大肠杆菌，艰难梭菌和霍乱弧菌的发病机理。我们重点介绍这些研究如何确认先前确定的机制，并且重要的是揭示新颖的机制。我们还讨论了模型开发所面临的挑战，包括整合环境条件，先天免疫细胞和驻留微生物组的平台工程，以及对最近开发的抗菌药物和疫苗进行临床前测试的潜力。</p>

<h2>Pubmed_ID: 32783770</h2>

<h3>Intestinal microbiota-derived tryptophan metabolites are predictive of Ah receptor activity</h3>

<h3>肠道菌群来源的色氨酸代谢产物可预测Ah受体的活性</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1788899</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32783770/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Commensal microbiota-dependent tryptophan catabolism within the gastrointestinal tract is known to exert profound effects upon host physiology, including the maintenance of epithelial barrier and immune function. A number of abundant microbiota-derived tryptophan metabolites exhibit activation potential for the aryl hydrocarbon receptor (AHR). Gene expression facilitated by AHR activation through the presence of dietary or microbiota-generated metabolites can influence gastrointestinal homeostasis and confer protection from intestinal challenges. Utilizing untargeted mass spectrometry-based metabolomics profiling, combined with AHR activity screening assays, we identify four previously unrecognized tryptophan metabolites, present in mouse cecal contents and human stool, with the capacity to activate AHR. Using GC/MS and LC/MS platforms, quantification of these novel AHR activators, along with previously established AHR-activating tryptophan metabolites, was achieved, providing a relative order of abundance. Using physiologically relevant concentrations and quantitative gene expression analyses, the relative efficacy of these tryptophan metabolites with regard to mouse or human AHR activation potential is examined. These data reveal indole, 2-oxindole, indole-3-acetic acid and kynurenic acid as the dominant AHR activators in mouse cecal contents and human stool from participants on a controlled diet. Here we provide the first documentation of the relative abundance and AHR activation potential of a panel of microbiota-derived tryptophan metabolites. Furthermore, these data reveal the human AHR to be more sensitive, at physiologically relevant concentrations, to tryptophan metabolite activation than mouse AHR. Additionally, correlation analyses indicate a relationship linking major tryptophan metabolite abundance with AHR activity, suggesting these cecal/fecal metabolites represent biomarkers of intestinal AHR activity.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 胃肠道内的共生微生物依赖性色氨酸分解代谢对宿主生理产生深远影响，包括维持上皮屏障和免疫功能。许多丰富的微生物来源的色氨酸代谢物表现出芳烃受体（AHR）的激活潜力。通过饮食或微生物群产生的代谢物的存在，由AHR激活而促进的基因表达可以影响胃肠道的稳态，并保护肠道免受攻击。利用基于非靶向质谱的代谢组学分析，结合AHR活性筛选测定，我们确定了小鼠盲肠内容物和人类粪便中存在的四种先前无法识别的色氨酸代谢物，具有激活AHR的能力。使用GC/MS和LC/MS平台，可以对这些新型AHR活化剂以及先前建立的AHR活化色氨​​酸代谢产物进行定量，从而提供相对的丰度顺序。使用生理学相关浓度和定量基因表达分析，检查了这些色氨酸代谢物相对于小鼠或人AHR激活潜能的相对功效。这些数据表明，在饮食控制下的小鼠盲肠内容物和人类粪便中，吲哚，2-羟吲哚，吲哚-3-乙酸和犬尿酸是主要的AHR激活剂。在这里，我们提供了一组微生物群衍生的色氨酸代谢物的相对丰度和AHR活化潜力的第一个文献。此外，这些数据表明，在生理相关浓度下，人AHR比小鼠AHR对色氨酸代谢物的活化更为敏感。此外，相关分析表明，主要色氨酸代谢物丰度与AHR活性之间存在联系，表明这些盲肠/粪便代谢物代表了肠道AHR活性的生物标记。</p>

<h2>Pubmed_ID: 32779963</h2>

<h3>Vitamin D supplementation in pregnancy and early infancy in relation to gut microbiota composition and C. difficile colonization: implications for viral respiratory infections</h3>

<h3>与肠道菌群组成和艰难梭菌定殖有关的妊娠和婴儿早期维生素D补充：对病毒性呼吸道感染的影响</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1799734</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32779963/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: In Canada and the US, the infant diet is supplemented with vitamin D via supplement drops or formula. Pregnant and nursing mothers often take vitamin D supplements. Since little is known about the impact of this supplementation on infant gut microbiota, we undertook a study to determine the association between maternal and infant vitamin D supplementation, infant gut microbiota composition and Clostridioides difficile colonization in 1,157 mother-infant pairs of the CHILD (Canadian Healthy Infant Longitudinal Development) Cohort Study over 2009-2012. Logistic and MaAsLin regression were employed to assess associations between vitamin D supplementation, and C. difficile colonization, or other gut microbiota, respectively. Sixty-five percent of infants received a vitamin D supplement. Among all infants, infant vitamin D supplementation was associated with a lower abundance of genus Megamonas (q = 0.01) in gut microbiota. Among those exclusively breastfed, maternal prenatal supplementation was associated with lower abundance of Bilophila (q = 0.01) and of Lachnospiraceae (q = 0.02) but higher abundance of Haemophilus (q = 0.02). There were no differences in microbiota composition with vitamin D supplementation among partially and not breastfed infants. Neither infant nor maternal vitamin D supplementation were associated with C. difficile colonization, after adjusting for breastfeeding status and other factors. However, maternal consumption of vitamin-D fortified milk reduced the likelihood of C. difficile colonization in infants (adjustedOR: 0.40, 95% CI: 0.19-0.82). The impact of this compositional difference on later childhood health, especially defense against viral respiratory infection, may go beyond the expected effects of vitamin D supplements and remains to be ascertained.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 在加拿大和美国，婴儿饮食通过补充滴剂或配方奶粉补充了维生素D。孕妇和哺乳期母亲经常服用维生素D补充剂。由于对该补充剂对婴儿肠道菌群的影响知之甚少，我们进行了一项研究，以确定在1,157对CHILD（加拿大）母婴对中母婴维生素D补充剂，婴儿肠道菌群组成与艰难梭菌定殖之间的关系。2009-2012年婴儿健康纵向发展队列研究。使用Logistic和MaAsLin回归分别评估补充维生素D与艰难梭菌定植或其他肠道菌群之间的关联。65％的婴儿接受了维生素D补充剂。在所有婴儿中，补充婴儿维生素D与肠道菌群中大单胞菌属的丰富度较低（q=0.01）有关。在那些纯母乳喂养的母亲中，产前补充母亲的嗜酸性菌（q=0.01）和漆鞭草科（q=0.02）较低，而嗜血杆菌（q=0.02）较高。在部分和非母乳喂养的婴儿中，补充维生素D的微生物群组成没有差异。在调整母乳喂养状态和其他因素后，婴儿和母亲补充维生素D均与艰难梭菌定殖无关。但是，孕妇食用维生素D强化的牛奶可以降低婴儿艰难梭菌定植的可能性（调整后的OR：0.40，95％CI：0.19-0.82）。这种成分差异对儿童后期健康的影响，尤其是对病毒性呼吸道感染的防御作用，可能超出维生素D补充剂的预期效果，有待确定。</p>

<h2>Pubmed_ID: 32752913</h2>

<h3>Alternations of gut microbiota composition in neonates conceived by assisted reproductive technology and its relation to infant growth</h3>

<h3>辅助生殖技术对新生儿肠道菌群组成的改变及其与婴儿生长的关系</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1794466</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32752913/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: The gut microbiome in newborns may be strongly influenced by their intrinsic host microenvironmental factors (e.g., the gestational age) and has been linked to their short-term growth and potentially future health. It is yet unclear whether early microbiota composition is significantly different in newborns conceived by assisted reproductive technology (ART) when compared with those who were conceived spontaneously. Additionally, little is known about the effect of gut microbiota composition on weight gain in early infancy. We aimed to characterize the features and the determinants of the gut microbiome in ART newborns and to assess the impact of early microbiota composition on their weight gain in early infancy in mother-infant dyads enrolled in the China National Birth Cohort (CNBC). Among 118 neonates born by ART and 91 neonates born following spontaneous conception, we observed significantly reduced gut microbiota α-diversity and declined Bacteroidetes relative abundance in ART neonates. The microbiota composition of ART neonates was largely driven by specific ART treatments, hinting the importance of fetus intrinsic host microenvironment on the early microbial colonization. Following up these neonates for six months after their births, we observed the effects of gut microbiome composition on infant rapid weight gaining. Collectively, we identified features and determinants of the gut microbiota composition in ART neonates, and provided evidence for the importance of microbiota composition in neonatal growth.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 新生儿的肠道微生物组可能会受到其内在的宿主微环境因素（例如胎龄）的强烈影响，并且与他们的短期生长和未来的健康状况有关。尚不清楚，与自然怀孕的婴儿相比，辅助生殖技术（ART）怀孕的婴儿的早期菌群组成是否显着不同。另外，关于肠道菌群组成对婴儿早期体重增加的影响知之甚少。我们旨在表征ART新生儿中肠道微生物组的特征和决定因素，并评估早期微生物群组成对其在中国出生队列（CNBC）中登记的母婴二代婴儿早期体重增加的影响。在ART出生的118例新生儿和自然受孕后出生的91例新生儿中，我们观察到ART新生儿的肠道菌群α多样性显着降低，拟杆菌的相对丰度下降。ART新生儿的微生物群组成很大程度上受特定的ART治疗驱动，这暗示了胎儿固有宿主微环境对早期微生物定殖的重要性。在这些新生儿出生后六个月进行随访，我们观察到肠道微生物组成分对婴儿快速增重的影响。我们共同确定了ART新生儿肠道菌群组成的特征和决定因素，并为微生物菌群组成在新生儿生长中的重要性提供了证据。</p>

<h2>Pubmed_ID: 32747713</h2>

<h3>Concentration and chemical form of dietary zinc shape the porcine colon microbiome, its functional capacity and antibiotic resistance gene repertoire</h3>

<h3>日粮锌的浓度和化学形式影响猪结肠微生物组，其功能能力和抗生素抗性基因库</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1038/s41396-020-0730-3</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32747713/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: The ISME journal   ||| Not finding IF</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 2020 Nov</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Despite a well-documented effect of high dietary zinc oxide on the pig intestinal microbiota composition less is it yet known about changes in microbial functional properties or the effect of organic zinc sources. Forty weaning piglets in four groups were fed diets supplemented with 40 or 110 ppm zinc as zinc oxide, 110 ppm as Zn-Lysinate, or 2500 ppm as zinc oxide. Host zinc homeostasis, intestinal zinc fractions, and ileal nutrient digestibility were determined as main nutritional and physiological factors putatively driving colon microbial ecology. Metagenomic sequencing of colon microbiota revealed only clear differences at genus level for the group receiving 2500 ppm zinc oxide. However, a clear group differentiation according to dietary zinc concentration and source was observed at species level. Functional analysis revealed significant differences in genes related to stress response, mineral, and carbohydrate metabolism. Taxonomic and functional gene differences were accompanied with clear effects in microbial metabolite concentration. Finally, a selection of certain antibiotic resistance genes by dietary zinc was observed. This study sheds further light onto the consequences of concentration and chemical form of dietary zinc on microbial ecology measures and the resistome in the porcine colon.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 尽管高膳食氧化锌对猪肠道菌群组成的影响有充分的文献记载，但关于微生物功能特性的变化或有机锌源的影响知之甚少。在四组断奶仔猪中饲喂40只断奶仔猪，补充40或110ppm的氧化锌，110ppm的赖氨酸锌或2500ppm的氧化锌。寄主体内锌稳态，肠道锌级分和回肠养分消化率被确定为主要营养和生理因素，可能推动结肠微生物生态。结肠微生物群的元基因组测序显示，对于接受2500ppm氧化锌的组，其属水平仅存在明显差异。然而，在物种水平上观察到根据饮食锌浓度和来源的明显的群体分化。功能分析显示与应激反应，矿物质和碳水化合物代谢有关的基因存在显着差异。分类学和功能基因差异对微生物代谢物浓度具有明显影响。最后，观察到饮食锌对某些抗生素抗性基因的选择。这项研究进一步揭示了膳食锌的浓度和化学形式对微生物生态学措施和猪结肠抵抗系统的影响。</p>

<h2>Pubmed_ID: 32744162</h2>

<h3>The meconium microbiota shares more features with the amniotic fluid microbiota than the maternal fecal and vaginal microbiota</h3>

<h3>胎粪菌群比羊粪菌群和阴道菌群具有更多的羊水菌群特征。</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1794266</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32744162/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: The early-life gut microbiota is associated with potential development of diseases in adulthood. The sterile womb paradigm has been challenged by recent reports that revealed the presence of the meconium, amniotic fluid, and placenta microbiome. This study aimed to explore the maternal origin of the microbiota of neonate meconium by using the PacBio single-molecule real-time circular consensus sequencing technology. Such technology could produce high fidelity reads of full-length 16S rRNA genes, improving the sensitivity and specificity of taxonomic profiling. It also reduced the risk of false positives. This study analyzed the full-length 16S rRNA-based microbiota of maternal samples (amniotic fluid, feces, vaginal fluid, saliva) and first-pass meconium of 39 maternal-neonate pairs. Alpha- and beta-diversity analyses revealed sample type-specific microbiota features. Most sample types were dominated by sequences representing different genera (Lactobacillus and Curvibacter in the amniotic fluid and vaginal fluid microbiota; Bacillus and Escherichia/Shigella in the meconium microbiota; Bacteroides and Faecalibacterium in the maternal fecal microbiota; Streptococcus and Prevotella in the maternal saliva microbiota). Moreover, specific operational taxonomic units (OTUs) were identified in all sample types. Dyad analysis revealed common OTUs between the meconium microbiota and microbiota of multiple maternal samples. The meconium microbiota shared more features with the amniotic fluid microbiota than the maternal fecal and vaginal microbiota. Our results strongly suggested that the meconium microbiota was seeded from multiple maternal body sites, and the amniotic fluid microbiota contributed most to the seeding of the meconium microbiota among the investigated maternal body sites.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 早期肠道菌群与成年期疾病的潜在发展有关。最近的报道揭示了胎粪，羊水和胎盘微生物组的存在，对无菌子宫的范例提出了挑战。本研究旨在通过使用PacBio单分子实时循环共有序列测序技术探索新生儿胎粪微生物群的母源。此类技术可以产生全长16SrRNA基因的高保真读数，从而提高分类学谱分析的敏感性和特异性。这也减少了误报的风险。这项研究分析了孕妇样品（羊水，粪便，阴道液，唾液）和39对孕妇新生儿配对的初次通过胎粪的全长16SrRNA基微生物区系。α和β多样性分析揭示了样品类型特异性的微生物群特征。大多数样品类型由代表不同属的序列决定（羊水和阴道菌群中的乳酸杆菌和弯曲杆菌；胎粪菌群中的杆菌和大肠杆菌/志贺氏菌；产妇粪便菌群中的杆菌和费卡杆菌；孕妇唾液菌群中的链球菌和普氏杆菌。）。此外，在所有样本类型中都确定了特定的操作分类单位（OTU）。Dyad分析揭示了胎粪微生物群和多个母体样品的微生物群之间常见的OTU。胎粪微生物群与羊水微生物群相比，母体粪便和阴道微生物群具有更多的特征。我们的结果有力地表明，胎粪微生物群是从多个孕产妇身体部位播种的，而羊水微生物群是所调查的孕产妇身体部位中胎粪微生物群播种的最大贡献。</p>

<h2>Pubmed_ID: 32730134</h2>

<h3>Dysbiosis in a canine model of human fistulizing Crohn's disease</h3>

<h3>人性克罗恩病犬模型中的生物失调</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1785246</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32730134/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Crohn's disease (CD) is a chronic immune-mediated inflammatory condition caused by the loss of mucosal tolerance toward the commensal microbiota. On average, 29.5% and 42.7% CD patients experience perianal complications at 10 and 20 y after diagnosis, respectively. Perianal CD (pCD) result in high disease burden, diminished quality of life, and elevated health-care costs. Overall pCD are predictors of poor long-term outcomes. Animal models of gut inflammation have failed to fully recapitulate the human manifestations of fistulizing CD. Here, we evaluated dogs with spontaneous canine anal furunculosis (CAF), a disease with clinical similarities to pCD, as a surrogate model for understanding the microbial contribution of human pCD pathophysiology. By comparing the gut microbiomes between dogs suffering from CAF (CAF dogs) and healthy dogs, we show CAF-dog microbiomes are either very dissimilar (dysbiotic) or similar (healthy-like), yet unique, to healthy dog's microbiomes. Compared to healthy or healthy-like CAF microbiomes, dysbiotic CAF microbiomes showed an increased abundance of Bacteroides vulgatus and Escherichia coli and a decreased abundance of Megamonas species and Prevotella copri. Our results mirror what have been reported in previous microbiome studies of patients with CD; particularly, CAF dogs exhibited two distinct microbiome composition: dysbiotic and healthy-like, with determinant bacterial taxa such as E. coli and P. copri that overlap what it has been found on their human counterpart. Thus, our results support the use of CAF dogs as a surrogate model to advance our understanding of microbial dynamics in pCD.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 克罗恩氏病（CD）是一种慢性免疫介导的炎症，是由粘膜对共生微生物的耐受力丧失引起的。诊断后10年和20年，平均分别有29.5％和42.7％的CD患者经历肛周并发症。肛周CD（pCD）导致高疾病负担，生活质量下降和医疗保健费用增加。总体pCD是长期不良预后的预测指标。肠道炎症的动物模型未能完全概括瘘管CD的人类表现。在这里，我们评估了具有自发性犬肛门肛门真菌病（CAF）（与pCD具有临床相似性的疾病）的狗，作为了解人类pCD病理生理的微生物贡献的替代模型。通过比较患有CAF的狗（CAF狗）和健康的狗之间的肠道微生物群，我们发现CAF狗的微生物群与健康狗的微生物群非常不同（营养不良）或相似（类似于健康），但独特。与健康或类似健康的CAF微生物组相比，营养不良的CAF微生物组显示寻常型拟杆菌和大肠杆菌的丰度增加，大摩纳哥物种和普氏杆菌的丰度降低。我们的结果反映了先前对CD患者进行的微生物组研究的报道。特别是，CAF狗表现出两种截然不同的微生物组组成：营养不良型和健康型，其决定性细菌类群（如大肠杆菌和柯氏疟原虫）与人类同类动物重叠。因此，我们的结果支持使用CAF狗作为替代模型，以增进我们对pCD中微生物动力学的理解。</p>

<h2>Pubmed_ID: 32719402</h2>

<h3>Multi-omic meta-analysis identifies functional signatures of airway microbiome in chronic obstructive pulmonary disease</h3>

<h3>多组学荟萃分析可鉴定慢性阻塞性肺疾病中气道微生物组的功能特征</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1038/s41396-020-0727-y</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32719402/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: The ISME journal   ||| Not finding IF</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 2020 Nov</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: The interaction between airway microbiome and host in chronic obstructive pulmonary disease (COPD) is poorly understood. Here we used a multi-omic meta-analysis approach to characterize the functional signature of airway microbiome in COPD. We retrieved all public COPD sputum microbiome datasets, totaling 1640 samples from 16S rRNA gene datasets and 26 samples from metagenomic datasets from across the world. We identified microbial taxonomic shifts using random effect meta-analysis and established a global classifier for COPD using 12 microbial genera. We inferred the metabolic potentials for the airway microbiome, established their molecular links to host targets, and explored their effects in a separate meta-analysis on 1340 public human airway transcriptome samples for COPD. 29.6% of differentially expressed human pathways were predicted to be targeted by microbiome metabolism. For inferred metabolite-host interactions, the flux of disease-modifying metabolites as predicted from host transcriptome was generally concordant with their predicted metabolic turnover in microbiome, suggesting a synergistic response between microbiome and host in COPD. The meta-analysis results were further validated by a pilot multi-omic study on 18 COPD patients and 10 controls, in which airway metagenome, metabolome, and host transcriptome were simultaneously characterized. 69.9% of the proposed "microbiome-metabolite-host" interaction links were validated in the independent multi-omic data. Butyrate, homocysteine, and palmitate were the microbial metabolites showing strongest interactions with COPD-associated host genes. Our meta-analysis uncovered functional properties of airway microbiome that interacted with COPD host gene signatures, and demonstrated the possibility of leveraging public multi-omic data to interrogate disease biology.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 慢性阻塞性肺疾病（COPD）中气道微生物组与宿主之间的相互作用了解甚少。在这里，我们使用多组元荟萃分析方法来表征COPD中气道微生物组的功能特征。我们检索了所有公共COPD痰微生物组数据集，总共从16SrRNA基因数据集中提取了1640个样本，从世界各地的宏基因组数据集中提取了26个样本。我们使用随机效应荟萃分析确定了微生物分类学变化，并使用12个微生物属建立了COPD全局分类器。我们推断气道微生物组的代谢潜能，建立它们与宿主靶标的分子联系，并在单独的荟萃分析中对1340种COPD的公共人类气道转录组样品进行了研究。预计29.6％的差异表达人类途径将被微生物组代谢靶向。对于推断的代谢物与宿主的相互作用，从宿主转录组预测的疾病缓解代谢物的通量通常与其在微生物组中预测的代谢转换相一致，这表明COPD中微生物组与宿主之间存在协同反应。这项荟萃分析结果通过一项针对18名COPD患者和10名对照的多组学试验进一步验证，其中气道代谢组，代谢组和宿主转录组同时进行了表征。建议的“微生物组-代谢物-宿主”相互作用链接中有69.9％在独立的多组学数据中得到了验证。丁酸，高半胱氨酸和棕榈酸酯是与COPD相关宿主基因相互作用最强的微生物代谢产物。我们的荟萃分析揭示了与COPD宿主基因特征相互作用的气道微生物组的功能特性，并证明了利用公共多组学数据来询问疾病生物学的可能性。</p>

<h2>Pubmed_ID: 32715918</h2>

<h3>Toward a porcine in vivo model to analyze the pathogenesis of TLR5-dependent enteropathies</h3>

<h3>建立一个猪体内模型以分析TLR5依赖性肠病的发病机理</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1782163</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32715918/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Non-communicable diseases, such as the metabolic syndrome and inflammatory bowel disease, constitute serious public health threats in developed countries. Besides environmental factors, genetic predispositions contribute to the onset and progression of the disease. State-of-the-art mouse models recently highlight the involvement of Toll-like receptor 5 (TLR5)-driven microbiota composition in the development of metabolic disorders. Here, we discuss the causes and consequences of an altered enteric microbiota and provide information on a similar mechanism in another species, the pig. We show for the first time that a single nucleotide polymorphism in the porcine TLR5 gene conferring impaired functionality is associated with changes in the intestinal microbiota in adult sows and neonatal piglets. Changes in the developing adaptive cellular immune response support the concept of TLR5-driven changes of the microbe-host interplay also in the pig. Together, these findings suggest that pigs with impaired TLR-functionality might represent a model for TLR5-driven diseases in humans.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 诸如代谢综合征和炎症性肠病等非传染性疾病在发达国家构成严重的公共卫生威胁。除环境因素外，遗传易感性也有助于疾病的发作和发展。最新的小鼠模型强调了Toll样受体5（TLR5）驱动的微生物群组成与代谢紊乱的发展有关。在这里，我们讨论肠道微生物群改变的原因和后果，并提供有关另一种物种（猪）中类似机制的信息。我们首次显示，在猪TLR5基因中赋予功能受损的单核苷酸多态性与成年母猪和新生仔猪肠道菌群的变化有关。不断发展的适应性细胞免疫反应的变化也支持了TLR5驱动的微生物与宿主之间相互作用的变化。总之，这些发现表明，TLR功能受损的猪可能代表了人类TLR5驱动疾病的模型。</p>

<h2>Pubmed_ID: 32691669</h2>

<h3>TH1 cell-inducing Escherichia coli strain identified from the small intestinal mucosa of patients with Crohn's disease</h3>

<h3>从克罗恩病患者的小肠粘膜中鉴定出可诱导TH1细胞的大肠杆菌菌株</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1788898</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32691669/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Dysbiotic microbiota contributes to the pathogenesis of Crohn's disease (CD) by regulating the immune system. Although pro-inflammatory microbes are probably enriched in the small intestinal (SI) mucosa, most studies have focused on fecal microbiota. This study aimed to examine jejunal and ileal mucosal specimens from patients with CD via double-balloon enteroscopy. Comparative microbiome analysis revealed that the microbiota composition of CD SI mucosa differs from that of non-CD controls, with an increased population of several families, including Enterobacteriaceae, Ruminococcaceae, and Bacteroidaceae. Upon anaerobic culturing of the CD SI mucosa, 80 bacterial strains were isolated, from which 9 strains representing 9 distinct species (Escherichia coli, Ruminococcus gnavus, Klebsiella pneumoniae, Erysipelatoclostridium ramosum, Bacteroides dorei, B. fragilis, B. uniformis, Parabacteroides distasonis, and Streptococcus pasteurianus) were selected on the basis of their significant association with CD. The colonization of germ-free (GF) mice with the 9 strains enhanced the accumulation of TH1 cells and, to a lesser extent, TH17 cells in the intestine, among which an E. coli strain displayed high potential to induce TH1 cells and intestinal inflammation in a strain-specific manner. The present results indicate that the CD SI mucosa harbors unique pro-inflammatory microbiota, including TH1 cell-inducing E. coli, which could be a potential therapeutic target.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 营养不良微生物群通过调节免疫系统，促进了克罗恩病（CD）的发病。尽管促炎性微生物可能富含小肠（SI）粘膜，但大多数研究都集中在粪便微生物群上。这项研究旨在通过双气囊肠镜检查来检查CD患者的空肠和回肠粘膜标本。比较的微生物组分析显示，CDSI粘膜的微生物群组成与非CD对照不同，包括肠杆菌科，瘤胃菌科和拟杆菌科在内的数个家庭的种群增加。在厌氧培养CDSI粘膜上，分离出80个细菌菌株，其中9个菌株代表9种不同的菌种（大肠杆菌，鲁美球菌，肺炎克雷伯菌，产气荚膜芽孢杆菌，Bacteroidesdorei，脆弱型芽孢杆菌，均匀芽孢杆菌，副细菌）根据其与CD的显着相关性，选择了巴斯德氏菌和巴斯德链球菌。用这9种菌株对无菌（GF）小鼠进行的定殖可增强肠道中TH1细胞的积累，并在较小程度上增强TH17细胞的积累，其中大肠杆菌菌株具有诱导TH1细胞和肠道炎症的高潜力以应变特定的方式。目前的结果表明，CDSI粘膜具有独特的促炎微生物菌群，包括诱导TH1细胞的大肠杆菌，这可能是潜在的治疗靶点。</p>

<h2>Pubmed_ID: 32686598</h2>

<h3>Gut microbiota regulate tumor metastasis via circRNA/miRNA networks</h3>

<h3>肠道菌群通过circRNA / miRNA网络调节肿瘤转移</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1788891</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32686598/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Background: Increasing evidence indicates that gut microbiota plays an important role in cancer progression. However, the underlying mechanism remains largely unknown. Here, we report that broad-spectrum antibiotics (ABX) treatment leads to enhanced metastasis by the alteration of gut microbiome composition. Methods: Cancer LLC and B16-F10 cell metastasis mouse models, and microarray/RNA sequencing analysis were used to reveal the regulatory functions of microbiota-mediated circular RNA (circRNA)/microRNA (miRNA) networks that may contribute to cancer metastasis. Results: The specific pathogen-free (SPF) mice with ABX treatment demonstrated enhanced lung metastasis. Fecal microbiota transplantation (FMT) from SPF mice or Bifidobacterium into germ-free mice significantly suppressed lung metastasis. Mechanistically, gut microbiota impacts circRNA expression to regulate levels of corresponding miRNAs. Specifically, such modulations of gut microbiota inhibit mmu_circ_0000730 expression in an IL-11-dependent manner. Bioinformatics analysis combined with luciferase reporter assays revealed reciprocal repression between mmu_circ_0000730 and mmu-miR-466i-3p. We further showed that both mmu-miR-466i-3p and mmu-miR-466 f-3p suppresses a number of genes involved in epithelial-mesenchymal transition (EMT) and stemness of cancer stem cells such as SOX9. Conclusions: These results provide evidence of a previously unrecognized regulatory role of non-coding RNAs in microbiota-mediated cancer metastasis, and thus, the microbiome may serve as a therapeutic target.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 背景：越来越多的证据表明，肠道菌群在癌症进展中起着重要作用。但是，基本机制仍然未知。在这里，我们报告说，广谱抗生素（ABX）治疗通过改变肠道微生物组组成导致转移增强。方法：使用癌症LLC和B16-F10细胞转移小鼠模型以及微阵列/RNA测序分析来揭示微生物群介导的环状RNA（circRNA）/microRNA（miRNA）网络的调控功能，这可能有助于癌症转移。结果：经过ABX处理的特定无病原体（SPF）小鼠表现出增强的肺转移能力。从SPF小鼠或双歧杆菌到无菌细菌的粪便微生物菌群移植（FMT）显着抑制了肺转移。从机制上讲，肠道菌群会影响circRNA表达，从而调节相应miRNA的水平。具体而言，肠道微生物群的这种调节以IL-11-依赖性方式抑制mmu_circ_0000730表达。生物信息学分析与萤光素酶报告基因分析相结合，揭示了mmu_circ_0000730与mmu-miR-466i-3p之间的相互抑制。我们进一步显示，mmu-miR-466i-3p和mmu-miR-466f-3p都抑制许多与上皮间质转化（EMT）和癌症干细胞干细胞（例如SOX9）有关的基因。结论：这些结果提供了以前无法识别的非编码RNA在微生物群介导的癌症转移中的调节作用的证据，因此，微生物组可以作为治疗靶标。</p>

<h2>Pubmed_ID: 32684075</h2>

<h3>Changes in the fecal bacterial microbiota associated with disease severity in alcoholic hepatitis patients</h3>

<h3>酒精性肝炎患者粪便细菌群的变化与疾病严重程度的关系</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1785251</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32684075/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Background and aims: Alcoholic hepatitis is the most severe form of alcohol-related liver disease. While the gut microbiome is known to play a role in disease development and progression, less is known about specific compositional changes of the gut bacterial microbiome associated with disease severity. Therefore, the aim of our study was to correlate gut microbiota features with disease severity in alcoholic hepatitis patients. Methods: We used 16S rRNA gene sequencing on fecal samples from 74 alcoholic hepatitis patients, which were enrolled at 9 centers in Europe, the United States, and Mexico in a multi-center observational study. The relative abundance of gut bacterial taxa on genus level, as well as the microbiome diversity, was correlated to various clinical, laboratory, and histologic parameters. Results: We observed a negative correlation between the model for end-stage liver disease score and Shannon diversity, independent of potentially confounding factors (Padjust = 0.046). Alcoholic hepatitis patients with more severe disease had significantly decreased relative abundances of Akkermansia while the relative abundance of Veillonella was increased. We observed a reduction in the Bacteroides abundance (Padjust = 0.048) and Shannon diversity (Padjust = 0.018) in antibiotic-treated patients and patients receiving steroids had an increase in Veillonella abundance (Padjust = 0.005), which was both independent of potentially confounding factors. Conclusion: We observed distinct changes in the gut bacterial microbiome of alcoholic hepatitis patients with more severe disease. The gut bacterial microbiome might be an attractive target to prevent and treat this deadly disease.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 背景与目的：酒精性肝炎是酒精相关性肝病的最严重形式。虽然已知肠道微生物组在疾病的发展和进程中起作用，但对肠道细菌微生物组与疾病严重程度相关的特定组成变化的了解却很少。因此，我们研究的目的是使酒精性肝炎患者的肠道菌群特征与疾病严重程度相关联。方法：我们对74例酒精性肝炎患者的粪便样本进行了16SrRNA基因测序，这些样本在欧洲，美国和墨西哥的9个中心进行了多中心观察研究。肠道菌群在属水平上的相对丰度以及微生物组的多样性与各种临床，实验室和组织学参数相关。结果：我们观察到终末期肝病评分模型与香农多样性之间存在负相关关系，而与潜在的混杂因素无关（Padjust=0.046）。酒精中毒和重症的肝炎患者阿克曼病的相对丰度显着降低，而韦永氏菌的相对丰度则升高。我们观察到抗生素治疗的患者中拟杆菌的丰度（Padjust=0.048）和香农多样性（Padjust=0.018）降低，接受类固醇的患者Veillonella丰度有所增加（Padjust=0.005），这两者均与潜在的混杂因素无关。结论：我们观察到酒精性肝炎病情较重的患者肠道细菌微生物组发生了明显变化。肠道细菌微生物组可能是预防和治疗这种致命疾病的诱人靶标。</p>

<h2>Pubmed_ID: 32681160</h2>

<h3>The gut microbiota of brood parasite and host nestlings reared within the same environment: disentangling genetic and environmental effects</h3>

<h3>在相同环境中饲养的寄生虫和宿主雏鸟的肠道菌群：消除遗传和环境影响</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1038/s41396-020-0719-y</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32681160/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: The ISME journal   ||| Not finding IF</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 2020 Nov</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Gut microbiota are essential for host health and survival, but we are still far from understanding the processes involved in shaping their composition and evolution. Controlled experimental work under lab conditions as well as human studies pointed at environmental factors (i.e., diet) as the main determinant of the microbiota with little evidence of genetic effects, while comparative interspecific studies detected significant phylogenetic effects. Different species, however, also differ in diet, feeding behavior, and environmental characteristics of habitats, all of which also vary interspecifically, and, therefore, can potentially explain most of the detected phylogenetic patterns. Here, we take advantage of the reproductive strategy of avian brood parasites and investigate gut microbiotas (esophageal (food and saliva) and intestinal) of great spotted cuckoo (Clamator glandarius) and magpie (Pica pica) nestlings that grow in the same nests. We also estimated diet received by each nestling and explored its association with gut microbiota characteristics. Although esophageal microbiota of magpies and great spotted cuckoos raised within the same environment (nest) did not vary, the microbiota of cloacal samples showed clear interspecific differences. Moreover, diet of great spotted cuckoo and magpie nestlings explained the microbiota composition of esophageal samples, but not of cloaca samples. These results strongly suggest a genetic component determining the intestinal microbiota of host and parasitic bird species, indicating that interspecific differences in gut morphology and physiology are responsible for such interspecific differences.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 肠道菌群对于宿主的健康和生存至关重要，但我们仍然距离了解影响其组成和进化的过程还很远。在实验室条件下进行的受控实验工作以及人类研究均指出，环境因素（即饮食）是微生物群的主要决定因素，几乎没有遗传效应的证据，而种间比较研究则发现了显着的系统发育效应。但是，不同物种的饮食，进食行为和栖息地的环境特征也有所不同，所有这些物种之间也存在种间差异，因此可以潜在地解释大多数检测到的系统发育模式。在这里，我们利用鸟类繁殖的寄生虫的繁殖策略，研究了在同一巢中生长的大杜鹃（Clamatorglandarius）和喜（（Picapica）雏鸟的肠道微生物群（食道（食物和唾液）和肠道）。我们还估计了每个雏鸟的饮食，并探讨了其与肠道菌群特征的关系。尽管在同一环境（巢）中饲养的喜pies和大型布杜鹃的食管菌群没有变化，但泄殖腔样品的菌群显示出明显的种间差异。而且，布谷鸟和喜nest雏鸟的饮食可以解释食道样本的微生物群组成，而泄殖腔样本则不能。这些结果强烈表明，遗传因素决定了宿主和寄生鸟类的肠道菌群，表明肠道形态和生理上的种间差异是造成这种种间差异的原因。</p>

<h2>Pubmed_ID: 32663105</h2>

<h3>Cancer-protective effect of a synbiotic combination between Lactobacillus gasseri 505 and a Cudrania tricuspidata leaf extract on colitis-associated colorectal cancer</h3>

<h3>加塞氏乳杆菌505和a木叶片提取物的合生元组合对结肠炎相关的大肠癌的抗癌作用</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1785803</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32663105/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Previously, a synbiotic combination of probiotic Lactobacillus gasseri 505 (LG) and a new prebiotic, Cudrania tricuspidata leaf extract (CT) in fermented milk, designated FCT, showed an in vitro immunomodulatory effect and antioxidant activity. Although synbiotic combination might have cancer-protective effects, these activities have not been fully validated in vivo. Ten-week treatment of LG, CT, or FCT to azoxymethane (AOM)/dextran sodium sulfate (DSS)-induced colitis-associated colorectal cancer (CAC) mouse model reduced both the incidence of colonic tumors and damage to the colonic mucosa effectively, suggesting a cancer-protective effect. To understand these, biomarkers associated with inflammation, colon barrier, apoptosis, and cancer cell proliferation were monitored in AOM/DSS group versus LG/CT/FCT groups. A synbiotic combination (FCT) down-regulated pro-inflammatory cytokines (TNF-α, IFN-γ, IL-1β, and IL-6) and inflammation-associated enzymes (iNOS and COX-2), and up-regulated anti-inflammatory cytokines (IL-4 and IL-10). In addition, colon barrier experiment revealed that biomarkers of mucus layer (MUC-2 and TFF3) and tight junction (occludin and ZO-1) were up-regulated. Subsequent apoptosis experiment showed that pro-apoptotic factors (p53, p21, and Bax) were up-regulated and anti-apoptotic factors (Bcl-2 and Bcl-xL) were down-regulated. Furthermore, comparative metagenome analysis of gut microbiota revealed that Staphylococcus decreased but Lactobacillus, Bifidobacterium, and Akkermansia increased, supporting their protective effects, accompanied by increased short-chain fatty acids (SCFAs). Taken together, the FCT administration showed cancer-protective effects by reducing the risk of colitis-associated colon cancer via regulation of inflammation, carcinogenesis, and compositional change of gut microbiota. Consequently, the synbiotic combination (FCT) could be a novel potential health-protective natural agent against CAC.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 以前，益生菌格氏乳杆菌505（LG）和新型益生元，即发酵乳中的Cudraniatricuspidata叶提取物（CT）的共生组合，即FCT，具有体外免疫调节作用和抗氧化活性。尽管合生元组合可能具有抗癌作用，但这些活性尚未在体内得到充分验证。LG，CT或FCT对乙氧基甲烷（AOM）/右旋糖酐硫酸钠（DSS）诱导的结肠炎相关结直肠癌（CAC）小鼠模型进行的十周治疗有效地降低了结肠肿瘤的发生率和对结肠粘膜的损害，提示有保护癌症的作用。为了理解这些，在AOM/DSS组与LG/CT/FCT组中监测了与炎症，结肠屏障，凋亡和癌细胞增殖相关的生物标志物。一种合生元组合（FCT）下调促炎细胞因子（TNF-α，IFN-γ，IL-1β和IL-6）和炎症相关酶（iNOS和COX-2），并上调抗炎性细胞因子（IL-4和IL-10）。此外，结肠屏障实验显示粘液层（MUC-2和TFF3）和紧密连接（occludin和ZO-1）的生物标志物被上调。随后的凋亡实验表明，促凋亡因子（p53，p21和Bax）被上调，而抗凋亡因子（Bcl-2和Bcl-xL）被下调。此外，对肠道菌群的比较元基因组分析表明，葡萄球菌减少，而乳酸杆菌，双歧杆菌和阿克曼菌增加，支持它们的保护作用，同时增加短链脂肪酸（SCFA）。综上所述，FCT给药通过调节炎症，致癌作用和肠道菌群组成来降低结肠炎相关结肠癌的风险，从而显示出癌症保护作用。因此，合生元组合（FCT）可能是针对CAC的新型潜在的健康保护性天然药物。</p>

<h2>Pubmed_ID: 32663059</h2>

<h3>The gut microbiome stability is altered by probiotic ingestion and improved by the continuous supplementation of galactooligosaccharide</h3>

<h3>益生菌摄入会改变肠道微生物组的稳定性，而不断补充低聚半乳糖会改善肠道微生物组的稳定性</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1785252</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32663059/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: The stable gut microbiome plays a key role in sustaining host health, while the instability of gut microbiome also has been found to be a risk factor of various metabolic diseases. At the ecological and evolutionary scales, the inevitable competition between the ingested probiotic and indigenous gut microbiome can lead to an increase in the instability. It remains largely unclear if and how exogenous prebiotic can improve the overall gut microbiome stability in probiotic consumption. In this study, we used Lactobacillus plantarum HNU082 (Lp082) as a model probiotic to examine the impact of the continuous or pulsed supplementation of galactooligosaccharide (GOS) on the gut microbiome stability in mice using shotgun metagenomic sequencing. Only continuous GOS supplement promoted the growth of probiotic and decreased its single-nucleotide polymorphisms (SNPs) mutation under competitive conditions. Besides, persistent GOS supplementation increased the overall stability, reshaped the probiotic competitive interactions with Bacteroides species in the indigenous microbiome, which was also evident by over-abundance of carbohydrate-active enzymes (CAZymes) accordingly. Also, we identified a total of 793 SNPs arisen in probiotic administration in the indigenous microbiome. Over 90% of them derived from Bacteroides species, which involved genes encoding transposase, CAZymes, and membrane proteins. However, neither GOS supplementation here de-escalated the overall adaptive mutations within the indigenous microbes during probiotic intake. Collectively, our study demonstrated the beneficial effect of continuous prebiotic supplementation on the ecological and genetic stability of gut microbiomes.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 稳定的肠道微生物组在维持宿主健康中起着关键作用，而肠道微生物组的不稳定性也被认为是各种代谢疾病的危险因素。在生态和进化尺度上，摄入的益生菌和本地肠道微生物组之间不可避免的竞争会导致不稳定性的增加。在益生菌消费中，外源益生元是否以及如何改善肠道整体微生物组的稳定性尚不清楚。在这项研究中，我们使用植物乳杆菌HNU082（Lp082）作为模型益生菌，使用散弹枪宏基因组测序研究了连续或脉冲补充低聚半乳糖（GOS）对小鼠肠道微生物组稳定性的影响。只有连续的GOS补充剂才能在竞争条件下促进益生菌的生长并降低其单核苷酸多态性（SNPs）突变。此外，持久性GOS的补充增加了整体稳定性，重塑了益生菌与本地微生物组中拟杆菌属的竞争性相互作用，这也相应地表现为碳水化合物活性酶（CAZymes）过量。此外，我们确定了在土著微生物组中益生菌给药中产生的总共793个SNP。其中超过90％来自拟杆菌属，其中涉及编码转座酶，CAZymes和膜蛋白的基因。然而，在益生菌摄入期间，此处既没有添加GOS也没有降低土著微生物内部的总体适应性突变。总的来说，我们的研究证明了连续补充益生元对肠道微生物群生态和遗传稳定性的有益作用。</p>

<h2>Pubmed_ID: 32658601</h2>

<h3>Extremely preterm neonates have more Lactobacillus in meconium than very preterm neonates - the in utero microbial colonization hypothesis</h3>

<h3>极早产儿在胎粪中的乳杆菌比极早产儿多-子宫内微生物定植假说</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1785804</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32658601/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Growing evidence suggests that maternal microbiota can influence the neonates' gut colonization. However, the mechanisms of vertical bacterial transmission remain poorly defined. We believed that the first colonizers of the newborn come from the mother's gut and vagina during pregnancy and that this is independent of the mode of delivery. We conducted an observational longitudinal study to evaluate the link between the maternal gut microbiota and the meconium's microbiota in extremely and very preterm neonates. Bacterial DNA was extracted from samples and specific bacterial groups were quantified by RT-PCR. In this cohort of 117 preterm neonates, we detected bacterial DNA in 88% of meconium samples. Meconium microbiota of neonates born after 28 gestational weeks (very preterm neonates) showed stronger correlations with their mothers' fecal microbiota. However, neonates born before 28 gestational weeks (extremely preterm neonates) had more Lactobacillus - genus that dominated the vaginal microbiota - than very preterm neonates, regardless of the mode of delivery. Collectively, these data support the hypothesis that maternal bacteria from the gut and vagina can play a role in shaping neonates' gut microbiota and that mother-to-infant bacterial transmission is a controlled and time-specific process. ClinicalTrials.gov Identifier: NCT03663556.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 越来越多的证据表明，母体微生物群会影响新生儿的肠道定植。但是，垂直细菌传播的机制仍然不清楚。我们认为，新生儿的第一批定居者在怀孕期间来自母亲的肠道和阴道，这与分娩方式无关。我们进行了一项观察性纵向研究，以评估极早产儿的肠道菌群与胎粪菌群之间的联系。从样品中提取细菌DNA，并通过RT-PCR定量特定细菌群。在这117个早产儿队列中，我们在88％的胎粪样本中检测到细菌DNA。妊娠28周后出生的新生儿胎粪菌群（非常早产儿）与母亲的粪便微生物群相关性更强。但是，无论分娩方式如何，在妊娠28周之前出生的新生儿（极早产儿）比绝大多数早产儿具有更多的乳杆菌（占阴道菌群的属）。总的来说，这些数据支持以下假设：来自肠道和阴道的母体细菌可以在塑造新生儿的肠道菌群中发挥作用，而母婴细菌的传播是一个受控制且特定于时间的过程。ClinicalTrials.gov标识符：NCT03663556。</p>

<h2>Pubmed_ID: 32618494</h2>

<h3>Hemolysin BL from novel Bacillus toyonensis BV-17 induces antitumor activity both in vitro and in vivo</h3>

<h3>来自新型芽孢杆菌BV-17的溶血素BL在体内和体外均诱导抗肿瘤活性</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1782158</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32618494/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: The gut microbiota plays an important role in cancer development and immunotherapy. Bacterial toxins have enormous antitumor potential due to their cytotoxicity and ability to activate the immune system. Using 16S rRNA gene sequencing, we compared the gut microbiota composition of fecal samples from healthy individuals and patients with colorectal cancer (CRC) and observed that the genus Bacillus was common in the healthy donors but was absent in the CRC patients. Further, we isolated a novel Bacillus toyonensis BV-17 from the fecal samples of the healthy individuals. Our results showed that the supernatant of the Bacillus toyonensis BV-17 cultures could quickly kill various tumor cell lines within minutes in vitro, by causing cell membrane disruption, blebbing, and leakage of cytoplasmic content. Fast protein liquid chromatography (FPLC) and mass spectrometry analysis identified hemolysin BL (HBL) as the effector molecule, which exhibits a different cytotoxicity mechanism compared to previous studies. Intra-tumor injection of low dose HBL inhibited the growth of both treated and untreated tumors in mice. The outcomes of this pioneer study suggest that HBL exhibits antitumor activity and is a potential chemotherapeutic agent that could be engineered to target only tumor cells in future.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 肠道菌群在癌症发展和免疫治疗中起着重要作用。细菌毒素具有细胞毒性和激活免疫系统的能力，因此具有巨大的抗肿瘤潜力。使用16SrRNA基因测序，我们比较了健康人和结直肠癌（CRC）患者粪便样品的肠道菌群组成，并观察到芽孢杆菌属在健康供体中很常见，但在CRC患者中却不存在。此外，我们从健康个体的粪便样品中分离了一种新型的芽孢杆菌芽孢杆菌BV-17。我们的结果表明，Toonensis芽孢杆菌BV-17培养物的上清液可在体外在几分钟内迅速杀死各种肿瘤细胞系，从而引起细胞膜破裂，起泡和细胞质内容物泄漏。快速蛋白液相色谱（FPLC）和质谱分析确定溶血素BL（HBL）是效应分子，与以前的研究相比，其表现出不同的细胞毒性机制。肿瘤内低剂量HBL的注射抑制小鼠中已治疗和未治疗肿瘤的生长。这项先驱研究的结果表明，HBL具有抗肿瘤活性，并且是一种潜在的化学治疗剂，将来可被设计成仅靶向肿瘤细胞。</p>

<h2>Pubmed_ID: 32615913</h2>

<h3>Longitudinal gut microbiome changes in alcohol use disorder are influenced by abstinence and drinking quantity</h3>

<h3>酒精使用障碍的纵向肠道微生物组变化受戒酒和饮酒量的影响</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1758010</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32615913/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Many patients with alcohol use disorder (AUD) consume alcohol chronically and in large amounts that alter intestinal microbiota, damage the gastrointestinal tract, and thereby injure other organs via malabsorption and intestinal inflammation. We hypothesized that alcohol consumption and subsequent abstinence would change the gut microbiome in adults admitted to a treatment program. Stool and oral specimens, diet data, gastrointestinal assessment scores, anxiety, depression measures and drinking amounts were collected longitudinally for up to 4 weeks in 22 newly abstinent inpatients with AUD who were dichotomized as less heavy drinkers (LHD, <10 drinks/d) and very heavy drinkers (VHD, 10 or more drinks/d). Next-generation 16 S rRNA gene sequencing was performed to measure the gut and oral microbiome at up to ten time points/subject and LHD and VHD were compared for change in principal components, Shannon diversity index and specific genera. The first three principal components explained 46.7% of the variance in gut microbiome diversity across time and all study subjects, indicating the change in gut microbiome following abstinence. The first time point was an outlier in three-dimensional principal component space versus all other time points. The gut microbiota in LHD and VHD were significantly dissimilar in change from day 1 to day 5 (p = .03) and from day 1 to week 3 (p = .02). The VHD drinking group displayed greater change from baseline. The Shannon diversity index of the gut microbiome changed significantly during abstinence in five participants. In both groups, the Shannon diversity was lower in the oral microbiome than gut. Ten total genera were shared between oral and stool in the AUD participants. These data were compared with healthy controls from the Human Microbiome Project to investigate the concept of a core microbiome. Rapid changes in gut microbiome following abstinence from alcohol suggest resilience of the gut microbiome in AUD and reflects the benefits of refraining from the highest levels of alcohol and potential benefits of abstinence.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 许多患有酒精使用障碍（AUD）的患者长期大量饮酒，这会改变肠道菌群，损害胃肠道，从而通过吸收不良和肠道炎症伤害其他器官。我们假设饮酒和随后的戒酒会改变接受治疗方案的成年人的肠道微生物组。纵向收集了22名刚戒断的AUD住院患者的粪便和口腔标本，饮食数据，胃肠道评估评分，焦虑，抑郁量度和饮酒量，长达4周，这些患者被分为轻度饮酒者（LHD，<10杯/天）和非常沉重的饮酒者（VHD，每天喝10杯或更多）。进行了下一代16SrRNA基因测序，以测量肠道和口腔微生物组的最高时间点为10个时间点/受试者，并比较了LHD和VHD的主要成分，香农多样性指数和特定属的变化。前三个主要成分解释了整个时间段和所有研究对象的肠道微生物组多样性的46.7％的变化，表明禁欲后肠道微生物组的变化。第一个时间点是三维主成分空间与所有其他时间点的异常值。从第1天到第5天（p=.03）和从第1天到第3周（p=.02），LHD和VHD中的肠道菌群变化显着不同。VHD饮酒组与基线相比显示出更大的变化。在五位参与者的节制期间，肠道微生物组的香农多样性指数发生了显着变化。在两组中，口腔微生物组的香农多样性均低于肠道。AUD参加者的口腔和粪便共有10个属。将这些数据与人类微生物组计划的健康对照进行比较，以研究核心微生物组的概念。戒酒后肠道微生物组的快速变化表明肠道微生物组在澳元中具有恢复力，反映出戒除酒精含量最高的好处以及戒酒的潜在好处。</p>

<h2>Pubmed_ID: 32588725</h2>

<h3>Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans</h3>

<h3>肠道通透性，微生物移位，十二指肠和粪便微生物群的变化及其与人类酒精性肝病进展的关系</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1782157</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32588725/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Background: Animal data suggest a role of the gut-liver axis in progression of alcoholic liver disease (ALD), but human data are scarce especially for early disease stages. Methods: We included patients with alcohol use disorder (AUD) who follow a rehabilitation program and matched healthy controls. We determined intestinal epithelial and vascular permeability (IP) (using urinary excretion of 51Cr-EDTA, fecal albumin content, and immunohistochemistry in distal duodenal biopsies), epithelial damage (histology, serum iFABP, and intestinal gene expression), and microbial translocation (Gram - and Gram + serum markers by ELISA). Duodenal mucosa-associated microbiota and fecal microbiota were analyzed by 16 S rRNA sequencing. ALD was staged by Fibroscan® (liver stiffness, controlled attenuation parameter) in combination with serum AST, ALT, and CK18-M65. Results: Only a subset of AUD patients had increased 51Cr-EDTA and fecal albumin together with disrupted tight junctions and vasculature expression of plasmalemma Vesicle-Associated Protein-1. The so-defined increased intestinal permeability was not related to changes of the duodenal microbiota or alterations of the intestinal epithelium but associated with compositional changes of the fecal microbiota. Leaky gut alone did not explain increased microbial translocation in AUD patients. By contrast, duodenal dysbiosis with a dominance shift toward specific potential pathogenic bacteria genera (Streptococcus, Shuttleworthia, Rothia), increased IP and elevated markers of microbial translocation characterized AUD patients with progressive ALD (steato-hepatitis, steato-fibrosis). Conclusion: Progressive ALD already at early disease stages is associated with duodenal mucosa-associated dysbiosis and elevated microbial translocation. Surprisingly, such modifications were not linked with increased IP. Rather, increased IP appears related to fecal microbiota dysbiosis.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 背景：动物数据提示肠肝轴在酒精性肝病（ALD）进程中的作用，但人类数据稀少，尤其是在疾病早期。方法：我们纳入了遵循康复计划并匹配健康对照的酒精滥用障碍（AUD）患者。我们确定了肠上皮和血管通透性（IP）（使用51Cr-EDTA的尿液排泄，粪便白蛋白含量和十二指肠远端活检的免疫组化），上皮损伤（组织学，血清iFABP和肠基因表达）以及微生物移位（Gram-和革兰氏+血清标志物（通过ELISA）。通过16SrRNA测序分析十二指肠粘膜相关菌群和粪便菌群。ALD通过结合血清AST，ALT和CK18-M65（肝脏硬度，可控制的衰减参数）进行分级。结果：只有一部分AUD患者的51Cr-EDTA和粪便白蛋白增加，血浆膜囊泡相关蛋白1的紧密连接和脉管系统表达受损。如此增加的肠通透性与十二指肠微生物群的改变或肠上皮的改变无关，而与粪便微生物群的组成改变有关。肠道泄漏本身并不能解释AUD患者微生物易位的增加。相比之下，十二指肠营养不良的特点是向特定的潜在病原菌属（链球菌，Shuttleworthia，Rothia）转移，IP升高和微生物易位标记升高，这些特点是AUD患者进行性ALD（脂肪性肝炎，脂肪性纤维化）。结论：已经在疾病早期阶段进行的ALD与十二指肠粘膜相关的营养不良和微生物易位相关。令人惊讶的是，此类修改与IP的增加没有关联。相反，IP增加似乎与粪便微生物群失调有关。</p>

<h2>Pubmed_ID: 32586195</h2>

<h3>The autoimmune susceptibility gene, PTPN2, restricts expansion of a novel mouse adherent-invasive E. coli</h3>

<h3>自身免疫敏感性基因PTPN2限制新型小鼠粘附侵袭性大肠杆菌的扩增</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1775538</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32586195/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Inflammatory bowel disease (IBD) pathogenesis involves significant contributions from genetic and environmental factors. Loss-of-function single-nucleotide polymorphisms (SNPs) in the protein tyrosine phosphatase non-receptor type 2 (PTPN2) gene increase IBD risk and are associated with altered microbiome population dynamics in IBD. Expansion of intestinal pathobionts, such as adherent-invasive E. coli (AIEC), is strongly implicated in IBD pathogenesis as AIEC increases pro-inflammatory cytokine production and alters tight junction protein regulation - suggesting a potential mechanism of pathogen-induced barrier dysfunction and inflammation. We aimed to determine if PTPN2 deficiency alters intestinal microbiome composition to promote expansion of specific bacteria with pathogenic properties. In mice constitutively lacking Ptpn2, we identified increased abundance of a novel mouse AIEC (mAIEC) that showed similar adherence and invasion of intestinal epithelial cells, but greater survival in macrophages, to the IBD-associated AIEC, LF82. Furthermore, mAIEC caused disease when administered to mice lacking segmented-filamentous bacteria (SFB), and in germ-free mice but only when reconstituted with a microbiome, thus supporting its classification as a pathobiont, not a pathogen. Moreover, mAIEC infection increased the severity of, and prevented recovery from, induced colitis. Although mAIEC genome sequence analysis showed >90% similarity to LF82, mAIEC contained putative virulence genes with >50% difference in gene/protein identities from LF82 indicating potentially distinct genetic features of mAIEC. We show for the first time that an IBD susceptibility gene, PTPN2, modulates the gut microbiome to protect against a novel pathobiont. This study generates new insights into gene-environment-microbiome interactions in IBD and identifies a new model to study AIEC-host interactions.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 炎症性肠病（IBD）发病机理涉及遗传和环境因素的重大贡献。蛋白酪氨酸磷酸酶非受体2型（PTPN2）基因功能丧失的单核苷酸多态性（SNP）增加IBD风险，并与IBD中微生物组种群动态变化有关。肠病原生物的扩张，例如黏附侵入性大肠杆菌（AIEC），与IBD发病机理密切相关，因为AIEC增加了促炎性细胞因子的产生并改变了紧密连接蛋白的调节-表明病原体诱导的屏障功能障碍和炎症的潜在机制。我们旨在确定PTPN2缺乏症是否会改变肠道微生物组组成，以促进具有致病特性的特定细菌的扩增。在组成型缺乏Ptpn2的小鼠中，我们发现与IBD相关的AIEC，LF82相比，新型小鼠AIEC（mAIEC）的丰度增加，该AIEC显示出与肠上皮细胞相似的粘附和侵袭，但在巨噬细胞中的存活率更高。此外，mAIEC会在缺乏分段丝状细菌（SFB）的小鼠中以及在无菌小鼠中（但仅在用微生物组重构时）引起疾病，因此支持将其分类为病原体而不是病原体。而且，mAIEC感染增加了诱发性结肠炎的严重性并阻止了其恢复。尽管mAIEC基因组序列分析显示与LF82的相似性>90％，但mAIEC包含推定的毒力基因，与LF82的基因/蛋白质同一性差异>50％，表明mAIEC可能具有不同的遗传特征。我们首次表明，IBD易感基因PTPN2调节肠道微生物组，以防御新型病原菌。这项研究对IBD中的基因-环境-微生物组相互作用产生了新的见解，并确定了研究AIEC-宿主相互作用的新模型。</p>

<h2>Pubmed_ID: 32584650</h2>

<h3>Bifidobacterium longum alleviates irritable bowel syndrome-related visceral hypersensitivity and microbiota dysbiosis via Paneth cell regulation</h3>

<h3>长双歧杆菌通过Paneth细胞调节减轻肠易激综合征相关的内脏超敏反应和微生物群失调</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1782156</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32584650/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Although the oral administration of Bifidobacterium longum (B. longum) relieves the signs of irritable bowel syndrome (IBS) in clinical settings, the mechanisms underlying its effects are unclear. In this study, we evaluated the precise effects of B. longum on IBS via regulation of Paneth cell function. We confirmed the beneficial effects of B. longum on defecation habits and visceral hypersensitivity in WAS rats. Further analysis revealed that B. longum enhanced mucosal repair, promoted lysozyme production, and ameliorated dysbiosis of the microbiota in WAS rats. These processes are closely correlated with Paneth cell functions. In vitro, we incubated primary cultured enteroids with B. longum and found that B. longum promoted the proliferation of these organoids; this may be attributed to the upregulation of the stem niche factors WNT3A and TGF-β, which are secreted by Paneth cells. Based on our findings, we propose that B. longum relieves IBS by restoring the antimicrobial activity and stem niche maintenance function of Paneth cells.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 尽管口服双歧杆菌（长双歧杆菌）可缓解临床环境中肠易激综合征（IBS）的症状，但其作用机理尚不清楚。在这项研究中，我们通过调节Paneth细胞功能评估了长双歧杆菌对IBS的精确作用。我们证实了长双歧杆菌对WAS大鼠排便习惯和内脏超敏反应的有益作用。进一步的分析表明，长双歧杆菌增强了粘膜修复，促进了溶菌酶的产生，并改善了WAS大鼠中微生物群的营养不良。这些过程与Paneth细胞功能密切相关。在体外，我们用长双歧杆菌孵育了原代培养的类肠素，发现长双歧杆菌可促进这些类器官的增殖。这可能归因于Paneth细胞分泌的干生境因子WNT3A和TGF-β的上调。根据我们的发现，我们建议长双歧杆菌通过恢复Paneth细胞的抗菌活性和干生位维持功能来缓解IBS。</p>

<h2>Pubmed_ID: 32584649</h2>

<h3>Peptidase PepP is a novel virulence factor of Campylobacter jejuni contributing to murine campylobacteriosis</h3>

<h3>肽酶PepP是空肠弯曲菌的新型致病因子，可导致鼠类弯曲杆菌病</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1770017</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32584649/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Mechanisms of host-pathogen interactions resulting in immunopathological responses upon human Campylobacter jejuni infection are not completely understood, but the recent availability of murine infection models mimicking key features of campylobacteriosis helps solving this dilemma. During a screen for proteases expressed by C. jejuni, we identified a peptidase of the M24 family as a potential novel virulence factor, which was named PepP. The gene is strongly conserved in various Campylobacter species. A constructed deletion mutant ΔpepP of C. jejuni strain 81-176 grew as efficiently compared to isogenic wild-type (WT) or pepP complemented bacteria. To shed light on the potential role of this protease in mediating immunopathological responses in the mammalian host, we perorally challenged microbiota-depleted IL-10-/- mice with these strains. All strains stably colonized the murine gastrointestinal tract with comparably high loads. Remarkably, pepP deficiency was associated with less severe induced malaise, with less distinct apoptotic and innate immune cell responses, but also with more pronounced proliferative/regenerative epithelial cell responses in the large intestine at d6post-infection. Furthermore, pro-inflammatory mediators were lower in the colon, ileum, and mesenteric lymph nodes of mice that had been challenged with the ΔpepP mutant compared to the WT or pepP complemented strains. This also held true for extra-intestinal organs including liver, kidneys, and lungs, and, strikingly, to systemic compartments. Taken together, protease PepP is a novel virulence determinant involved in mediating campylobacteriosis. The finding that apoptosis in the colon is significantly diminished in mice infected with the pepP mutant highlights the epithelial layer as the first and main target of PepP in the intestine.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 宿主-病原体相互作用的机制导致对人空肠弯曲菌感染的免疫病理反应尚不完全清楚，但是模仿弯曲菌的关键特征的鼠类感染模型的最新可用性有助于解决这一难题。在筛选空肠弯曲杆菌表达的蛋白酶的过程中，我们鉴定了M24家族的一种肽酶作为一种潜在的新型毒力因子，称为PepP。该基因在各种弯曲杆菌属中高度保守。与同基因野生型（WT）或pepP互补细菌相比，空肠弯曲杆菌81-176的构建缺失突变ΔpepP的生长效率很高。为了阐明这种蛋白酶在哺乳动物宿主中介导免疫病理反应中的潜在作用，我们用这些菌株经口挑战了消耗微生物群的IL-10-/-小鼠。所有菌株均以相当高的负荷稳定地定居在鼠的胃肠道中。值得注意的是，pepP缺乏与较少严重的诱发不适，较少的凋亡和先天免疫细胞反应有关，也与感染后d6大肠中较明显的增殖/再生上皮细胞反应有关。此外，与WT或pepP互补菌株相比，用ΔpepP突变体攻击的小鼠的结肠，回肠和肠系膜淋巴结中的促炎性介质较低。对于包括肝，肾和肺在内的肠外器官，尤其是全身性隔室，也是如此。两者合计，蛋白酶PepP是一种新型的介导弯曲杆菌病的毒力决定因素。在被pepP突变体感染的小鼠中，结肠细胞凋亡显着减少的发现凸显出上皮层是肠道中PepP的第一个也是主要靶标。</p>

<h2>Pubmed_ID: 32584645</h2>

<h3>Life-long dynamics of the swine gut microbiome and their implications in probiotics development and food safety</h3>

<h3>猪肠道微生物组的终生动力学及其对益生菌发展和食品安全的影响</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1773748</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32584645/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: The swine gut microbiome has received remarkable attention in recent years given that pigs serve not only as important sources for animal-derived food but also as excellent biomedical models for human health. However, despite recent advances in the understanding of the swine gut microbiome, many important biological and ecological questions are still largely unanswered. In a recent study, we characterized the life-long dynamics of the swine gut microbiome from birth to market. We showed distinct shifts in gut microbiome structure along different growth stages mainly driven by diet. Here, we summarize these discoveries and provide additional data related to the core swine gut microbiome, probiotics development in the swine industry, and foodborne pathogens in the pork supply chain.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 近年来，猪肠道微生物组受到了极大的关注，因为猪不仅是动物源食品的重要来源，而且还是人类健康的出色生物医学模型。然而，尽管最近对猪肠道微生物组的理解有了进步，但许多重要的生物学和生态学问题仍未得到解答。在最近的一项研究中，我们描述了从出生到上市的猪肠道微生物组的终生动力学。我们显示了肠道微生物组结构在不同生长阶段的明显变化，这些变化主要受饮食驱动。在这里，我们总结这些发现，并提供与核心猪肠道微生物组，养猪业中益生菌的发展以及猪肉供应链中食源性病原体有关的其他数据。</p>

<h2>Pubmed_ID: 32579470</h2>

<h3>Germ-free housing conditions do not affect aortic root and aortic arch lesion size of late atherosclerotic low-density lipoprotein receptor-deficient mice</h3>

<h3>无病菌的居住条件不会影响晚期动脉粥样硬化低密度脂蛋白受体缺陷型小鼠的主动脉根和主动脉弓病变大小</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1767463</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32579470/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: The microbiota has been linked to the development of atherosclerosis, but the functional impact of these resident bacteria on the lesion size and cellular composition of atherosclerotic plaques in the aorta has never been experimentally addressed with the germ-free low-density lipoprotein receptor-deficient (Ldlr-/- ) mouse atherosclerosis model. Here, we report that 16 weeks of high-fat diet (HFD) feeding of hypercholesterolemic Ldlr-/- mice at germ-free (GF) housing conditions did not impact relative aortic root plaque size, macrophage content, and necrotic core area. Likewise, we did not find changes in the relative aortic arch lesion size. However, late atherosclerotic GF Ldlr-/- mice had altered inflammatory plasma protein markers and reduced smooth muscle cell content in their atherosclerotic root plaques relative to CONV-R Ldlr-/- mice. Neither absolute nor relative aortic root or aortic arch plaque size correlated with age. Our analyses on GF Ldlr-/- mice did not reveal a significant contribution of the microbiota in late aortic atherosclerosis.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 微生物群与动脉粥样硬化的发展有关，但从未通过无菌低密度脂蛋白受体缺陷型（Ldlr-/-）小鼠动脉粥样硬化模型。在这里，我们报告在无菌（GF）居住条件下高胆固醇饮食Ldlr-/-小鼠高脂饮食（HFD）喂养16周不会影响相对主动脉根斑块大小，巨噬细胞含量和坏死核心面积。同样，我们也没有发现主动脉弓相对病变大小的变化。但是，相对于CONV-RLdlr-/-，晚期动脉粥样硬化GFLdlr-/-小鼠的动脉粥样硬化根斑块中的炎症性血浆蛋白标志物发生改变，平滑肌细胞含量降低。绝对主动脉根或相对主动脉根或主动脉弓斑的大小均与年龄无关。我们对GFLdlr-/-小鼠的分析未揭示微生物群在晚期主动脉粥样硬化中的重要作用。</p>

<h2>Pubmed_ID: 32576065</h2>

<h3>Serum metabolites reflecting gut microbiome alpha diversity predict type 2 diabetes</h3>

<h3>反映肠道微生物组α多样性的血清代谢物可预测2型糖尿病</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1778261</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32576065/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Type 2 diabetes (T2D) is associated with reduced gut microbiome diversity, although the cause is unclear. Metabolites generated by gut microbes also appear to be causative factors in T2D. We therefore searched for serum metabolites predictive of gut microbiome diversity in 1018 females from TwinsUK with concurrent metabolomic profiling and microbiome composition. We generated a Microbial Metabolites Diversity (MMD) score of six circulating metabolites that explained over 18% of the variance in microbiome alpha diversity. Moreover, the MMD score was associated with a significantly lower odds of prevalent (OR[95%CI] = 0.22[0.07;0.70], P = .01) and incident T2D (HR[95%CI] = 0.31[0.11,0.90], P = .03). We replicated our results in 1522 individuals from the ARIC study (prevalent T2D: OR[95%CI] = 0.79[0.64,0.96], P = .02, incident T2D: HR[95%CI] = 0.87[0.79,0.95], P = .003). The MMD score mediated 28%[15%,94%] of the total effect of gut microbiome on T2D after adjusting for confounders. Metabolites predicting higher microbiome diversity included 3-phenylpropionate(hydrocinnamate), indolepropionate, cinnamoylglycine and 5-alpha-pregnan-3beta,20 alpha-diol monosulfate(2) of which indolepropionate and phenylpropionate have already been linked to lower incidence of T2D. Metabolites correlating with lower microbial diversity included glutarate and imidazole propionate, of which the latter has been implicated in insulin resistance. Our results suggest that the effect of gut microbiome diversity on T2D is largely mediated by microbial metabolites, which might be modifiable by diet.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 尽管病因尚不清楚，但2型糖尿病（T2D）与肠道微生物组多样性降低有关。肠道微生物产生的代谢产物似乎也是T2D的致病因素。因此，我们从TwinsUK中搜索可预测1018位女性肠道微生物组多样性的血清代谢物，同时进行代谢组学分析和微生物组组成分析。我们生成了六个循环代谢物的微生物代谢物多样性（MMD）评分，这解释了微生物组alpha多样性中超过18％的差异。此外，MMD评分与患病率（OR[95％CI]=0.22[0.07;0.70]，P=.01）和入射T2D（HR[95％CI]=0.31[0.11,0.90]]，P=.03）。我们在ARIC研究中的1522个人中复制了我们的结果（流行的T2D：OR[95％CI]=0.79[0.64,0.96]，P=.02，事件T2D：HR[95％CI]=0.87[0.79,0.95]，P=.003）。校正混杂因素后，MMD评分介导了肠道微生物组对T2D的总作用的28％[15％，94％]。预测更高微生物组多样性的代谢物包括3-苯基丙酸酯（氢肉桂酸酯），吲哚丙酸酯，肉桂酰甘氨酸和5-α-pregnan-3beta，20α-二醇单硫酸盐（2），其中吲哚丙酸酯和苯基丙酸酯已经与T2D的发生率降低相关。与较低的微生物多样性相关的代谢物包括戊二酸和咪唑丙酸酯，其中后者与胰岛素抵抗有关。我们的研究结果表明，肠道微生物组多样性对T2D的影响很大程度上是由微生物代谢产物介导的，这可以通过饮食改变。</p>

<h2>Pubmed_ID: 32576050</h2>

<h3>Sex-specific maternal calcium requirements for the prevention of nonalcoholic fatty liver disease by altering the intestinal microbiota and lipid metabolism in the high-fat-diet-fed offspring mice</h3>

<h3>通过改变高脂饮食后代小鼠的肠道菌群和脂质代谢，预防非酒精性脂肪肝疾病的性别特异性母体钙需求</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1768645</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32576050/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: The significance of maternal appropriate calcium intakes for energy metabolism in the offspring has been recognized. Nonalcoholic fatty liver disease (NAFLD) is considered as the hepatic manifestation of metabolic syndrome. So in this study, we proposed that there were long-term effects of maternal calcium status on the progress of NAFLD by altering the intestinal microbiota and lipid metabolism with attention to potential sex differences among the mouse offspring. Thirty-four-week female C57BL/6 J mice were subjected to obtain low, normal and high calcium reproductive diets throughout the gestation and lactation. After weaning, both the male and female mouse offspring were fed with the high-fat diet for 16 weeks, with the normal diet as control. Biochemical indicators in the plasma and hepatic tissue were measured using ELISA or enzymatic methods. The expression of lipid metabolism, inflammatory and fibrosis related genes was determined by RT-PCR. The intestinal microbiota was analyzed by 16S rRNA high-throughput sequencing. Maternal normal and low calcium intake could, respectively, inhibit the progress of high-fat diet induced NAFLD in the male and female mouse offspring, which was characterized by the least lipid droplets, inflammatory infiltration and fibrosis, the lowest concentrations of free fatty acids and triglyceridethe lowest expression of genes involving in de novo lipogenesis and the highest expression of genes related to lipid oxidation and hydrolysis, inflammatory, and fibrosis. Pyrosequencing of 16S rRNA genes revealed that the male mouse offspring with maternal normal calcium intake and the female mouse offspring with maternal low calcium intake, after the high-fat diet feeding, had distinct intestinal microbiota, which was closer to thosein mice with the normal diet feeding. Analysis of the functional features for the different microbiota was compatible with the expression of genes associated with lipogenesis, lipid oxidation and hydrolysis. Thus, there is a sex-specific manner for maternal calcium requirement to inhibit the progress of offspring NAFLD, that might be less for the female offspring and more for the male offspring.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 人们已经认识到母体适当摄入钙对于后代能量代谢的重要性。非酒精性脂肪肝疾病（NAFLD）被认为是代谢综合征的肝表现。因此，在这项研究中，我们提出母体钙状态对NAFLD的进展具有长期影响，可以通过改变肠道菌群和脂质代谢，并注意小鼠后代之间的性别差异来改善NAFLD的进展。在整个妊娠和哺乳期，对34周的雌性C57BL/6J小鼠进行低，正常和高钙的生殖饮食。断奶后，雄性和雌性小鼠后代均以高脂饮食喂养16周，以正常饮食为对照。使用ELISA或酶法测量血浆和肝组织中的生化指标。通过RT-PCR确定脂质代谢，炎性和纤维化相关基因的表达。通过16SrRNA高通量测序分析肠道菌群。母体正常和低钙摄入分别可以抑制高脂饮食诱导的雄性和雌性小鼠后代的NAFLD的进展，其特征是脂质滴最少，炎症浸润和纤维化最少，游离脂肪酸和甘油三酸酯涉及新生脂肪形成的基因的最低表达，与脂质氧化和水解，炎性和纤维化相关的基因的最高表达。16SrRNA基因的焦磷酸测序表明，高脂饮食喂养后，母本钙摄入量正常的雄性小鼠后代和母体钙摄入量低的雌性小鼠后代具有明显的肠道菌群，与正常饮食的小鼠相近。喂养。分析不同微生物群的功能特征与与脂肪形成，脂质氧化和水解相关的基因表达兼容。因此，母体需要钙来抑制后代NAFLD的发展，这是一种针对性别的方式，对于雌性后代而言可能更少，而雄性后代则可能更多。</p>

<h2>Pubmed_ID: 32573326</h2>

<h3>Glycated milk protein fermented with Lactobacillus rhamnosus ameliorates the cognitive health of mice under mild-stress condition</h3>

<h3>鼠李糖乳杆菌发酵的糖化乳蛋白改善了轻度应激条件下小鼠的认知健康</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1756690</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32573326/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: This study aimed to investigate the effects of glycated milk casein (Gc) fermented with Lactobacillus rhamnosus 4B15 (FGc) on the intestinal microbiota and physiological and behavioral properties in mice under chronic stress. Mice were administered Gc or FGc for 10 weeks and then exposed to unpredictable chronic mild stress (UCMS) for 7 weeks. FGc administration restored alterations of gut microbiota induced by UCMS. Moreover, FGc significantly reduced the stress-induced increase in serum corticosterone and decrease in serotonin levels. Anxiety-like behaviors induced by UCMS were also significantly decreased in the FGc group. UCMS-induced dysregulation of gene and protein expression related to neuroendocrine function, neuronal development, and inflammation, and gut-blood-brain barrier function was controlled by FGc pre-treatment. These results strongly suggest the protective effects of FGc targeting of intestinal microbiota for abnormal brain activity, which is consistent with the view that FGc plays an important role in regulating stress-related gut-brain axis disorders.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 这项研究旨在研究鼠李糖乳杆菌4B15（FGc）发酵的糖化酪蛋白（Gc）对慢性应激小鼠肠道菌群以及生理和行为特性的影响。给小鼠Gc或FGc给药10周，然后暴露于不可预测的慢性轻度应激（UCMS）7周。FGc管理恢复了UCMS诱导的肠道菌群的改变。此外，FGc显着降低了应激诱导的血清皮质酮水平的升高和血清素水平的降低。在FGc组中，UCMS引起的焦虑样行为也明显减少。UCMS诱导的与神经内分泌功能，神经元发育和炎症以及肠血脑屏障功能有关的基因和蛋白质表达失调由FGc预处理控制。这些结果强烈表明，FGc靶向肠道菌群对脑部异常活动具有保护作用，这与以下观点一致：FGc在调节应激相关的肠脑轴疾病中起重要作用。</p>

<h2>Pubmed_ID: 32573321</h2>

<h3>Colonization by Enterobacteriaceae is crucial for acute inflammatory responses in murine small intestine via regulation of corticosterone production</h3>

<h3>肠杆菌科细菌的定殖通过调节皮质酮的产生对于鼠小肠的急性炎症反应至关重要</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1765946</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32573321/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Although dysbiosis in the gut microbiota is known to be involved in several inflammatory diseases, whether any specific bacterial taxa control host response to inflammatory stimuli is still elusive. Here, we hypothesized that dysbiotic indigenous taxa could be involved in modulating host response to inflammatory triggers. To test this hypothesis, we conducted experiments in germ-free (GF) mice and in mice colonized with dysbiotic taxa identified in conventional (CV) mice subjected to chemotherapy-induced mucositis. First, we report that the absence of microbiota decreased inflammation and damage in the small intestine after administration of the chemotherapeutic agent 5-fluorouracil (5-FU). Also, 5-FU induced a shift in CV microbiota resulting in higher amounts of Enterobacteriaceae, including E. coli, in feces and small intestine and tissue damage. Prevention of Enterobacteriaceae outgrowth by treating mice with ciprofloxacin resulted in diminished 5-FU-induced tissue damage, indicating that this bacterial group is necessary for 5-FU-induced inflammatory response. In addition, monocolonization of germ-free (GF) mice with E. coli led to reversal of the protective phenotype during 5-FU chemotherapy. E. coli monocolonization decreased the basal plasma corticosterone levels and blockade of glucocorticoid receptor in GF mice restored inflammation upon 5-FU treatment. In contrast, treatment of CV mice with ciprofloxacin, that presented reduction of Enterobacteriaceae and E. coli content, induced an increase in corticosterone levels. Altogether, these findings demonstrate that Enterobacteriaceae outgrowth during dysbiosis impacts inflammation and tissue injury in the small intestine. Importantly, indigenous Enterobacteriaceae modulates host production of the anti-inflammatory steroid corticosterone and, consequently, controls inflammatory responsiveness in mice.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 尽管已知肠道菌群中的营养不良与多种炎性疾病有关，但仍然不清楚是否有任何特定的细菌类群控制宿主对炎性刺激的反应。在这里，我们假设营养不良的本地类群可能参与调节宿主对炎症触发的反应。为了验证这一假设，我们在无菌（GF）小鼠和在常规（CV）小鼠中接受化疗诱导的粘膜炎鉴定的具有营养不良类群的小鼠中进行了实验。首先，我们报告说，在使用化学治疗剂5-氟尿嘧啶（5-FU）后，微生物群的缺乏降低了小肠的炎症和损害。同样，5-FU引起CV微生物群的转移，导致粪便中肠杆菌科细菌（包括大肠杆菌）的含量增加，并对小肠和组织造成损害。通过用环丙沙星治疗小鼠来预防肠杆菌科细菌的生长，导致减少的5-FU诱导的组织损伤，表明该细菌群对于5-FU诱导的炎症反应是必需的。另外，用大肠杆菌对无菌（GF）小鼠进行单菌落化导致5-FU化疗期间保护性表型的逆转。大肠杆菌的单结肠化降低了GF小鼠的基础血浆皮质类固醇水平，而糖皮质激素受体的阻断在5-FU治疗后恢复了炎症。相反，用环丙沙星治疗CV小鼠会降低肠杆菌科和大肠杆菌含量，从而导致皮质酮水平升高。总而言之，这些发现表明，在营养不良期间肠杆菌科细菌的生长会影响小肠​​的炎症和组织损伤。重要的是，本地肠杆菌科可调节抗炎类固醇皮质酮的宿主产生，因此可控制小鼠的炎症反应。</p>

<h2>Pubmed_ID: 32564657</h2>

<h3>Luminal microbiota related to Crohn's disease recurrence after surgery</h3>

<h3>手术后与克罗恩病复发有关的发光菌群</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1778262</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32564657/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Background: Microbial factors are likely to be involved in the recurrence of Crohn's disease (CD) after bowel resection. We investigated the luminal microbiota before and longitudinally after surgery, in relation to disease recurrence, using 16S metagenomic techniques. Methods: In the prospective Post-Operative Crohn's Endoscopic Recurrence (POCER) study, fecal samples were obtained before surgery and 6, 12, and 18 months after surgery from 130 CD patients. Endoscopy was undertaken to detect disease recurrence, defined as Rutgeerts score ≥i2, at 6 months in two-thirds of patients and all patients at 18 months after surgery. The V2 region of the 16S rRNA gene was sequenced using Illumina MiSeq. Cluster analysis was performed at family level, assessing microbiome community differences between patients with and without recurrence. Results: Six microbial cluster groups were identified. The cluster associated with maintenance of remission was enriched for the Lachnospiraceae family [adjusted OR 0.47 (0.27-0.82), P = .007]. The OTU diversity of Lachnospiraceae within this cluster was significantly greater than in all other clusters. The cluster enriched for Enterobacteriaceae was associated with an increased risk of disease recurrence [adjusted OR 6.35 (1.24-32.44), P = .026]. OTU diversity of Enterobacteriaceae within this cluster was significantly greater than in other clusters. Conclusions: Luminal bacterial communities are associated with protection from, and the occurrence of, Crohn's disease recurrence after surgery. Recurrence may relate to a higher abundance of facultatively anaerobic pathobionts from the Enterobacteriaceae family. The ecologic change of depleted Lachnospiraceae, a genus of butyrate-producing bacteria, may permit expansion of Enterobacteriaceae through luminal environmental perturbation.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 背景：肠道切除后克罗恩病（CD）的复发可能与微生物因素有关。我们使用16S宏基因组学技术研究了手术前后腔内微生物群与疾病复发的关系。方法：在前瞻性术后克罗恩内镜下复发（POCER）研究中，从130名CD患者手术前，手术后6、12和18个月获得粪便样本。在三分之二的患者以及术后18个月的所有患者中，进行了内镜检查以检测疾病复发，定义为Rutgeerts评分≥i2。使用IlluminaMiSeq对16SrRNA基因的V2区进行测序。在家庭层面进行聚类分析，评估有无复发患者之间的微生物组群落差异。结果：确定了六个微生物簇群。与鞭毛科家族保持缓解相关的群集丰富[调整OR0.47（0.27-0.82），P=.007]。该群集内的斜鞭藻科的OTU多样性显着大于所有其他群集。富含肠杆菌科的菌群与疾病复发的风险增加相关[校正后的OR6.35（1.24-32.44），P=.026]。肠杆菌科的OTU多样性明显高于其他集群。结论：发光细菌群落与术后克罗恩病复发的保护和发生有关。复发可能与来自肠杆菌科的兼性厌氧菌有较高的关系。枯草杆菌科（一种产丁酸盐的细菌）的生态变化可能会通过腔内环境扰动使肠杆菌科扩大。</p>

<h2>Pubmed_ID: 32552401</h2>

<h3>Dynamic analysis of human small intestinal microbiota after an ingestion of fermented milk by small-intestinal fluid perfusion using an endoscopic retrograde bowel insertion technique</h3>

<h3>内窥镜逆行肠插入技术通过小肠液体灌流摄入发酵乳后人类小肠微生物群的动态分析</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1766942</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32552401/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Probiotic products have been shown to have beneficial effects on human hosts, but what happens in the gastrointestinal tract after its ingestion remains unclear. Our aim was to investigate the changes within the small intestines after a single intake of a fermented milk product containing a probiotic. We have periodically collected the small-intestinal fluids from the terminal ileum of seven healthy subjects for up to 7 h after ingestion by small-intestinal fluid perfusion using an endoscopic retrograde bowel insertion technique. The bacterial composition of the terminal ileum clearly revealed that the ingested probiotics (Lactobacillus casei strain Shirota: LcS and Bifidobacterium breve strain Yakult: BbrY) occupied the ileal microbiota for several hours, temporarily representing over 90% of the ileal microbiota in several subjects. Cultivation of ileal fluids showed that under a dramatic pH changes before reaching the terminal ileum, a certain number of the ingested bacteria survived (8.2 ± 6.4% of LcS, 7.8 ± 11.0% of BbrY). This means that more than 1 billion LcS and BbrY cells reached the terminal ileum with their colony-forming ability intact. These results indicate that there is adequate opportunity for the ingested probiotics to continuously stimulate the host cells in the small intestines. Our data suggest that probiotic fermented milk intake affects intestinal microbes and the host, explaining part of the process from the intake of probiotics to the exertion of their beneficial effects on the host.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 益生菌产品已显示对人体宿主具有有益作用，但尚不清楚摄入后在胃肠道中会发生什么。我们的目的是调查单次摄入含有益生菌的发酵乳产品后小肠内的变化。我们采用内窥镜逆行肠插入技术，通过小肠液体灌流，在摄取后长达7小时内，定期收集了7名健康受试者末端回肠的小肠液体。回肠末端的细菌组成清楚地表明，摄入的益生菌（干酪乳杆菌Shirota菌株：LcS和短双歧杆菌Yakult菌株：BbrY）占据了回肠菌群数小时，暂时代表了多个受试者中回肠菌群的90％以上。回肠液的培养表明，在到达末端回肠之前，pH发生了显着变化，一定数量的摄入细菌得以存活（LcS的8.2±6.4％，BbrY的7.8±11.0％）。这意味着超过10亿个LcS和BbrY细胞以完整的集落形成能力到达了回肠末端。这些结果表明，摄入的益生菌有足够的机会连续刺激小肠中的宿主细胞。我们的数据表明，益生菌发酵乳的摄入会影响肠道微生物和宿主，从而解释了从摄入益生菌到对宿主发挥有益作用的过程的一部分。</p>

<h2>Pubmed_ID: 32552337</h2>

<h3>Stool processing speed and storage duration do not impact the clinical effectiveness of fecal microbiota transplantation</h3>

<h3>粪便的处理速度和储存时间不影响粪便菌群移植的临床效果</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1768777</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32552337/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: No abstract</p>

<p style="line-height:1.8;margin:20px"> 摘要: 没有摘要</p>

<h2>Pubmed_ID: 32552224</h2>

<h3>Gut Bacteria have a novel sweet tooth: ribose sensing and scavenging from fiber</h3>

<h3>肠道细菌具有一种新颖的甜食：核糖感​​测和纤维清除</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1770667</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32552224/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Dietary fiber is known to influence symbiotic gut microbiota community structure and physiology; however, how and if dietary fiber can induce further exogenous nutrient uptake within gut microbes is ill-defined. Recent findings highlight how during periods of high-fiber consumption, a prevalent gut bacteria senses and scavenges the ubiquitous sugar ribose. This molecular adaptation exemplifies how particular gut microbes have developed a sophisticated system to scavenge nutrients in a diet-dependent manner.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 已知膳食纤维会影响共生肠道微生物群的结构和生理。但是，如何以及是否通过膳食纤维诱导肠道微生物进一步吸收外源营养。最近的发现突显出在高纤维消耗期间，普遍的肠道细菌如何感知并清除普遍存在的糖核糖。这种分子适应性例证了特定的肠道微生物如何开发出复杂的系统以饮食依赖的方式清除营养。</p>

<h2>Pubmed_ID: 32529941</h2>

<h3>The interplay between the gut microbiota and NLRP3 activation affects the severity of acute pancreatitis in mice</h3>

<h3>肠道菌群和NLRP3激活之间的相互作用影响小鼠急性胰腺炎的严重程度</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1770042</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32529941/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Early dysbiosis of the gut microbiota is associated with the severity of acute pancreatitis (AP), although the underlying mechanism is unclear. Here, we investigated the role of crosstalk between NLRP3 and the gut microbiota in the development of AP utilizing gut microbiota deficient mice, as well as NLRP3 knockout (KO) mouse models. Pancreatic damage and systemic inflammation were improved in antibiotic-treated (Abx) and germ-free (GF) mice, accompanied by weakened activity of the intestinal NLRP3 inflammasome. Interestingly, fecal microbiota transplantation (FMT) reactivated the intestinal NLRP3 inflammasome and exacerbated the disease in Abx and GF mice. Although the gut barrier in GF and Abx mice was disrupted, gut microbiota deficiency ameliorated the severity of AP, probably due to the reduction in bacterial translocation from the gut to the pancreas. The composition of the gut microbiota was significantly different between NLRP3 KO mice and wild-type (WT) mice at baseline, and there were alterations in response to the induction of AP. While a dramatic shift in the gut microbiota with overgrowth of Escherichia-Shigella was observed in WT mice suffering from AP, there was no significant change in NLRP3 KO mice with or without AP, suggesting that NLRP3 deficiency counteracts AP-induced microbial disturbance. With a strengthened gut barrier and decreased systemic inflammation, NLRP3 KO mice showed less severe AP, as revealed by reduced pancreatic neutrophilic infiltration and necrosis. Taken together, these results identified the bidirectional modulation between the gut microbiota and NLRP3 in the progression of AP, which suggests the interplay of the host and microbiome during AP.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 肠道菌群早期失调与急性胰腺炎（AP）的严重程度有关，尽管其潜在机制尚不清楚。在这里，我们调查了肠道菌群缺乏小鼠和NLRP3基因敲除（KO）小鼠模型中NLRP3和肠道菌群之间的串扰在AP发育中的作用。抗生素治疗（Abx）和无菌细菌（GF）小鼠的胰腺损伤和全身炎症得到改善，同时肠道NLRP3炎性小体的活性减弱。有趣的是，粪便微生物群移植（FMT）重新激活了肠道NLRP3炎性小体，并加剧了Abx和GF小鼠的疾病。尽管GF和Abx小鼠的肠屏障被破坏，但肠道菌群缺乏改善了AP的严重程度，这可能是由于细菌从肠向胰腺的移位减少所致。NLRP3KO小鼠和野生型（WT）小鼠之间的肠道菌群组成在基线时显着不同，并且对AP的诱导反应有所改变。尽管在患有AP的WT小鼠中观察到肠道菌群随埃希氏菌-志贺氏菌过度生长而发生了巨大变化，但有或没有AP的NLRP3KO小鼠均无显着变化，这表明NLRP3缺乏可抵消AP引起的微生物干扰。通过增强的肠道屏障和减少的全身炎症，NLRP3KO小鼠表现出较轻的AP，如胰腺中性粒细胞浸润和坏死的减少所显示。两者合计，这些结果确定了肠道菌群与NLRP3之间在AP进程中的双向调节，这提示了AP期间宿主与微生物组之间的相互作用。</p>

<h2>Pubmed_ID: 32522072</h2>

<h3>Lactobacillus rhamnosus probiotic prevents airway function deterioration and promotes gut microbiome resilience in a murine asthma model</h3>

<h3>鼠李糖乳杆菌益生菌可预防鼠哮喘模型中的气道功能恶化并增强肠道微生物组的适应力</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1766345</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32522072/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Allergic asthma is a highly prevalent inflammatory disease of the lower airways, clinically characterized by airway hyperreactivity and deterioration of airway function. Immunomodulatory probiotic bacteria are increasingly being explored to prevent asthma development, alone or in combination with other treatments. In this study, wild-type and recombinant probiotic Lactobacillus rhamnosus GR-1 were tested as preventive treatment of experimental allergic asthma in mice. Recombinant L. rhamnosus GR-1 was designed to produce the major birch pollen allergen Bet v 1, to promote allergen-specific immunomodulation. Administration of wild-type and recombinant L. rhamnosus GR-1 prevented the development of airway hyperreactivity. Recombinant L. rhamnosus GR-1 also prevented elevation of airway total cell counts, lymphocyte counts and lung IL-1β levels, while wild-type L. rhamnosus GR-1 inhibited airway eosinophilia. Of note, a shift in gut microbiome composition was observed after asthma development, which correlated with the severity of airway inflammation and airway hyperreactivity. In the groups that received L. rhamnosus GR-1, this asthma-associated shift in gut microbiome composition was not observed, indicating microbiome-modulating effects of this probiotic. These data demonstrate that L. rhamnosus GR-1 can prevent airway function deterioration in allergic asthma. Bet v 1 expression by L. rhamnosus GR-1 further contributed to lower airway inflammation, although not solely through the expected reduction in T helper 2-associated responses, suggesting involvement of additional mechanisms. The beneficial effects of L. rhamnosus GR-1 correlate with increased gut microbiome resilience, which in turn is linked to protection of airway function, and thus further adds support to the existence of a gut-lung axis.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 过敏性哮喘是下呼吸道的高度流行的炎症性疾病，临床上以气道反应过度和气道功能恶化为特征。越来越多地探索免疫调节性益生菌单独或与其他疗法联合使用以预防哮喘的发展。在这项研究中，测试了野生型和重组益生菌鼠李糖乳杆菌GR-1作为小鼠实验性过敏性哮喘的预防性治疗。重组鼠李糖乳杆菌GR-1被设计为产生主要的桦树花粉变应原Betv1，以促进变应原特异性免疫调节。野生型和重组鼠李糖乳杆菌GR-1的使用可防止气道高反应性的发展。重组鼠李糖乳杆菌GR-1还可防止气道总细胞计数，淋巴细胞计数和肺IL-1β水平升高，而野生型鼠李糖乳杆菌GR-1抑制气道嗜酸性粒细胞增多。值得注意的是，哮喘发生后观察到肠道微生物组组成发生变化，这与气道炎症和气道高反应性的严重程度相关。在接受鼠李糖乳杆菌GR-1的组中，未观察到与哮喘相关的肠道微生物组组成发生变化，表明该益生菌具有微生物组调节作用。这些数据表明，鼠李糖乳杆菌GR-1可以预防过敏性哮喘中的气道功能恶化。鼠李糖乳杆菌GR-1的Betv1表达进一步促进了气道炎症的降低，尽管这不仅是由于预期的与T辅助2相关的反应减少所致，还暗示了其他机制的参与。鼠李糖乳杆菌GR-1的有益作用与肠道微生物组弹性的增强有关，而肠道微生物组的弹性又与保护气道功能有关，因此进一步增加了肠肺轴的存在。</p>

<h2>Pubmed_ID: 32515657</h2>

<h3>Human resident gut microbe Bacteroides thetaiotaomicron regulates colonic neuronal innervation and neurogenic function</h3>

<h3>人体常驻肠道细菌拟杆菌属细菌可调节结肠神经元神经支配和神经源性功能</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1766936</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32515657/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Background and aims: As the importance of gut-brain interactions increases, understanding how specific gut microbes interact with the enteric nervous system (ENS), which is the first point of neuronal exposure becomes critical. Our aim was to understand how the dominant human gut bacterium Bacteroides thetaiotaomicron (Bt) regulates anatomical and functional characteristics of the ENS. Methods: Neuronal cell populations, as well as enteroendocrine cells, were assessed in proximal colonic sections using fluorescent immunohistochemistry in specific pathogen-free (SPF), germ-free (GF) and Bt conventionalized-germ-free mice (Bt-CONV). RNA expression of tight junction proteins and toll-like receptors (TLR) were measured using qPCR. Colonic motility was analyzed using in vitro colonic manometry. Results: Decreased neuronal and vagal afferent innervation observed in GF mice was normalized by Bt-CONV with increased neuronal staining in mucosa and myenteric plexus. Bt-CONV also restored expression of nitric oxide synthase expressing inhibitory neurons and of choline acetyltransferase and substance P expressing excitatory motor neurons comparable to those of SPF mice. Neurite outgrowth and glial cells were upregulated by Bt-CONV. RNA expression of tight junction protein claudin 3 was downregulated while TLR2 was upregulated by Bt-CONV. The enteroendocrine cell subtypes L-cells and enterochromaffin cells were reduced in GF mice, with Bt-CONV restoring L-cell numbers. Motility as measured by colonic migrating motor complexes (CMMCs) increased in GF and Bt-CONV. Conclusion: Bt, common gut bacteria, is critical in regulating enteric neuronal and enteroendocrine cell populations, and neurogenic colonic activity. This highlights the potential use of this resident gut bacteria for maintaining healthy gut function.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 背景和目的：随着肠脑相互作用的重要性的提高，了解特定肠道微生物如何与肠道神经系统（ENS）相互作用（肠道神经系统暴露的第一步）变得至关重要。我们的目的是了解人类的肠道细菌细菌拟杆菌（Bteroidesthetaiotaomicron）（Bt）如何调节ENS的解剖学和功能特征。方法：使用荧光免疫组织化学方法在特定的无病原体（SPF），无细菌（GF）和Bt常规无菌的小鼠（Bt-CONV）中评估近端结肠切片中神经元细胞和肠内分泌细胞的数量。使用qPCR测量紧密连接蛋白和toll样受体（TLR）的RNA表达。使用体外结肠测压法分析结肠运动性。结果：通过Bt-CONV可以使GF小鼠神经元和迷走神经传入神经减少，并使粘膜和肌间神经丛的神经元染色增加。与SPF小鼠相比，Bt-CONV还恢复了表达一氧化氮合酶的抑制性神经元以及表达胆碱乙酰转移酶和P物质的兴奋性运动神经元的表达。Bt-CONV上调了神经突的生长和神经胶质细胞。Bt-CONV下调紧密连接蛋白claudin3的RNA表达，而TLR2上调。GF小鼠的肠内分泌细胞亚型L细胞和肠嗜铬细胞减少，Bt-CONV恢复L细胞数量。通过结肠迁移运动复合物（CMMC）测得的运动能力在GF和Bt-CONV中增加。结论：Bt是常见的肠道细菌，在调节肠道神经元和肠内分泌细胞的数量以及神经原性结肠活性中至关重要。这突出了这种常驻肠道细菌在维持健康肠道功能方面的潜在用途。</p>

<h2>Pubmed_ID: 32507008</h2>

<h3>Alteration in gut microbiota is associated with dysregulation of cytokines and glucocorticoid therapy in systemic lupus erythematosus</h3>

<h3>肠道菌群的改变与系统性红斑狼疮的细胞因子调节异常和糖皮质激素治疗有关</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1768644</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32507008/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: A growing corpus of evidence implicates the involvement of the commensal microbiota and immune cytokines in the initiation and progression of systemic lupus erythematosus (SLE). Glucocorticoids have been widely used in the treatment of SLE patients, however, glucocorticoid treatment carries a higher risk of other diseases. Using the 16S rRNA technique, we investigated the differences between the gut microbiota associated with the immune cytokines of SLE and relevant glucocorticoid treatment in a female cohort of 20 healthy control subjects (HC), 17 subjects with SLE (SLE-G), and 20 SLE patients having undergone glucocorticoid treatment (SLE+G). We observed that the diversity and structure of the microbial community in SLE+G patients were significantly changed compared to that of SLE-G patients, whereas the gut microbial community of the SLE+G group showed a similarity with the HC group, which implicate that the shift in the gut microbiome could represent a return to homeostasis. Furthermore, the up-regulations of immune cytokines in SLE-G were identified as closely related to gut dysbiosis, which indicates that the overrepresented genera in SLE patients may play roles in regulating expression level of these immune cytokines. This associated analysis of gut microbiota, glucocorticoid therapy, and immune factors might provide novel and insightful clues revealing the pathogenesis of SLE patients.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 越来越多的证据表明共生微生物和免疫细胞因子参与系统性红斑狼疮（SLE）的发生和发展。糖皮质激素已广泛用于治疗SLE患者，但是糖皮质激素治疗会带来其他疾病的较高风险。我们使用16SrRNA技术，在20名健康对照受试者（HC），17例SLE（SLE-G）和20名女性队列中研究了与SLE免疫细胞因子相关的肠道菌群和相关糖皮质激素治疗之间的差异接受糖皮质激素治疗（SLE+G）的SLE患者。我们观察到，与SLE-G患者相比，SLE+G患者的微生物群落的多样性和结构发生了显着变化，而SLE+G组的肠道微生物群落与HC组相似，这表明肠道微生物组的转变可能意味着体内稳态的恢复。此外，SLE-G中免疫细胞因子的上调与肠道营养不良密切相关，这表明SLE患者中过高的属可能在调节这些免疫细胞因子的表达水平中发挥作用。肠道微生物群，糖皮质激素治疗和免疫因子的相关分析可能会提供新颖而有见地的线索，揭示SLE患者的发病机理。</p>

<h2>Pubmed_ID: 32501768</h2>

<h3>Amyotrophic lateral sclerosis and intestinal microbiota-toward establishing cause and effect</h3>

<h3>肌萎缩性侧索硬化症和肠道菌群朝着确定因果关系</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1767464</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32501768/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: The intestinal microbiota may be involved, through metabolic gut-brain interactions, in a variety of neurological conditions. In this addendum, we summarize the findings of our recent study investigating the potentially modulatory influence of the microbiome in a transgenic ALS mouse model, and the possible application to human disease. We found that transgenic mice show evidence of dysbiosis, even at the pre-symptomatic stage, and have a more severe disease course under germ-free conditions or after receiving broad-spectrum antibiotics. We demonstrated that Akkermansia muciniphila ameliorated the disease in mice and that this may be due to the production of nicotinamide. We then conducted a preliminary study in human ALS and identified functionally similar alterations within the metagenome. Furthermore, we found that patients with ALS had lower systemic and CSF levels of nicotinamide, suggesting that the changes observed in the mouse model may be relevant to human disease.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 在各种神经系统疾病中，肠道微生物区可能通过代谢性肠脑相互作用而参与。在此附录中，我们总结了我们最近的研究结果，该研究调查了微生物组在转基因ALS小鼠模型中的潜在调节作用，以及对人类疾病的可能应用。我们发现，转基因小鼠即使在有症状的前期也显示出营养不良的迹象，并且在无菌条件下或接受广谱抗生素治疗后病情更严重。我们证明了Akkermansiamuciniphila改善了小鼠的疾病，这可能是由于烟酰胺的产生。然后，我们对人ALS进行了初步研究，并确定了基因组中功能相似的改变。此外，我们发现ALS患者的烟酰胺的全身和脑脊液水平较低，这表明在小鼠模型中观察到的变化可能与人类疾病有关。</p>

<h2>Pubmed_ID: 32453977</h2>

<h3>Indonesian children fecal microbiome from birth until weaning was different from microbiomes of their mothers</h3>

<h3>印尼儿童从出生到断奶的粪便微生物组与母亲的微生物组不同</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1761240</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32453977/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Gastrointestinal (GI) microbiota play an important role in human health and wellbeing and the first wave of gut microbes arrives mostly through vertical transmission from mother to child. This study has undertaken to understand the microbiota profile of healthy Southeast Asian mother-infant pairs. Here, we examined the fecal, vaginal and breast milk microbiota of Indonesian mothers and the fecal microbiota of their children from less than 1 month to 48 months old. To determine the immune status of children and the effect of diet at different ages, we examined the level of cytokines, bile acids in the fecal water and weaning food frequency. The fecal microbiota of the children before weaning contained mainly Bacteroides and Bifidobacterium, which presented at low abundance in the samples of mothers. After weaning, the fecal microbiome of children was mainly of the Prevotella type, with decreasing levels of Bifidobacterium, thus becoming more like the fecal microbiome of the mother. The abundance of infant fecal commensals generally correlated inversely with potential pathogens before weaning. The fecal Bifidobacterium in children correlated inversely with the consumption of complex carbohydrates and fruits after weaning. The specific cytokines related to the proliferation and maturation of immunity were found to increase after weaning. A decreasing level of primary bile acids and an increase of secondary bile acids were observed after weaning. This study highlights the change in the GI microbiota of infants to adult-type microbiota after weaning and identifies diet as a major contributing factor.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 胃肠道（GI）菌群在人类健康和福祉中起着重要作用，而肠道微生物的第一波潮主要通过母婴之间的垂直传播而到达。这项研究旨在了解健康的东南亚母婴对的微生物群特征。在这里，我们检查了印尼母亲的粪便，阴道和母乳菌群以及其小于1个月至48个月大的孩子的粪便菌群。为了确定儿童的免疫状态和不同年龄饮食的影响，我们检查了粪便水中的细胞因子，胆汁酸水平和断奶食物的频率。断奶前儿童的粪便微生物群主要含有拟杆菌和双歧杆菌，在母亲的样品中其菌落含量较低。断奶后，儿童的粪便微生物组主要是普勒沃氏菌类型，双歧杆菌水平降低，因此变得更像母亲的粪便微生物组。断奶前婴儿粪便的丰度通常与潜在病原体呈负相关。断奶后儿童粪便中的双歧杆菌与复杂碳水化合物和水果的摄入量成反比。断奶后发现与免疫增殖和成熟相关的特定细胞因子增加。断奶后观察到伯胆汁酸水平降低而仲胆汁酸水平升高。这项研究突出了断奶后婴儿的胃肠道菌群向成年型菌群的变化，并确定饮食是主要的促成因素。</p>

<h2>Pubmed_ID: 32453670</h2>

<h3>Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics</h3>

<h3>肠道微生物群修饰在结直肠癌治疗中的治疗方法-粪便微生物群移植，益生元，益生菌和合生元</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1764309</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32453670/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/01/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: The link between gut microbiota and the development of colorectal cancer has been investigated. An imbalance in the gut microbiota promotes the progress of colorectal carcinogenesis via multiple mechanisms, including inflammation, activation of carcinogens, and tumorigenic pathways as well as damaging host DNA. Several therapeutic methods are available with which to alter the composition and the activity of gut microbiota, such as administration of prebiotics, probiotics, and synbiotics; these can confer various benefits for colorectal cancer patients. Nowadays, fecal microbiota transplantation is the most modern way of modulating the gut microbiota. Even though data regarding fecal microbiota transplantation in colorectal cancer patients are still rather limited, it has been approved as a clinical method of treatment-recurrent Clostridium difficile infection, which may also occur in these patients. The major benefits of fecal microbiota transplantation include modulation of immunotherapy efficacy, amelioration of bile acid metabolism, and restoration of intestinal microbial diversity. Nonetheless, more studies are needed to assess the long-term effects of fecal microbiota transplantation. In this review, the impact of gut microbiota on the efficiency of anti-cancer therapy and colorectal cancer patients' overall survival is also discussed.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 肠道菌群与结直肠癌的发展之间的联系已得到研究。肠道菌群失衡可通过多种机制促进结直肠癌发生的进展，包括炎症，致癌物激活，致癌途径以及破坏宿主DNA。有几种治疗方法可用来改变肠道菌群的组成和活性，例如施用益生元，益生菌和合生元。这些可以为结直肠癌患者带来各种益处。如今，粪便微生物群移植是调节肠道微生物群的最现代方法。尽管关于结直肠癌患者粪便微生物群移植的数据仍然相当有限，但已被批准为治疗复发性艰难梭菌感染的临床方法，这些患者中也可能发生这种情况。粪便微生物群移植的主要好处包括调节免疫疗法的功效，改善胆汁酸的代谢以及恢复肠道微生物的多样性。尽管如此，需要更多的研究来评估粪便微生物群移植的长期效果。在这篇综述中，还讨论了肠道菌群对抗癌治疗效率和大肠癌患者总体生存的影响。</p>

<h2>Pubmed_ID: 32432992</h2>

<h3>An ethical investigation into the microbiome: the intersection of agriculture, genetics, and the obesity epidemic</h3>

<h3>微生物组的伦理调查：农业，遗传学和肥胖病流行的交集</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1760712</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32432992/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: There is growing evidence of the interconnectivity between animals, humans, and the environment, which has manifested in the One Health perspective that takes all three into account for a more comprehensive vision of health. Over the past century, agriculture has become increasingly industrialized with a particular rise in the amount of livestock raised and meat produced. In order to fulfill such market demands, livestock farmers and agricultural corporations have artificially selected for and bred their cash animals to be more and more metabolically efficient via genetic and human-driven means. However, by selecting for more metabolically efficient animals, we may have inadvertently been selecting for obesogenic gut microbiota. This is further compounded by the potential obesogenic and microbiome-altering role antibiotics play in livestock. Evidence suggests that there is the potential for interspecies gut microbe transmissibility. It is notable that there has been a concurrent multispecies obesity epidemic across the same timeframe, which raises questions about potential connections between these epidemics. If it is the case that humans have inadvertently influenced their own obesity epidemic via the artificial selection of and antibiotic administration to livestock, then this holds significant ethical implications. This analysis considers current meat consumption trends, the impacts of livestock on climate change, and animal ethics. The paper concludes that due to the potential significant impact yet tenuous nature of the evidence on this subject stemming from research silos, there is a definitive ethical impetus for researchers to bridge these silos to better understand the true nature of the issue. This case is emblematic of an overarching ethics-driven need for deeper collaboration between isolated but related research disciplines to better characterize issues of public health relevance. It also raises concerns regarding inherent value-driven strife that may arise between competing One Health domains.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 越来越多的证据表明动物，人与环境之间的相互联系，这一点在“一个健康”的观点中得到了体现，该观点将这三个方面都纳入了对健康的更全面了解。在过去的一个世纪中，农业已变得越来越工业化，牲畜和肉类的产量特别增加。为了满足这样的市场需求，牲畜养殖者和农业公司通过遗传和人工驱动手段人工选择并繁育了他们的现金动物，使其代谢效率越来越高。但是，通过选择代谢效率更高的动物，我们可能会无意中选择了致肥胖的肠道菌群。抗生素在牲畜中发挥潜在的致肥胖作用和改变微生物的作用，进一步加剧了这种情况。有证据表明，种间肠道微生物具有潜在的传播能力。值得注意的是，在同一时间段内并存的多物种肥胖病流行，这引发了关于这些流行病之间潜在联系的疑问。如果情况是人类通过对牲畜的人工选择和抗生素管理而无意中影响了自己的肥胖病流行，那么这将具有重大的伦理意义。该分析考虑了当前的肉类消费趋势，牲畜对气候变化的影响以及动物伦理。该论文的结论是，由于研究孤岛对这一问题的潜在重大影响和微不足道的性质，研究人员存在确定的道德动力，可以桥接这些孤岛以更好地理解问题的真实性质。该案例象征着以道德为主导的总体需求，即需要在孤立但相关的研究学科之间进行更深入的合作，以更好地描述与公共卫生相关的问题。这也引发了人们对相互竞争的“一站式”服务域之间可能发生的内在价值驱动冲突的担忧。</p>

<h2>Pubmed_ID: 32403964</h2>

<h3>The probiotic L. casei LC-XCAL™ improves metabolic health in a diet-induced obesity mouse model without altering the microbiome</h3>

<h3>益生菌干酪乳杆菌LC-XCAL™可改善饮食诱发的肥胖小鼠模型的代谢健康，而无需改变微生物组</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1747330</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32403964/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Chronic low-grade inflammation associated with obesity may be a target for improvement of metabolic health. Some exopolysaccharide (EPS)-producing bacteria have been shown to have anti-inflammatory effects in gastrointestinal inflammatory conditions. However, evidence for the role of EPS-producing probiotics in the management of obesity and associated conditions is scarce and the role of the microbiota is unclear. In this study, two probiotic candidates were screened for their effects on metabolic health using the diet-induced obesity (DIO) mouse model. Mice fed a high-fat diet supplemented with the anti-inflammatory, EPS-producing strain L. casei LC-XCAL™ showed significantly reduced hepatic triglycerides, hepatic total cholesterol, and fat pad weight compared to those fed a high-fat diet alone, likely as a result of reduced energy absorption from food. 16-S rRNA amplicon analysis of the fecal microbiota of these mice indicated that the altered metabolic phenotype as a result of the L. casei LC-XCAL strain administration was not associated with an overall change in the composition or inferred functional capacity of the fecal microbiota despite some abundance changes in individual taxa and functions. These findings provide evidence that specific microbial strategies can improve metabolic health independent of the microbiome and reinforce the importance of carefully selecting the most appropriate strain for specific indications by thorough screening programmes.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 与肥胖有关的慢性低度炎症可能是改善代谢健康的目标。已经显示一些产生胞外多糖（EPS）的细菌在胃肠炎性疾病中具有抗炎作用。但是，关于产生EPS的益生菌在肥胖症和相关疾病管理中的作用的证据很少，微生物群的作用尚不清楚。在这项研究中，使用饮食诱导肥胖症（DIO）小鼠模型筛选了两个益生菌候选物对代谢健康的影响。与仅饲喂高脂饮食的小鼠相比，饲喂高脂饮食并补充有抗炎，EPS的产乳杆菌L.caseiLC-XCAL™的小鼠显示出明显降低的肝甘油三酸酯，肝脏总胆固醇和脂肪垫的重量，可能是由于食物吸收能量减少所致。对这些小鼠粪便菌群的16-SrRNA扩增子分析表明，施用干酪乳杆菌LC-XCAL菌株导致的代谢表型改变与粪便菌群的成分总体变化或推断的功能能力无关。尽管个别分类单元和功能发生了很多变化。这些发现提供了证据，表明特定的微生物策略可以独立于微生物组而改善代谢健康，并通过全面的筛查程序来加强针对特定适应症仔细选择最合适菌株的重要性。</p>

<h2>Pubmed_ID: 32200683</h2>

<h3>Probiotic-directed modulation of gut microbiota is basal microbiome dependent</h3>

<h3>益生菌指导的肠道菌群调节是基础微生物组依赖的</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1736974</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32200683/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: As an effective means to improve quality of life and prevent diseases, the demand for probiotics and related products has increased in recent years. However, it is still unclear whether a particular probiotic strain will have similar beneficial effects on healthy adults from different regions. In this study, the probiotic Lactobacillus casei Zhang (LCZ) was consumed by healthy adults from six different Asian regions and the changes in gut microbiota were compared using PacBio single molecule, real-time (SMRT) sequencing technology based on samples collected before, during and after consumption of LCZ. Our results reveal that the effect of LCZ consumption on individuals was closely related to the composition of that individual's basal gut microbiota. A Gut Microbiota Variability Index (GMVI) was proposed to quantitatively compare the effects of LCZ on human gut microecology. Subjects from Xinjiang and Singapore regions had the highest and lowest GMVI, respectively. In general, consumption of LCZ increased the relative abundance of certain beneficial bacteria such as Lactobacillus, Roseburia, Coprococcus and Eubacterium rectale, while it inhibited growth of certain harmful bacteria such as Blautia and Ralstonia pickettii. In addition, consumption of LCZ was responsible for the conversion of some participants from Prevotella copri/Faecalibacterium prausnitzii (PF) enterotype to Faecalibacterium prausnitzii/Bacteroides dorei (FB) enterotype and consistently increased the abundance of lactic acid bacteria in the gut. It also increased/enhanced phosphate metabolic modules, amino acid transport systems, and isoleucine biosynthesis, but conversely decreased lipopolysaccharide biosynthesis. These changes could have health benefits for healthy adults.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 作为改善生活质量和预防疾病的有效手段，近年来对益生菌和相关产品的需求在增加。然而，尚不清楚特定的益生菌菌株是否会对来自不同地区的健康成年人产生类似的有益作用。在这项研究中，来自六个亚洲地区的健康成年人食用了益生菌干酪乳杆菌（LCZ），并使用PacBio单分子实时（SMRT）测序技术，根据之前，期间和之后收集的样品比较了肠道菌群的变化。消耗掉LCZ之后。我们的研究结果表明，食用LCZ对个体的影响与该个体基础肠道菌群的组成密切相关。提出了肠道菌群变异指数（GMVI），以定量比较LCZ对人类肠道微生态的影响。新疆和新加坡地区的受试者的GMVI分别最高和最低。通常，食用LCZ会增加某些有益细菌（如乳酸杆菌，玫瑰菌，协球菌和直肠真细菌）的相对丰度，同时会抑制某些有害细菌（如蓝藻和拟南芥）的生长。此外，LCZ的消耗是导致一些参与者从普雷沃氏杆菌/普氏杆菌（PF）肠型转化为普氏杆菌/多形杆菌（FB）肠型的原因，并不断增加肠道中乳酸菌的丰度。它还增加/增强了磷酸盐代谢模块，氨基酸转运系统和异亮氨酸的生物合成，但相反降低了脂多糖的生物合成。这些变化对健康的成年人可能具有健康益处。</p>

<h2>Pubmed_ID: 32169907</h2>

<h3>A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8 + T cells in mice</h3>

<h3>通过调制小鼠CD8 + T细胞，从Akkermansia muciniphila或巴氏杀菌细菌纯化的膜蛋白钝化结肠炎相关的肿瘤发生。</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1136/gutjnl-2019-320105</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32169907/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut   ||| Not finding IF</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 2020 Nov</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Objective: Gut microbiota have been linked to inflammatory bowel disease (IBD) and colorectal cancer (CRC). Akkermansia muciniphila (A. muciniphila) is a gram-negative anaerobic bacterium that is selectively decreased in the faecal microbiota of patients with IBD, but its causative role and molecular mechanism in blunting colitis-associated colorectal cancer (CAC) remain inconclusive. This study investigates how A. muciniphila engages the immune response in CAC. Design: Mice were given dextran sulfate sodium to induce colitis, followed by azoxymethane to establish CAC with or without pasteurised A. muciniphila or a specific outer membrane protein (Amuc_1100) treatment. Faeces from mice and patients with IBD or CRC were collected for 16S rRNA sequencing. The effects of A. muciniphila or Amuc_1100 on the immune response in acute colitis and CAC were investigated. Results: A. muciniphila was significantly reduced in patients with IBD and mice with colitis or CAC. A. muciniphila or Amuc_1100 could improve colitis, with a reduction in infiltrating macrophages and CD8+ cytotoxic T lymphocytes (CTLs) in the colon. Their treatment also decreased CD16/32+ macrophages in the spleen and mesenteric lymph nodes (MLN) of colitis mice. Amuc_1100 elevated PD-1+ CTLs in the spleen. Moreover, A. muciniphila and Amuc_1100 blunted tumourigenesis by expanding CTLs in the colon and MLN. Remarkably, they activated CTLs in the MLN, as indicated by TNF-α induction and PD-1downregulation. Amuc_1100 could stimulate and activate CTLs from splenocytes in CT26 cell conditioned medium. Conclusions: These data indicate that pasteurised A. muciniphila or Amuc_1100 can blunt colitis and CAC through the modulation of CTLs.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 目的：肠道菌群与炎症性肠病（IBD）和结直肠癌（CRC）有关。Akkermansiamuciniphila（A.muciniphila）是革兰氏阴性厌氧菌，在IBD患者的粪便菌群中选择性降低，但其在钝化结肠炎相关结直肠癌（CAC）中的致病作用和分子机制仍未定论。这项研究调查了A.muciniphila如何参与CAC中的免疫反应。设计：给小鼠给予右旋糖酐硫酸钠诱导结肠炎，然后用乙氧基甲烷建立经或不经巴氏杀菌的粘液曲霉或特定外膜蛋白（Amuc_1100）处理的CAC。收集小鼠和IBD或CRC患者的粪便用于16SrRNA测序。研究了黏液曲霉或Amuc_1100对急性结肠炎和CAC免疫反应的影响。结果：IBD患者和结肠炎或CAC小鼠的黏液曲霉明显减少。黏液曲霉或Amuc_1100可以改善结肠炎，减少结肠中浸润的巨噬细胞和CD8+细胞毒性T淋巴细胞（CTL）。他们的治疗还减少了结肠炎小鼠脾脏和肠系膜淋巴结（MLN）中的CD16/32+巨噬细胞。Amuc_1100脾脏中的PD-1+CTL升高。此外，黏液曲霉和Amuc_1100通过扩大结肠和MLN中的CTL抑制了肿瘤的发生。值得注意的是，它们激活了MLN中的CTL，如TNF-α诱导和PD-1下调所表明的。Amuc_1100可以刺激和激活CT26细胞条件培养基中脾细胞的CTL。结论：这些数据表明，巴氏消毒的黏液曲霉或Amuc_1100可以通过调节CTL来钝化结肠炎和CAC。</p>

<h2>Pubmed_ID: 32129694</h2>

<h3>MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE</h3>

<h3>肠道菌感染和细菌性肠病的微生物学研究</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1725220</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32129694/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Inflammatory bowel disease (IBD) is characterized by chronic intestinal inflammation that includes Crohn´s disease (CD) and ulcerative colitis (UC). Although the etiology is still unknown, some specific factors have been directly related to IBD, including genetic factors, abnormal intestinal immunity, and/or gut microbiota modifications. Recent findings highlight the primary role of the gut microbiota closely associated with a persistent inappropriate inflammatory response. This gut environment of dysbiosis in a susceptible IBD host can increasingly worsen and lead to colonization and infection with some opportunistic pathogens, especially Clostridium difficile. C. difficile is an intestinal pathogen considered the main cause of antibiotic-associated diarrhea and colitis and an important complication of IBD, which can trigger or worsen an IBD flare. Recent findings have highlighted the loss of bacterial cooperation in the gut ecosystem, as well as the pronounced intestinal dysbiosis, in patients suffering from IBD and concomitant C. difficile infection (CDI). The results of intestinal microbiota studies are still limited and often difficult to compare because of the variety of disease conditions. However, these data provide important clues regarding the main modifications and interrelations in the complicated gut ecosystem to better understand both diseases and to take advantage of the development of new therapeutic strategies. In this review, we analyze in depth the gut microbiota changes associated with both forms of IBD and CDI and their similarity with the dysbiosis that occurs in CDI. We also discuss the metabolic pathways that favor the proliferation or decrease in several important taxa directly related to the disease.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 炎症性肠病（IBD）的特征在于慢性肠道炎症，包括克罗恩病（CD）和溃疡性结肠炎（UC）。尽管病因尚不明确，但某些特定因素已与IBD直接相关，包括遗传因素，肠道免疫异常和/或肠道菌群改变。最近的发现突出了肠道微生物群与持续的不适当的炎症反应密切相关的主要作用。在易感的IBD宿主中，这种营养不良的肠道环境可能会日益恶化，并导致定居和感染某些机会性病原体，尤其是艰难梭菌。艰难梭菌是一种肠道病原体，被认为是与抗生素有关的腹泻和结肠炎的主要原因，也是IBD的重要并发症，可引发或加剧IBD发作。最近的发现凸显了患有IBD和伴随艰难梭菌感染（CDI）的患者肠道生态系统中细菌协作的丧失，以及明显的肠道营养不良。由于疾病状况的多样性，肠道菌群研究的结果仍然有限，并且通常难以比较。但是，这些数据提供了有关复杂肠道生态系统中主要修饰和相互关系的重要线索，以更好地了解两种疾病并利用新治疗策略的发展。在这篇综述中，我们深入分析了与IBD和CDI两种形式相关的肠道菌群变化，以及它们与CDI中发生的营养不良的相似性。我们还将讨论有利于与该疾病直接相关的几种重要分类单元的增殖或减少的代谢途径。</p>

<h2>Pubmed_ID: 32051205</h2>

<h3>Southern Chinese populations harbour non-nucleatum Fusobacteria possessing homologues of the colorectal cancer-associated FadA virulence factor</h3>

<h3>南方华人人群携带无结核梭菌，具有与大肠癌相关的FadA毒力因子的同源物</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1136/gutjnl-2019-319635</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32051205/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut   ||| Not finding IF</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 2020 Nov</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Objective: Fusobacteria are not common nor relatively abundant in non-colorectal cancer (CRC) populations, however, we identified multiple Fusobacterium taxa nearly absent in western and rural populations to be comparatively more prevalent and relatively abundant in southern Chinese populations. We investigated whether these represented known or novel lineages in the Fusobacterium genus, and assessed their genomes for features implicated in development of cancer. Methods: Prevalence and relative abundances of fusobacterial species were calculated from 3157 CRC and non-CRC gut metagenomes representing 16 populations from various biogeographies. Microbial genomes were assembled and compared with existing reference genomes to assess novel fusobacterial diversity. Phylogenetic distribution of virulence genes implicated in CRC was investigated. Results: Irrespective of CRC disease status, southern Chinese populations harboured increased prevalence (maximum 39% vs 7%) and relative abundances (average 0.4% vs 0.04% of gut community) of multiple recognised and novel fusobacterial taxa phylogenetically distinct from Fusobacterium nucleatum. Genomes assembled from southern Chinese gut metagenomes increased existing fusobacterial diversity by 14.3%. Homologues of the FadA adhesin linked to CRC were consistently detected in several monophyletic lineages sister to and inclusive of F. varium and F. ulcerans, but not F. mortiferum. We also detected increased prevalence and relative abundances of F. varium in CRC compared with non-CRC cohorts, which together with distribution of FadA homologues supports a possible association with gut disease. Conclusion: The proportion of fusobacteria in guts of southern Chinese populations are higher compared with several western and rural populations in line with the notion of environment/biogeography driving human gut microbiome composition. Several non-nucleatum taxa possess FadA homologues and were enriched in CRC cohorts; whether this imposes a risk in developing CRC and other gut diseases deserves further investigation.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 目的：在非结直肠癌（CRC）人群中，梭菌并不常见，也相对不丰富，但是，我们发现在西部和农村人群中几乎不存在的多个梭菌分类群在中国南方人群中相对更普遍并且相对丰富。我们研究了这些基因代表了Fusobacter属中的已知谱系还是新颖谱系，并评估了它们的基因组是否涉及癌症的发展。方法：从代表不同生物地理学的16个种群的3157个CRC和非CRC肠道元基因组中，计算出了梭菌的患病率和相对丰度。组装微生物基因组，并将其与现有的参考基因组进行比较，以评估新型的梭菌多样性。研究了涉及CRC的毒力基因的系统发生分布。结果：与CRC疾病状况无关，华南人群在系统发育上不同于核梭形杆菌的流行病菌数量最多（最大39％vs7％），相对丰度（平均肠道菌群平均0.4％vs0.04％）在系统发育上与众不同。由中国南方肠道元基因组组装而成的基因组使现有的梭菌多样性增加了14.3％。在与F.varium和F.ulcerans包括但不包括F.mortiferum的多个单系谱系中，始终检测到与CRC相关的FadA粘附素的同源物。与非CRC人群相比，我们还检测到CRC中F.varium的患病率和相对丰度增加，这与FadA同源物的分布一起可能与肠道疾病有关。结论：与环境/生物地理学驱动人类肠道微生物组组成的观念相一致，中国南方人群肠道中的梭菌细菌比例高于西方和农村人群。几种非核类群具有FadA同源物，并在CRC人群中富集。这是否对发展为CRC和其他肠道疾病具有风险，值得进一步研究。</p>

<h2>Pubmed_ID: 32041744</h2>

<h3>Discovery of the gut microbial signature driving the efficacy of prebiotic intervention in obese patients</h3>

<h3>肠道微生物特征的发现推动了肥胖患者益生元干预的功效</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1136/gutjnl-2019-319726</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/32041744/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut   ||| Not finding IF</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 2020 Nov</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Objective: The gut microbiota has been proposed as an interesting therapeutic target for metabolic disorders. Inulin as a prebiotic has been shown to lessen obesity and related diseases. The aim of the current study was to investigate whether preintervention gut microbiota characteristics determine the physiological response to inulin. Design: The stools from four obese donors differing by microbial diversity and composition were sampled before the dietary intervention and inoculated to antibiotic-pretreated mice (hum-ob mice; humanised obese mice). Hum-ob mice were fed with a high-fat diet and treated with inulin. Metabolic and microbiota changes on inulin treatment in hum-ob mice were compared with those obtained in a cohort of obese individuals supplemented with inulin for 3 months. Results: We show that hum-ob mice colonised with the faecal microbiota from different obese individuals differentially respond to inulin supplementation on a high-fat diet. Among several bacterial genera, Barnesiella, Bilophila, Butyricimonas, Victivallis, Clostridium XIVa, Akkermansia, Raoultella and Blautia correlated with the observed metabolic outcomes (decrease in adiposity and hepatic steatosis) in hum-ob mice. In addition, in obese individuals, the preintervention levels of Anaerostipes, Akkermansia and Butyricicoccus drive the decrease of body mass index in response to inulin. Conclusion: These findings support that characterising the gut microbiota prior to nutritional intervention with prebiotics is important to increase the positive outcome in the context of obesity and metabolic disorders.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 目的：肠道菌群已被提出作为代谢紊乱的有趣治疗靶标。菊粉作为益生元已被证明可以减轻肥胖症和相关疾病。本研究的目的是调查干预前肠道菌群的特征是否决定了对菊粉的生理反应。设计：在饮食干预之前，对来自四个肥胖供体的粪便进行了取样，这些粪便的微生物多样性和组成各不相同，然后将它们接种到抗生素预处理的小鼠中（hum-ob小鼠；人源化的肥胖小鼠）。喂Hum-ob小鼠高脂饮食并用菊粉治疗。比较了在hum-ob小鼠中菊粉治疗后代谢和微生物群的变化，与在补充了菊粉3个月的肥胖个体队列中获得的变化。结果：我们显示，定植于不同肥胖个体粪便微生物群的hum-ob小鼠对高脂饮食中的菊粉补充有不同的反应。在几个细菌属中，Barnesiella，Bilophila，Butyricimonas，Victivallis，XIVa梭状芽胞杆菌，Akkermansia，Raoultella和Blautia与在hum-ob小鼠中观察到的代谢结局（脂肪减少和肝脂肪变性）相关。另外，在肥胖个体中，厌氧菌，阿克曼病和丁球菌的干预前水平促使对菊粉的体重指数下降。结论：这些发现支持在使用益生元进行营养干预之前表征肠道菌群对于增加肥胖和代谢紊乱的积极结果非常重要。</p>

<h2>Pubmed_ID: 31983316</h2>

<h3>Dietary restriction increases protective gut bacteria to rescue lethal methotrexate-induced intestinal toxicity</h3>

<h3>饮食限制增加肠道保护性细菌以拯救甲氨蝶呤致死的肠道毒性</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2020.1714401</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/31983316/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Methotrexate (MTX) is a typical chemotherapeutic drug that is widely used in the treatment of various malignant diseases as well as autoimmune diseases, with gastrointestinal toxicity being its most prominent complication which could have a significant effect on the prognosis of patients. Yet effective ways to alleviate such complications remains to be explored. Here we show that 30% dietary restriction (DR) for 2 weeks dramatically increased the survival rate of 2-month-old female mice after lethal-dose MTX exposure. DR significantly reduced intestinal inflammation, preserved the number of basal crypt PCNA-positive cells, and protected the function of intestinal stem cells (ISCs) after MTX treatment. Furthermore, ablating intestinal microbiota by broad-spectrum antibiotics completely eliminated the protective effect achieved by DR. 16S rRNA gene deep-sequencing analysis revealed that short-term DR significantly increased the Lactobacillus genus, with Lactobacillus rhamnosus GG gavage partially mimicking the rescue effect of DR on the intestines of ad libitum fed mice exposed to lethal-dose MTX. Together, the current study reveals that DR could be a highly effective way to alleviate the lethal injury in the intestine after high-dose MTX treatment, which is functionally mediated by increasing the protective intestinal microbiota taxa in mice. Keywords: Dietary restriction, Methotrexate, Gut microbiota, Intestinal stem cells, intestinal toxicity.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 甲氨蝶呤（MTX）是一种典型的化学治疗药物，广泛用于治疗各种恶性疾病以及自身免疫性疾病，其中胃肠道毒性是其最突出的并发症，可能对患者的预后产生重大影响。然而，减轻这种并发症的有效方法仍有待探索。在这里，我们显示了30％的饮食限制（DR）2周可显着提高致死剂量MTX暴露后2个月大的雌性小鼠的存活率。DR显着减少肠道炎症，保留了基底隐窝PCNA阳性细胞的数量，并在MTX治疗后保护了肠道干细胞（ISC）的功能。此外，用广谱抗生素消融肠道菌群完全消除了DR的保护作用。16SrRNA基因深度测序分析显示，短期DR显着增加了乳杆菌属，鼠李糖乳杆菌GG灌胃部分模拟了DR对暴露于致死剂量MTX的随意喂养小鼠肠道的拯救作用。总之，当前的研究表明，DR可能是减轻大剂量MTX治疗后肠道致死性损伤的一种有效方法，该作用在功能上是通过增加小鼠的保护性肠道菌群来介导的。关键词：饮食限制，甲氨蝶呤，肠道菌群，肠干细胞，肠毒性。</p>

<h2>Pubmed_ID: 31983281</h2>

<h3>Effect of wheat bran derived prebiotic supplementation on gastrointestinal transit, gut microbiota, and metabolic health: a randomized controlled trial in healthy adults with a slow gut transit</h3>

<h3>麦麸来源的益生元补充剂对胃肠道转运，肠道菌群和代谢健康的影响：在肠道缓慢转运的健康成年人中的随机对照试验</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2019.1704141</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/31983281/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Acute intake of the wheat bran extract Arabinoxylan-Oligosaccharide (AXOS) modulates the gut microbiota, improves stool characteristics and postprandial glycemia in healthy humans. Yet, little is known on how long-term AXOS intake influences gastrointestinal (GI) functioning, gut microbiota, and metabolic health. In this randomized, placebo-controlled, double-blind study, we evaluated the effects of AXOS intake on GI function and metabolic health in adults with slow GI transit without constipation. Forty-eight normoglycemic adults were included with whole-gut transit time (WGTT) of >35 h receiving either 15 g/day AXOS or placebo (maltodextrin) for 12-wks. The primary outcome was WGTT, and secondary outcomes included stool parameters, gut permeability, short-chain fatty acids (SCFA), microbiota composition, energy expenditure, substrate oxidation, glucose, insulin, lipids, gut hormones, and adipose tissue (AT) function. WGTT was unchanged, but stool consistency softened after AXOS. 12-wks of AXOS intake significantly changed the microbiota by increasing Bifidobacterium and decreasing microbial alpha-diversity. With a good classification accuracy, overall microbiota composition classified responders with decreased WGTT after AXOS. The incretin hormone Glucagon-like protein 1 was reduced after AXOS compared to placebo. Energy expenditure, plasma metabolites, AT parameters, SCFA, and gut permeability were unchanged. In conclusion, intake of wheat bran extract increases fecal Bifidobacterium and softens stool consistency without major effects on energy metabolism in healthy humans with a slow GI transit. We show that overall gut microbiota classified responders with decreased WGTT after AXOS highlighting that GI transit and change thereof were associated with gut microbiota independent of Bifidobacterium. NCT02491125.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 麦麸提取物阿拉伯木聚糖寡糖（AXOS）的急性摄入可调节健康人的肠道菌群，改善粪便特性和餐后血糖。然而，关于AXOS的长期摄入如何影响胃肠（GI）功能，肠道菌群和代谢健康的知之甚少。在这项随机，安慰剂对照，双盲研究中，我们评估了AXOS摄入量对没有便秘的缓慢GI转运的成年人的GI功能和代谢健康的影响。包括48名正常血糖成年人，其全肠运输时间（WGTT）>35小时，接受15g/天的AXOS或安慰剂（麦芽糊精）治疗12周。主要结果是WGTT，次要结果包括粪便参数，肠道通透性，短链脂肪酸（SCFA），微生物群组成，能量消耗，底物氧化，葡萄糖，胰岛素，脂质，肠道激素和脂肪组织（AT）功能。WGTT不变，但AXOS后大便稠度减弱。摄入12周的AXOS可通过增加双歧杆菌和减少微生物的α多样性来显着改变微生物群。凭借良好的分类准确性，整体微生物群组成对AXOS后WGTT降低的应答者进行了分类。与安慰剂相比，AXOS后肠降血糖素激素胰高血糖素样蛋白1减少。能量消耗，血浆代谢物，AT参数，SCFA和肠通透性均未改变。总之，摄入小麦麸皮提取物可增加粪便中的双歧杆菌并软化粪便的稠度，而对胃肠道转运缓慢的健康人的能量代谢没有重大影响。我们显示了AXOS后WGTT降低的整体肠道菌群分类响应者，突出显示了胃肠道转运及其变化与独立于双歧杆菌的肠道菌群相关。NCT02491125。</p>

<h2>Pubmed_ID: 31942825</h2>

<h3>Systematic review of human gut resistome studies revealed variable definitions and approaches</h3>

<h3>对人体肠道抵抗组研究的系统评价揭示了可变的定义和方法</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2019.1700755</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/31942825/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: In this review, we highlight the variations of gut resistome studies, which may preclude comparisons and translational interpretations. Of 22 included studies, a range of 12 to 2000 antibiotic resistance (AR) genes were profiled. Overall, studies defined a healthy gut resistome as subjects who had not taken antibiotics in the last three to 12 months prior to sampling. In studies with de novo assembly, AR genes were identified based on variable nucleotide or amino acid sequence similarities. Different marker genes were used for defining resistance to a given antibiotic class. Validation of phenotypic resistance in the laboratory is frequently lacking. Cryptic resistance, collateral sensitivity and the interaction with repressors or promotors were not investigated. International consensus is needed for selecting marker genes to define resistance to a given antibiotic class in addition to uniformity in phenotypic validation and bioinformatics pipelines.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 在这篇综述中，我们重点介绍了肠道抵抗组研究的各种变化，这些变化可能排除了比较和翻译解释的可能性。在22项纳入研究中，分析了12到2000种抗生素抗性（AR）基因。总体而言，研究将健康的肠道抵抗组定义为在采样前的最后3至12个月内未服用抗生素的受试者。在从头组装的研究中，AR基因是根据可变的核苷酸或氨基酸序列相似性鉴定的。使用不同的标记基因来定义对给定抗生素类别的抗性。经常缺乏实验室对表型耐药性的验证。没有研究隐窝抵抗力，附带敏感性以及与阻遏物或启动子的相互作用。除了表型验证和生物信息学流程的一致性外，还需要国际共识来选择标记基因来定义对给定抗生素类别的抗药性。</p>

<h2>Pubmed_ID: 31924126</h2>

<h3>Gut microbiota profiles in critically ill patients, potential biomarkers and risk variables for sepsis</h3>

<h3>重症患者肠道菌群谱，潜在生物标志物和败血症风险变量</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2019.1707610</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/31924126/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Critically ill patients are physiologically unstable and recent studies indicate that the intestinal microbiota could be involved in the health decline of such patients during ICU stays. This study aims to assess the intestinal microbiota in critically ill patients with and without sepsis and to determine its impact on outcome variables, such as medical complications, ICU stay time, and mortality. A multi-center study was conducted with a total of 250 peri-rectal swabs obtained from 155 patients upon admission and during ICU stays. Intestinal microbiota was assessed by sequencing the V3-V4 hypervariable regions of the 16S rRNA gene. Linear mixed models were used to integrate microbiota data with more than 40 clinical and demographic variables to detect covariates and minimize the effect of confounding factors. We found that the microbiota of ICU patients with sepsis has an increased abundance of microbes tightly associated with inflammation, such as Parabacteroides, Fusobacterium and Bilophila species. Female sex and aging would represent an increased risk for sepsis possibly because of some of their microbiota features. We also evidenced a remarkable loss of microbial diversity, during the ICU stay. Concomitantly, we detected that the abundance of pathogenic species, such as Enterococcus spp., was differentially increased in sepsis patients who died, indicating these species as potential biomarkers for monitoring during ICU stay. We concluded that particular intestinal microbiota signatures could predict sepsis development in ICU patients. We propose potential biomarkers for evaluation in the clinical management of ICU patients.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 重症患者的生理状况不稳定，最近的研究表明，在ICU住院期间，肠道菌群可能与此类患者的健康下降有关。这项研究旨在评估患有或不患有败血症的危重患者的肠道菌群，并确定其对结果变量的影响，例如医疗并发症，ICU停留时间和死亡率。一项多中心研究对入院时和重症监护病房住院期间从155名患者中获得的共250颗直肠周拭子进行了研究。通过对16SrRNA基因的V3-V4高变区进行测序来评估肠道菌群。线性混合模型用于将微生物群数据与40多个临床和人口统计学变量整合在一起，以检测协变量并最小化混杂因素的影响。我们发现，ICU败血症患者的微生物群具有与炎症紧密相关的大量微生物，如副细菌，梭菌和嗜酸性菌。性别和衰老可能由于某些微生物群特征而导致败血症的风险增加。在ICU停留期间，我们还证明了微生物多样性的显着丧失。同时，我们检测到死亡的败血症患者中病原菌种类（如肠球菌）的丰度有所增加，表明这些菌种可作为在ICU住院期间进行监测的潜在生物标记。我们得出结论，特定的肠道菌群特征可以预测ICU患者的脓毒症发展。我们提出潜在的生物标志物，以评估ICU患者的临床管理。</p>

<h2>Pubmed_ID: 31760871</h2>

<h3>Triclocarban exposure exaggerates colitis and colon tumorigenesis: roles of gut microbiota involved</h3>

<h3>三氯卡班暴露会加剧结肠炎和结肠肿瘤的发生：肠道菌群的作用</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2019.1690364</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/31760871/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Triclocarban (TCC) is a widely used antimicrobial ingredient in consumer products and is a ubiquitous contaminant in the environment. In 2016, the FDA removed TCC from over-the-counter handwashing products, but this compound is still approved for use in many other personal care products. A better understanding of its impact on human health could lead to significant impact for public health and regulatory policies. Here we show that exposure to low-dose TCC exaggerated the severity of colitis and exacerbated the development of colitis-associated colon tumorigenesis, via gut microbiota-dependent mechanisms. Exposure to TCC increased dextran sodium sulfate (DSS)- and interleukin 10 (IL-10) knockout-induced colitis, and exaggerated azoxymethane (AOM)/DSS-induced colon tumorigenesis in mice. Regarding the mechanisms, TCC exposure reduced the diversity and altered the composition of gut microbiota and failed to promote DSS-induced colitis in mice lacking the microbiota, supporting that the presence of the microbiota is critical for the pro-colitis effects of TCC. Together, these results support TCC could be a novel risk factor for colitis and colitis-associated colon cancer, and further regulatory policies on this compound could be needed.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 三氯卡班（TCC）是消费品中广泛使用的抗菌成分，并且是环境中普遍存在的污染物。2016年，FDA从非处方洗手产品中删除了TCC，但该化合物仍被批准用于许多其他个人护理产品中。更好地了解其对人类健康的影响可能会对公共卫生和监管政策产生重大影响。在这里，我们显示，通过肠道菌群依赖性机制，低剂量TCC暴露会加剧结肠炎的严重性，并加剧结肠炎相关结肠肿瘤发生的发展。暴露于TCC会增加小鼠右旋糖酐硫酸钠（DSS）和白介素10（IL-10）的敲除诱导的结肠炎，并加剧乙氧基甲烷（AOM）/DSS诱导的结肠肿瘤发生。关于机制，TCC暴露降低了缺乏微生物群的小鼠中肠道微生物群的多样性并改变了肠道微生物群的组成，并且未能促进DSS诱导的结肠炎，这表明微生物群的存在对于TCC的结肠炎前效应至关重要。总之，这些结果支持TCC可能是结肠炎和与结肠炎相关的结肠癌的一种新的危险因素，因此可能需要对该化合物进一步的监管政策。</p>

<h2>Pubmed_ID: 31684806</h2>

<h3>Origins of human milk microbiota: new evidence and arising questions</h3>

<h3>人乳微生物群的起源：新证据和新出现的问题</h3>

<p style="margin:20px"> <font face="arial"> <b>DOI: 10.1080/19490976.2019.1667722</b> </font> </P>

<p style="margin:20px"> <font face="arial" <b>URL: https://pubmed.ncbi.nlm.nih.gov/31684806/</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b>Journal: Gut microbes  {'ISSN': '1949-0976', 'Name': 'gut microbes', '2015': '0', '2016': '0', '2017': '0', '2018': '7.823', '2019': '7.74'}</b> </font> </P>

<p style="margin:20px"> <font face="arial" color="blue"> <b> Date: 11/09/2020</b> </font> </p>

<p style="line-height:1.8;margin:20px"> Abstract: Human milk contains a diverse community of bacteria. The growing appreciation of commensal microbes and increasing availability of high-throughput technology has set the stage for a theory-driven approach to the study of milk microbiota, and translation of this knowledge to improve maternal and child health. We recently profiled the milk microbiota of healthy Canadian mothers and applied theory-driven causal modeling, finding that mode of breast milk feeding (nursing directly at the breast vs. pumping and feeding breast milk from a bottle) was significantly associated with milk microbiota composition. This observation could reflect an increased exposure to pumps and/or a decreased exposure to the infant mouth. Either way, it provides evidence for the retrograde mechanism of milk inoculation. Here, we discuss the implications of this research and related controversies, and raise new questions about the origins and function of milk bacteria.</p>

<p style="line-height:1.8;margin:20px"> 摘要: 母乳含有多种多样的细菌。对共生微生物的日益了解和高通量技术的日益普及，为理论驱动方法研究牛奶微生物群以及转化知识以改善母婴健康奠定了基础。我们最近对健康的加拿大母亲的牛奶菌群进行了分析，并应用了理论驱动的因果模型，发现母乳喂养方式（直接在母乳喂养与从瓶中泵送和喂养母乳）与菌群组成显着相关。该观察结果可能反映出增加了对泵的暴露和/或减少了对婴儿口的暴露。无论哪种方式，它都为牛奶接种的逆行机制提供了证据。在这里，我们讨论了这项研究的意义和相关争议，并对牛奶细菌的起源和功能提出了新的问题。</p>

</body>
</html>

